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Abstract(Allergic( asthma( is( a( type( I( hypersensitivity( reaction,( mediated( by( IgE.( Severe(asthma(is(inadequately(treated(with(existing(medicines.(A(greater(understanding(of(IgE(structure(and(function,(and(how(it(relates(to(its(receptors,(FcεRI(and(CD23,(is( required( to( improve( therapeutic( intervention.( An( evolutionary( approach( has(been(used(to(further(this(understanding,(with(the(investigation(of(three(proteins(that( are( evolutionarily( related( to( human( IgE:( platypus( IgE,( chicken( IgY( and(human(IgM.(The(sequences(of(these(proteins(were(compared(and(constructs(were(designed( that( contained( different( fragments( of( the( constant( regions( of( these(antibodies.( A( (His)6Ztag( was( attached( to( the( CZterminus( of( IgMZFc,( Fcµ3Z4((fragment(containing(only(CH3Z4(domains),(IgYZFc,(and(platypus(IgEZFc,(and(these(were( successfully( purified( using( two( different( methods:( one( using( affinity(columns(specific(to(the(protein(and(the(other(method(using(a(nickel(NTA(column(and( size( exclusion( chromatography.(The(proteins(were( then( checked(using(SDS(PAGE( analysis( and( Mass( Spectrometry.( The( proteins( were( successfully(crystallized(and(significant( steps( taken( to( improve( the(diffraction(quality(of( the(crystals.( A( crystal( structure( of( human( Fcε3Z4( was( determined( at( the( highest(resolution( seen( to( date( and( a( more( extensive( carbohydrate( structure( was(observed.(A(detailed(analysis(of(the(flexibility(of(the(Cε3(was(performed(using(BZfactors( and( a( new( method( for( comparing( the( quaternary( structure( of( IgE( is(proposed(and(comparison(made(with(all(previously(determined(free(and(receptor(bound(structures.(The(thermal(stability(of(the(antibody(structures(was(measured(using( Differential( Scanning( Fluorimetry( to( identify( different( unfolding(characteristics( for( the( Cε2( and( Cε3( domains.( Substantial( progress( towards( the(structure(determination(of(IgMZFc,(which(crystallised(as(a(hexamer,(is(reported.(( (
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Chapter(1 INTRODUCTION(1.1 Asthma(Asthma( is( a( disease( that( affects( 5.4( million( people( in( the( UK( and( can( present(severely((Wenzel(and(Busse,(2007),(or(in(a(more(mild(form((Zeiger(et#al.,(2005).(Mild( asthma( can,( in( most( cases,( be( treated( with( localised( or( systemic(corticosteroids.( These( dampen( the( sufferer’s( immune( response,( and( reduce(symptoms.(However,( a( small(number(of( severe(patients(do(not( respond(well( to(this( treatment( (Wenzel(and(Busse,(2007).(Although(a( low(proportion(of(asthma(sufferers( are( considered( severe,( around( 10%,( this( group( is( the( least( well(understood(and(has(the(highest(mortality(rate,(with(3(deaths(in(the(UK(attributed(to( asthma( every( day.( Understanding( the(mechanisms( of( asthma( in( detail( could(lead( to( novel( treatments( that( would( benefit( severe( asthmatics( primarily,( but(could( also( be( adapted( for( use( with( other( severe( allergies( (Wenzel( and( Busse,(2007).((Allergic(asthma(is(a(type(I(hypersensitivity(reaction(mediated(by(immunoglobulin(E,(IgE((Gould(and(Sutton,(2008).(Atopic(asthma(is(characterised(by(the(presence(of(serum(IgE(specific(for(allergens(in(the(environment((Takhar(et#al.,(2007).(IgE(is(part(of(a(protein(network(that(includes(its(high(affinity(receptor,(FcεRI,(expressed(on(mast(cells,(basophils(and(antigen(presenting(cells((APCs),(and(a(lower(affinity(receptor,(CD23,(expressed(on(BZcells.(One(key( factor( in( this(allergic( response( is(the(high(affinity(with(which(IgE(binds(to(FcεRI,(and(that(it(does(so(in(the(absence(of( an( allergen( (Gould( and( Sutton,( 2008).( The( halfZlife( of( this( interaction( is(approximately(2(weeks(and( is(due(to(an(extremely(slow(dissociation(rate(of( IgE(from( FcεRI,( compared( with( IgG( from( FcγRIII,( which( has( a( halfZlife( of( a( few(
INTRODUCTION((((Chapter(1(
(( 22(
minutes.(This(enables(vast(numbers(of(mast(cells(to(be(primed(and(sensitised,(so(that(when(allergen(enters(the(system(a(rapid,(potent(response(is(created.((IgE( has( evolved( to( target( parasitic( infection( (Capron( et#al.,( 1975)( therefore( the(strength(of(this(response(may(serve(to(allow(parasites,(which(are(unusually(large(pathogens,( to( be( eliminated( effectively.( Understanding( the( interaction( between(IgE( and( its( highZaffinity( receptor,( using( structural( studies,( may( allow( this(interaction( to( be( blocked,( providing( a( more( targeted( treatment( for( allergic(patients.(This(has(already(been(attempted(with(a(humanised(monoclonal(antiZIgE(antibody,(omalizumab((Xolair®),(which(is(on(the(market(for(moderate(to(severe(asthma.(It(works(by(preventing(the(binding(of(IgE(to(FcεRI(on(mast(cells.(It(is(an(effective( treatment,( reducing(both( the(need( for( inhaled( corticosteroids,( and( the(incidence(of(hospitalisation(of(patients.(However,( it(has(a(high(cost(and(must(be(administered(with(a(physician(present,(as(there(is(risk(of(anaphylaxis((Davydov,(2005).(
1.2 Human(IgE(and(its(receptors(
1.2.1 Domain#structure#The(structure(of(IgE(is(similar(to(that(of(Immunoglobulin(G,(IgG((Figure(1.1).(IgE(consists(of(two(identical(heavy(chains,(comprised(of(one(variable(domain,(VH,(and(four(constant(domains(Cε1,(Cε2,(Cε3(and(Cε4,(as(well(as(two(identical(light(chains(comprised(of(a(variable,(VL(and(constant,(CL(domain.( IgG(has(a( flexible( linker( in(place(of( the(Cε2(domain(of( IgE,(with(Cγ2(and(Cγ3(being(homologous( to(Cε3(and(Cε4(respectively.(The(Fab((fragment(antigen(binding)(region(of( IgE(contains( the(antigenZbinding( region( and( consists( of( the( VH,( VL,( Cɛ1( and( CL( domains.( The( Fc(
INTRODUCTION((((Chapter(1(
(( 23(
region( (Fragment( crystallisable),( which( contains( the( receptor( binding( sites,(consists(of(the(disulphideZlinked(dimer(of(the(Cɛ2,(Cɛ3(and(Cɛ4(domains((IgEZFc(or( Fcε2Z4).( Another( fragment( that( can( be(made( is( the( Fcɛ3Z4( fragment,( which(consists(of(the(disulphideZlinked(dimer(of(just(the(Cɛ3(and(Cɛ4(domains.(((
(
Figure#1.1#Domain#structure#of#IgE#A(representation(of(IgE(and(IgG,(showing(sites(of(disulphide(linkages((black(lines(and( ‘SS’)( and( the( NZlinked( glycosylation( (black( hexagons).( The( disulphide(linkages(and(the(NZlinked(glycosylation(sites(are(present(on(both(chains.(Adapted(from(Gould(&(Sutton(2008((
































2000).( Although( the( Cε2( domains( are( not( directly( involved( in( binding,( they(contribute(to(this(slow(offZrate(since(the(Fcε3Z4(fragment,(lacking(these(domains,(has(a(somewhat(faster(offZrate((koff((=(3.2(x(10Z3sZ1)((McDonnell(et#al.,(2001).((The(overall( affinities( of( IgEZFc( and( Fcε3Z4( for( FcεRI( are,( however,( comparable( and(both(are(high((Ka(≈(1010(MZ1).((The(CD23(binding(site(lies(between(the(Cε3(and(Cε4(domains,(but( is(dominated(by(contacts(with(Cε3;( the(affinity(of(both( IgEZFc(and(Fcε3Z4(for(CD23(is(lower((Ka(≈(107(MZ1),(with(one(binding(site(in(each(chain.((The(Cε3(domain(is(thus(the(critical(domain(for(receptor(binding.(((
1.2.3 Cε3#domains#The( Cε3( domains,( when( expressed( in( isolation,( are( disordered,( with( no(recognisable(secondary(structure,(as(shown(by(far(UV(circular(dichroism((CD),(or(hydrophobic(core,(as(shown(by(near(UV(CD((Henry(et#al.,(2000;(Borthakur(et#al.,(2011).(This(pair(of(domains(is(known(to(be(sufficient(for(binding(of(FcεRI,(albeit(with(a(lower(affinity(than(that(of(IgEZFc(or(IgE((Henry(et#al.,(2000).(It(is(also(the(domain( to( which( NZlinked( carbohydrate( is( attached,( at( a( site( (Asn394)( that( is(conserved(across(other(immunoglobulin(classes;(in(IgE(the(glycosylation(is(of(the(highZmannose(type((Arnold(et#al.,(2004).(((
1.2.4 Crystal#structures#There( are( several( crystal( structures( of( both( Fcε2Z4( and( Fcε3Z4( alone( and( in(complex(with( soluble( IgEZbinding( extracellular(domains(of( FcεRI( (sFcεRIα)( and(CD23((sCD23).(((
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In( July( 2000,( the( first( crystal( structure( of( IgE(was(published.( It(was( that( of( the(human( Fcε3Z4ZsFcεRIα( complex( (1F6A),( which( was( determined( to( 3.5Å(resolution((Garman(et#al.,(2000)(Figure(1.2).(The(crystal(structure(revealed(that(one(sFcεRIα(binds(to(one(Fcε3Z4(molecule,(through(interaction(at(two(sites.(Both(of( these( interaction(sites(are( found(on(the(Cε3(domains,(one(on(each(chain,(and(binding(of(one(receptor(precludes(binding(of(a(second.(((
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this( crystal( structure( revealed( that( the( Cε2( domains,( which( replace( the( hinge(region( of( IgG,( were( asymmetrically( folded( back( on( the( Cε3( and( Cε4( domains,(leading(to(an(acute(bend(in(the(molecule.(Previous(work(had(suggested(that(IgE(was( bent( in( solution,( but( the( extent( of( the( bend( was( unanticipated.( This(unanticipated(confirmation( led(to(speculation(that(this( feature(may(be(the(basis(for(the(remarkably(slow(dissociation(rate(of(the(Fcε2Z4ZFcεRI(complex.(((
(
Figure# 1.4# Apo# Fcε214# crystal# structure# and# extended,# fab# bound,# Fcε214#




‘open’(or(‘closed’(and(‘swing’.(The(crystal(structures,(along(with(the(all(previously(determined( crystal( structures( of( IgE,( were( analysed( and( revealed( that( the( apo(Fcε3Z4(structures(and(the(Fcε2Z4(structure(were(all(more(‘closed’(than(the(Fcε3Z4ZFcεRI(complex.((
(
Figure#1.5#Calcium#free#CD23#bound#to#Fcε314##Crystal( structure( of( Fcɛ3Z4( bound( to( 2( Der( CD23( fragments.( Der( CD23( is( the( cleavage(product(of(CD23(produced(by(Der(P1(protease( from(Dermatophagoides#pteronyssinus.(2(Fcε3Z4(chains(and(2(CD23(chains((displayed)(coloured;(Fcε3Z4(chain(A(–(red,(Fcε3Z4(chain(B( Z( green,( CD23( chain( A( –( light( blue( and( CD23( chain( B( dark( blue.( PDB( code( is( 4EZM((Dhaliwal(et#al.,(2012).((In( May( 2011,( the( Fcε2Z4ZsFcεRIα( complex( was( published,( determined( to( 3.4Å(resolution,( 2Y7Q,( along( with( a( higher( resolution( structure( of( apo( Fcε2Z4(determined( to(1.9Å( resolution,(2WQR( (Holdom(et#al.,#2011),( (Figure(1.2,( Figure(1.4).(The( complex( revealed,( unexpectedly,( that( receptor(binding( causes( the(Cε2(domains( to( bend( back( on( the( Cε3( and( Cε4( domains( even( more( acutely.( The(authors(performed(thermodynamic(analysis,(which(indicated(that(this(interaction(is(entropically(driven.(This(provided(an(explanation(as( to(why( the(Cε2(domains(have( such( a( dramatic( effect( on( receptor( binding,( despite( not( contacting( the(receptor(at(all.(
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(In(April(2012(the(structure(of(Fcε3Z4(bound(to(calciumZfree(sCD23(was(published((4EZM)( (Dhaliwal( et# al.,( 2012)( (Figure( 1.5).( This( structure( revealed( that( two(sCD23(domains(bind(to(the(Fcε3Z4,(which(confirmed(the(already(determined(2:1(stoichiometry.( The(binding( site( is( located( at( the( interface(between( the(Cε3( and(Cε4(domains,(and( is(distant( from(the(FcεRI(binding(site((Figure(1.5,(Figure(1.2).(The(binding(of(the(two(receptors(is(mutually(exclusive,(and(allosterically(linked,(allowing(IgE(to(function(independently(through(its(two(receptors.(((In( December( 2012( the( structure( of( Fcε3Z4( bound( to( an( engineered( protein(inhibitor,(DARPin(E2_79((Designed(Ankyrin(Repeat(Protein)(was(published((Kim(

















from#Wurzburg#and#Jardetzky#2009)#(a)(A(schematic(showing(how(the(openZclosed((side)(and(swing((top)(motions(of(the(IgEZFc(subunits(are(measured.(The(vertical(openZtoZclosed(distance(is(measured(from(the(Cα(of(residue(394(of(one(chain(to(the(Cα(of(residue(497(of(the(other(chain(in(the(dimer(pair((X394ZX497).(The(horizontal(swing(distance(is(measured(between(the(Cαs(of(residue(336(in(each(dimer((X336ZY336).((b)(A(plot(of(the(swing(vs.(the(open/closed(motion(of(the(IgE(chains.( All( distances( are( given( in( Å.( Chain( conformation( is( indicated( by( colour:( open((yellow),( intermediate( (pink),( closedZb( (green)( and( closedZa( (blue).( Grey( vertical( lines(indicate(members(of(the(dimer(pair(except(for(FCA(and(CE,(which(are(symmetric(dimers.(Subunits( from( the( different( crystals( are( named( by( their( crystal( form( and( their( chain(letter.( Subunits( from( crystal( forms(published( by(Wurzburg( and( Jardetzky( in( the( paper(include(CA,(CB,(and(CE(chains((C2),(PA,(PB,(PC(and(PD(chains((P21)(and(PBA,(PBB,(PBC,(PBD,(PBE(and(PBF(chains((P21(‘big’).(Previously(published(crystal(structures(include(the(closed(Fc((FCA),( the(Fc(bound(to( the(soluble(FcεRI(alpha(chain((FCB(and(FCD),(and( the(intact(Fc2Z4(structure(closed((24C)(and(open((24O)(chains((In(these(structures,(the(Cε3(domains(move(apart(into(an(“open”(conformation,(to(accommodate( FcεRI( binding( between( them,( compared( with( the( uncomplexed(fragments.( The( Fcε3Z4( domains( are( all( ‘closed’( and( the( Fcε2Z4( has( one( domain(defined(as(‘closed’(and(one(domain(defined(as(‘intermediate’.((
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Subsequently( to(Wurzburg(and( Jardetzky’s(analysis( the(structure(of( the(Fcε3Z4ZsCD23( was( determined.( Binding( of( sCD23( causes( the( Cε3( domains( to( adopt( a(more( ‘closed’( conformation,( and( in( this( way( the( binding( of( the( two( receptors,(whilst( occurring( at( distant( sites( at( either( end( of( the( Cε3( domains,( is( mutually(exclusive((Dhaliwal(et#al.,(2012);(Borthakur(et#al.,(2012).(((




Figure# 1.9# Thermal# unfolding# of# IgE# taken# from# Dorrington# and# Bennich,#





1.3.1 Comparative#immunology#Currently( much( effort( is( being( devoted( to( understanding( IgE( and( its( network(using( human( exZvivo( tissue( and( mouse( models.( However,( historically,( many(important( advances( in( immunology( have( been( gained( through( comparative(immunology,( which( examines( the( development( of( the( immune( system( during(evolution.(For(example,(observing(phagocytosis(in(starfish(and(sea(urchins(aided(the(understanding(of(self(versus(nonZself(recognition((Litman(and(Cooper,(2007).(Separate( cellular( and( humoral( immune( functions,( in( T( and( BZlymphocytes(respectively,( were( first( observed( from( studies( of( birds.( The( fact( that( antibody(repertoires( are( derived( from( gene( recombination(was( first( shown( in( chickens,(and(a(greater(understanding(of(TollZlike(receptors(was(gained(through(studying(insect( responses( to( pathogens( (Litman( and( Cooper,( 2007).( A( better(understanding(of(some(key(evolutionarily(related(proteins(may(therefore(provide(insight( into( the( structure( of( IgE( from( this( alternative( perspective,( and( identify(new(target(sites(for(therapeutic(intervention.(((The( comparison(of( evolutionarily( related(proteins(offers( insight( into(how( these(proteins(developed.(This(is(because,(as(Darwin(noted(in(‘On(the(Origin(of(Species’,(a(common(ancestor(connects(all(species.((
‘By the theory of natural selection all living species have been connected with the 
parent-species of each genus, by differences not greater than we see between the 
varieties of the same species at the present day; and these parent-species, now 
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generally extinct, have in their turn been similarly connected with more ancient 
species; and so on backwards, always converging to the common ancestor of each 
great class. So that the number of intermediate and transitional links, between all 
living and extinct species, must have been inconceivably great. But assuredly, if this 
theory be true, such have lived upon this earth.’  On(the(Origin(of(Species((Darwin,(1859)(pp.281Z282((First(Edition)((Direct(comparison(of(the(protein(of(interest(with(the(common(ancestor(would(be(the( ideal( way( to( ascertain( the( evolution( of( the( protein.( This,( however,( is( not(possible( as( the( nodes( of( the( evolutionary( tree( are( not( available( to( study,( as(evolution(does(not(stand(still.(All(that(is(available(to(study(are(existing(species(at(the( ends( of( the( branches( of( the( evolutionary( tree,( which( have( evolved( from(common(ancestors.((
‘In looking for the gradations by which an organ in any species has been 
perfected, we ought to look exclusively to its lineal ancestors; but this is scarcely ever 
possible, and we are forced in each case to look to species of the same group, that is to 
the collateral descendants from the same original parent-form, in order to see what 
gradations are possible, and for the chance of some gradations having been 
transmitted from the earlier stages of descent, in an unaltered or little altered 
condition.’ On(the(Origin(of(Species,((Darwin,(1859)(pp.(187((First(Edition)((
1.3.2 Immunoglobulin#evolution##It( is( possible( to( construct( a( phylogenetic( tree( based( on( physical( or( genetic(characteristics(of(species(allowing(evolutionary(relationships(to(be(inferred.(The(vertebrate(lineage((Figure(1.10)(early(on(evolved(an(adaptive(immune(response.(
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Figure#1.10#Phylogenetic#tree#of#the#tetrapod#(amniotes)#lineage#Note( the(divergence(of(mammals(and(birds/reptiles(occurred(315(million(years(ago( and( the( divergence( of( monotremes( from( other( mammals( occurred( 166(million(years(ago(((Wilson,(2008;(Amemiya(et#al.,(2013)((
1.3.3 Immunoglobulins#evolutionarily#related#to#IgE#There(are(several(significant(points(in(the(evolution(of(IgE(that(are(accessible(to(study,(to(gain(insight(into(this(protein((Figure(1.10).(The(first(is(immunoglobulin(M,(IgM((Figure(1.11),(which(is(the(only(immunoglobulin(to(be(found(in(all(jawed(




































































vertebrates1,2.( This( makes( it( most( likely( to( be( the( closest( to( the( evolutionary(ancestor(of(all(modern(immunoglobulins(that(is(available(today((Aveskogh(et#al.,(1999).(The(second( is( immunoglobulin(Y,( IgY,(which( is( found(first( in(amphibians(and(therefore(is(present(in(the(common(lineage(of(birds(and(mammals.(In(turtles,(reptiles,(crocodiles(and(birds(IgY(is(present.(However(upon(the(divergence(of(the(mammalian( and( reptilian( lineages(mammals( acquired( two( immunoglobulins( in(the( place( of( IgY,( namely( IgG( and( IgE.( These( two( are( found( exclusively( in( the(mammalian(lineage.(It(can(be(surmised(that(an(ancestor(of(IgY(was(the(precursor(for(IgE(and(IgG,(making(IgY(an(attractive(target(for(study(of(the(evolution(of(IgE((Mestecky(et#al.,(2005).(Thirdly(the(platypus,(Ornithorhynchus#anatinus,(is(thought(to(be(evolutionarily(the(oldest(extant(mammal.(It(has(IgE(and(IgY((GambónZDeza(
et#al.,(2009)(and(so(it(will(be(a(valuable(antibody(to(compare(with(human(IgE(and(chicken(IgY.(((
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1.4 IgM(IgM( is( thought( to( be( the( first( immunoglobulin( to( appear( during( vertebrate(evolution(and(it(is(considered(closest(to(the(original(primordial(immunoglobulin.(As(far(as(is(known(it(is(found(in(all(jawed(vertebrates((apart(from(the(coelacanth)(and( although( the( amino( acid( sequence( varies( significantly,( the( basic( domain(structure( remains( the( same( (Aveskogh(et#al.,( 1999).( It( is( an(excellent( target( for(study(of(antibody(evolution(as(it(gives(us(direct(insight(into(the(common(ancestor(of(all(immunoglobulins.((
1.4.1 IgM#function#IgM( is(an(essential( component(of( the( first( line(of(defence(against( infection.( It( is(expressed(on( the( surface(of(BZcells( as( the(BZcell( receptor( for(antigen(and( is( the(first( soluble( antibody( to( be( produced( when( antigen( enters( the( system.( It( is(sometimes(referred(to(as(the(‘natural(antibody’(as(it(does(not(display(high(affinity(to(antigens,(and(circulating(IgM(exists(prior(to(antigen(exposure.(It(is(secreted(as(a( polymer,( which( means( that( despite( its( low( affinity( and( multiZspecificity( it(possesses(multiple(binding(sites(that(give(rise(to(an(avidity(effect.(It(is(best(known(for(its(activation(of(C1q,(the(first(component(of(the(classical(complement(pathway.(((
1.4.2 IgM#structure#In(mammals(IgM(is(predominantly(a(pentamer(with(each(subunit(made(up(of(two(identical(heavy(chains(and( two( light( chains.(The(heavy(chains(are(comprised(of(one( variable( domain,( VH,( and( four( constant( domains( Cμ1,( Cμ2,( Cμ3( and( Cμ4,(whereas(the(light(chains(are(comprised(of(a(single(variable(and(constant(domain((Figure(1.11).(It(is(an(asymmetric(molecule(as(it(has(a(J(chain.(This(is(thought(to(
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catalyse(pentamer( formation,(as( in( its(absence(hexamers(are( formed((Bouvet(et#
al.,(1987).(As(it(is(the(largest(of(all(antibody(isotypes(it(does(not(diffuse(well(into(tissue( and( therefore( is( found( in( high( concentrations( in( the( blood( and( low(concentrations(in(the(interstitium.(For(this(reason(BZcells(expressing(IgM(reactive(to( an( antigen( will( undergo( class( switching( to( IgG,( which( is( smaller( and( more(diffusible,(once(the(affinity(for(antigen(has(reached(a(significantly(high(level.((No(part(of(human(IgM(has(ever(been(determined(using(XZray(crystallography,(and(there(are(only(crystal(structures(for(the(individual(Cµ2(and(Cµ4(domain(pairs(for(mouse(IgM((Müller(et#al.,(2013).(There(is(also(an(NMR(structure(of(mouse(Cµ3(The(Cµ2(domains(follow(the(same(dimerisation(pattern(as(the(Cε2(domains(however(the( Cµ4( domains( show( a( novel( arrangement( as( they( are( parallel( to( each( other((Müller(et#al.,(2013).(((Studies( on( the( structure( of( IgM( have( been( performed( in( solution,( but( there(remains( controversy( as( to( the( structure( of( IgM( in( the( absence( of( a( crystal(structure.(In(1991(Perkins(et#al.(used(synchrotron(XZray(scattering(and(molecular(graphics( modelling( using( IgG( domains( as( a( model( to( determine( the( possible(structure( of( IgM( (Perkins( et# al.,( 1991).( They( predicted( that( the( Fab2( fragment,(which(is(made(up(of(the(two(Fab(arms(and(linked(by(the(Cμ2(domains,(was(rigid(with( the( Fab( arms( at( 90°( to( each( other.( They( also( predicted( that(whole( IgM( is(planar( in( solution,( although( flexibility( was( found( between( the( Cμ2( and( Cμ3(domains.( They( found( binding( sites( for( C1q,( on( Cμ3( that( would( be( exposed( on(antigen(binding(as(Cμ2(and( the(Fab(arms(moved(out(of( the(way( (Perkins(et#al.,#1991)((Figure(1.12).(In(2009(another(group(modelled(IgM((Czajkowsky(and(Shao,(
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Figure#1.12#Schematic#of#IgM#to#illustrate#the#structural#controversy.#IgM( is( shown( as( a( dimer( for( clarity,( but( should( be( taken( to( represent( the(pentameric(form.((The( structure( of( IgMZFc( is( important( because( it(will( help( to( show(whether( the(bend( in( IgE( is( an( ancient( structure,( most( probably( found( in( the( primordial(immunoglobulin,( or( whether( it( is( a( recent( evolutionarily( development( that(contributes(uniquely(to(the(high(affinity(binding(of(IgE.(((
Perkins(et#al.#Model((1991)( Czajkowsky(and(Shao(Model((2009)(
In( absence( of( antigen,( IgM( is( in( a( planar(conformation.( Linker( between( Cμ2( and( Cμ3(domains(is(Hlexible((indicated(by(arrow).(
In( the( presence( of( antigen,( IgM( is( in( a( ‘staple’(conformation.( Bending( between( Cμ2( and( Cμ3(domains(reveals(C1q(binding(sites((indicated(by(arrows).(




























1.5.1 IgY#function#IgE(and( IgG(share(a( common(ancestor(with( IgY,( the(primary( serum(antibody(of(birds((Warr(et#al.,(1995).(IgY(is(structurally(similar(to(IgE(but(functionally(similar(to(IgG((Taylor(et#al.,(2009).(((














1.6.1 Platypus#has#mammalian#and#reptilian#features#The(platypus( is( the(oldest( extant(mammal(known.( It( is( a( semiZaquatic(mammal(that(is(thought(to(have(diverged(from(placental(and(marsupial(mammals(166(myr(ago( (Figure( 1.10).( Its( young( are( hatched( from( laid( eggs( but( are( fed( with( milk(secreted( from( the( underside( of( the( females,( thus( combining( both( modern(reptilian(and(mammalian(features(of(reproduction((Wilson,(2008).((
1.6.2 Platypus#IgH#gene#locus#In( 2009( GambónZDeza( et# al.( analysed( the( platypus( IgH( gene( locus.( It( has( both(mammalian(and( reptilian( features.(The(mammalian(genes( IgE,( IgG,( IgA(and( IgM(are(present(as(well(as(reptilian(IgD(and(IgY.(As(discussed(above(IgE(and(IgG(are(thought(to(have(evolved(from(a(gene(duplication(event(of(IgY.(The(IgY(seen(in(the(platypus(genome(is(more(closely(related(to(IgG(than(IgE(and(therefore(the(authors(suggest(IgG(arose(by(duplication(of(this(antibody.(The(absence(of(the(interZchain(disulphide(link(between(CH1(and(CH2(supports(this(conclusion,(as(this(disulphide(is(often(missing(from(IgG.(The(authors(show(that(the(platypus((Ornithorhynchus#




1.6.3 Structure#of#platypus#IgE#There( has( been( no( work( published( on( the( structure( of( platypus( IgE( and( it( is(unknown(whether(there(is(a(bend(between(the(Cε2(and(Cε3(domains,(as(seen(in(human( IgE.( To( determine(whether( this( bend( is( absent( or( in( a( different( form,( a(crystal(structure(is(required.((





2.1.2 Expression#system#pCEP4#The( pCEP4( expression( vector( (Life( Technologies)( is( designed( to( have( high(expression(due(to(a(CMV(promoter.(The(generic(expression(system(used(has(been(described(previously((Taylor(et#al.,(2009).(A(holding(vector,(pSP64,(containing(a(HindIIIZHindIII( cassette( containing( EcoRV,( mouse( kappa( light( chain( leader(sequence,( IgEZFc( (Young( et# al.,( 1995)( and( the( restriction( site( Pmel( introduced(after(the(stop(codon(of(IgEZFc.(The(cassette(was(removed(with(EcoRV(NEB)(and(Pmel(NEB)(restriction(sites,(and(replaced(with(pFcε2Z4,(cFυ2Z4(or(hFcµ2Z4,((see(Chapter(3),(flanked(by(EcoRV(and(PmeI(sites.(The(leader(and(Fc(sequences(were(removed(using(HindIII(and( ligated( into(a(HindIII(cut(pCEP4(vector( for( transient(transfections.((
2.1.3 Expression#system#Flp#In#The( Flp( In™( expression( system( (Life( Technologies)( is( designed( for( constitutive(expression( cell( lines.( It( allows( for( insertion( of( the( gene( of( interest( in( a( specific(location( in( the( genome( of( the( cell( line( of( choice.( Cells( first( have( a( Flp(Recombination(Target(site((FRT)(inserted(into(the(genome.(The(gene(of( interest(can(then(be(inserted(into(this(location(using(the(pcDNA5(expression(vector,(which(
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contains( FRT( sites( and( pOG44,( which( contains( the( sequence( of( the( Flp(recombinase(enzyme(and(causes(the(cells(to(produce(it.(These(two(vectors(are(coZtransfected(and(the(gene(of( interest( is( inserted(into(the(genome(of(the(host(cell.(The(gene(of(interest(was(inserted(into(the(pcDNA5(vector(using(PIPE(cloning((see(2.1.4)(and(the(vectors(were(transfected(using(Fugene™((Promega).(See(Figure(3.9,(for(a(diagram(explaining(the(Flp(In(System.((





2.1.5.1 Nested#PCR#In(nested(PCR,( the( first( round(of(PCR( is(used( to(add( something( small( such(as(a((His)6Ztag(to(the(end(of(the(gene(of(interest;(the(second(round(then(uses(the(PCR(product( as( a( template( to( which( something( else( can( be( added.( This( technique(works( by( utilising( a( primer( that( contains( a( section( homologous( to( the( gene( of(interest( and( another( section( containing( the( additional( moiety,( in( this( case( a((His)6Ztag.(During(the(PCR(reaction,(the(primer(is(incorporated(into(a(new(strand(of(DNA(and(therefore(the(new(strand(contains(the((His)6Ztag.(The(second(round(uses(the(PCR(products(from(the(first(round(to(add(something(else,(in(this(case(the(end( homologous( to( the( vector( as( required( for( PIPE( cloning.( The( PCR( was(performed( using( Phusion( HighZFidelity( PCR(master( mix( with( GC( Buffer( (NEB).(The(Master(Mix(contained(all(reagents(required(for(PCR(apart( from(the(primers(and( template( DNA.( For( each( reaction( primers( were( diluted( to( 0.5µM.( 20µl(reaction( volumes(were( used( for( all( reactions( apart( from( the( linearising( vector(
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reaction( for( which( a( 50µl( reaction( volume( was( used.( The( template( DNA( was(diluted( to( ~0.1ng.( Below( are( the( specific( PCR( conditions( and( primers( for( each(reaction(performed.(((
hFcµ2&4His!Round(1(to(add((His)6Ztag(Primers(5’Z3’((Sigma):((IGM(2Z4(R1(FWD:(ATC(CTT(CCA(GTG(ATT(GCT((IGM(2Z4(R1(RVS:(CTA(ATG(ATG(GTG(GTG(ATG(ATG(TTT(ACC(GGT(GGA(CTT(GTC((98°C(30s(/(98°C(10s,(57°C(15s,(72°C(15s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((Round(2(to(add(homologous(ends(Primers(5’Z3’((Sigma):((IGM(2Z4(R2(FWD:(AGA(TGC(CAG(ATG(TGA(TAT(CCT(TCC(AGT(GAT(TGC(TGA(GCT(G(IGM/Y(2Z4(R2(RVS:(ACT(AGC(GGG(TTT(AAA(CCT(AAT(GAT(GGT(GGT(GAT(GAT(GTT(T((98°C(30s(/(98°C(10s,(67°C(15s,(72°C(15s(/(Hold(14°C(( ( ( x30(cycles((
hFcµ3&4His!Round(1(to(add((His)6Ztag(Primers(5’Z3’((Sigma):((IGM(3Z4(R1(FWD:(ATCTGTGTCCCCGATCAAGACA(IGM(3Z4(R1(RVS:(CTAATGATGGTGGTGATGATGTTTACCGGTGGACTTGTC(((98°C(30s(/(98°C(10s,(57°C(15s,(72°C(15s(/(Hold(14°C(( ( ( x30(cycles((Round(2(to(add(homologous(ends(Primers(5’Z3’((Sigma):((
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IGM(3Z4(R2(FWD:(AGATGCCAGATGTGAT(IGM(3Z4(R2(RVS:(ATCAGCGGGTTTAAACCTAATGATGGTGGTGATGATGTTTT((((98°C(30s(/(98°C(10s,(62°C(15s,(72°C(15s(/(Hold(14°C(( ( ( x30(cycles((
cFcυ2&4His!Round(1(to(add((His)6Ztag(Primers(5’Z3’((Sigma):((IGY(R1(FWD:(ATC(GTC(GCC(CGA(GTA(GGG(IGY(R1(RVS:(CTA(ATG(ATG(GTG(GTG(ATG(ATG(TTT(ACC(AGC(CTG(TTT(CTG((98°C(30s(/(98°C(10s,(56°C(15s,(72°C(15s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((Round(2(to(add(homologous(ends(Primers(5’Z3’((Sigma):((IGY(R2(FWD:(AGA(TGC(CAG(ATG(TGA(TAT(CGT(CGC(CCG(AGT(AGG(GCC(CCC(A(IGM/Y(2Z4(R2(RVS:(ACT(AGC(GGG(TTT(AAA(CCT(AAT(GAT(GGT(GGT(GAT(GAT(GTT(T((98°C(30s(/(98°C(10s,(67°C(15s,(72°C(15s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((
pFcε2&4His!Round(1(to(add((His)6Ztag(Primers(5’Z3’((Sigma):((PLATYPUS(IGE(R1(RWD:(ATC(GAG(GCC(TCC(AAA(GAT(PLATYPUS(IGE(R1(RVS:(CTA(ATG(ATG(GTG(GTG(ATG(ATG(GTT(ACC(GGA(TGT(GTG(CTG((98°C(30s(/(98°C(10s,(60°C(15s,(72°C(15s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((Round(2(to(add(homologous(ends(
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Primers(5’Z3’((Sigma):(PLATYPUS(IGE(R2(FWD:(AGA(TGC(CAG(ATG(TGA(TAT(CGA(CGC(CTC(CAA(AGA(TCC(GAT(C(PLATYPUS(IGE(R2(RVS:(ATC(AGC(GGG(TTT(AAA(CCT(AAT(GAT(GGT(GGT(GAT(GAT(GGT(T((98°C(30s(/(98°C(10s,(69°C(15s,(72°C(15s(/;(Hold(14°C(( ( ( x30(cycles((
2.1.5.2 Vector#linearisation#Short(primers(5’Z3((Sigma):(LV(FWD:(GTTTAAACCCGCTGATCA((LV(RVS:(ATCACATCTGGCATCTGTA(((98°C(30s(/(98°C(10s,(54°C(15s,(72°C(75s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((Extended(primers(5’Z3’((Sigma):(LV(EXT(FWD:(GTT(TAA(ACC(CGC(TGA(TCA(GCC(LV(EXT(RVS:(ATC(ACA(TCT(GGC(ATC(TGT(AAG(C((Linearising(vector(reaction((98°C(30s(/(98°C(10s,(66°C(15s,(72°C(75s(/(72°C(5(mins;(Hold(14°C(( ( ( x30(cycles((
2.1.5.3 Colony#PCR#Colony( PCR( was( performed( to( check( that( the( colonies( contained( the( correct(insert.(The(PCR(was(set(up(using(Hot(Start(Taq(2X(Master(Mix((NEB)(following(the(manufacturer’s( instructions( with( a( 20µl( reaction( volume.( Primer( pairs( used(shown(below.(Instead(of(template(DNA(the(colony(was(picked(and(dipped(into(the(PCR(reaction.(The(individual(conditions(for(each(construct(are(shown(below.((
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pFcε2&4His!Primers(5’Z3’((Sigma):(FWD(R1(PIgE(FWD:(ATCGACGCCTCCAAAGAT(SQ(RVS((BGH):(TAGAAGGCACAGTCGAGG((95°C(10mins(/(95°C(1min,(54°C(30s,(72°C(1min(/(72°C(7(mins;(Hold(14°C(( ( ( ( x35(cycles((
cFcυ2&4His!Primers(5’Z3’((Sigma):(FWD(R1(IgY(FWD:(ATCGTCGCCCGAGTAGGG(SQ(RVS((BGH):(TAGAAGGCACAGTCGAGG((95°C(10mins(/(95°C(1min,(54°C(30s,(72°C(1min(/(72°C(7(mins;(Hold(14°C(( ( ( ( x35(cycles((
hFcµ2&4His!Primers(5’Z3’((Sigma):(FWD(R1(FWD:(ATCCTTCCAGTGATTGCT(SQ(RVS((BGH):(TAGAAGGCACAGTCGAGG((95°C(10mins(/(95°C(1min,(51°C(30s,(72°C(1min(/(72°C(7(mins;(Hold(14°C(( ( ( ( x35(cycles((
hFcµ3&4His!Primers(5’Z3’((Sigma):(IGM(3Z4(R2(FWD:(AGATGCCAGATGTGAT(SQ(RVS((BGH):(TAGAAGGCACAGTCGAGG((95°C(10mins(/(95°C(1min,(58°C(30s,(72°C(1min(/(72°C(7(mins;(Hold(14°C(( ( ( ( x35(cycles((
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2.1.6 DPN#I#digestion#DpnI( digestion( performed( with( NEB( enzyme( following( the( manufacturer’s(instructions.((((
2.1.7 Agarose#DNA#Gel#A(1%(agarose(gel(was(made(up(by(dissolving(1g(of(agarose(powder(into(100ml(of(TAE(or(TBE(buffer(as(required.(5µl(of(Gel(Red(was(added(to(the(solution(and(this(was( allowed( to( set( in( a( DNA( casting( tank.( Once( the( gel( had( set,( the( comb(was(removed( and( the( gel( was( placed( into( the( tank.( The( tank( was( filled( with( the(corresponding( buffer( that( it( had( been( made( with,( and( the( DNA( was( loaded(containing(5x(loading(dye((NEB).(The(gel(was(run(at(100mV(until(the(bands(could(be(visualised(on( the(gel(under(UV( light(or(using( a(blue( transZilluminator( (Clare(Chemical(Research)(so(as(to(not(damage(the(DNA(with(UV(for(gel(purification.((
2.1.8 Gel#extraction#Gel( extraction( was( performed( using( the( Qiagen( Gel( Extraction( Kit( and( the(manufacturer’s(instructions(were(followed.((




DNA( miniprep( was( performed( using( Qiagen( Miniprep( Kit( following( the(manufacturer’s(instructions.((
2.1.11 DNA#sequencing#Sequencing( was( performed( by( Eurofins( (Eurofins( Genomics,( Anzinger( Str.( 7a,(85560(Ebersberg,(Germany).(For(the(pCEP4(vector(the(sequencing(primers(used(were( pCEP( forward( (AGAGCTCGTTTAGTGAACCG)( and( EBV( reverse((GTGGTTTGTCCAAACTCATC).(For(pcDNA5(the(sequencing(primers(used(were(T7(forward( (TAATACGACTCACTATAGGG)( and( BGH( reverse((TAGAAGGCACAGTCGAGG).((
2.1.12 Transfection#




2.1.13 Cell#culture#Cells( were( cultured( in( DMEM( (life( Technologies)( fortified( with( 10%( FBS( (Life(Technologies)( and( 1%( PSG( (Life( Technologies).( The( cells( were( adherent( and(cultured(in(either(96(well(or(24(well(plates(or(into(small((T25),(medium((T75)(or(large( (T175)( tissue( culture( flasks( (Nunc).( The( cells( were( trypsinised( and(subsequently( split.( Briefly,( the(media(was( removed( and( the( cells(were(washed(with( preZwarmed( sterile( PBS( (Life( Technologies).( The( PBS( was( removed( and(trypsin(was(added(at(10%(of(the(media(volume(i.e.(if(the(media(volume(was(50ml(then(5ml(of(1%(trypsin((Life(Technologies)(was(used.(This(was(incubated(at(37°C(for(5(minutes(or(until(the(cells(had(completely(detached(from(the(flask.(Media(was(added( to( inhibit( the( trypsin( and( the( cells( were( spun( down( and( counted.( Cells(were( seeded( at( 2x105(per(ml.( Once( the( cells( had( been( transfected,( in( order( to(grow(them(up(for(protein(expression(they(were(seeded(into(5(T175(flasks.(Once(the( cells( were( confluent( they( were( trypsinised( and( seeded( into( 1( litre( of(Freestyle™( (Life( Technologies)( serum( free( media( fortified( with( 1%( penicillin(streptomycin.(The(cells(were(grown(for(three(weeks(and(then(harvested.((




2.1.15 Glucose#monitoring#of#cell#cultures#Glucose( levels(were(monitored( in( spinner( cultures( using( the(Aviva(Nano( blood(glucose(monitoring(system.(A(10µL(sample(of(cell(suspension(was(pipetted(onto(the( blood( glucose( strip( to( test( for( glucose( concentration.( If( the( glucose(concentration( fell( below( 20mmol/L( then( it( was( topped( up( to( 30mmol/L( using(sterile(glucose.((
2.1.16 Cell#counting#live/dead#Cells(were(trypsinised(and(20µl(was(removed(and(added(to(20µl(of(0.4%(trypan(blue(solution((Life(Technologies).(The(trypan(blue(is(absorbed(into(dead(cells(and(colours( them( blue.( The( live( and( dead( cells( were( then( counted( using( a(haemocytometer.((
2.1.17 Affinity#columns#Proteins(were(purified(on(an(AKTA(Prime(system((Amersham,(Uppsala(Sweden)(using(the(Affinity(Step(purification(method.(((
2.1.17.1 IgM#affinity#purification#For(hFcµ(2Z4(Dr(Rosy(Calvert(and(Dr(Alex(Taylor(generated(an(antiZIgM(column.(Briefly(a(µ(chain(specific(antibody((Sigma(I0759)(was(coupled(to(agarose(beads,(5ml(of( coupled(beads(was(packed( into(10mm(diameter(EconoZcolumn( (BioZrad,(737Z1011)( with( an( appropriate( flow( adaptor( (BioZrad,( 738Z0015).( The( column(was( run( at( 4°C(using( a(AKTA(prime( system(at( a( flow( rate( of( 1ml/min.(Binding(
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buffer( used( was( PBS( and( elution( buffer( 0.2M( glycine( pH2.5.( The( protein( was(eluted(in(1ml(fractions(into(test(tubes(containing(200µl(1M(Tris(pH(8.6(in(order(to(neutralise(the(eluate.((
2.1.17.2 IgY#affinity#purification#For( cFcυ2Z4(Dr(Rosy(Calvert( and(Dr(Alex(Taylor( generated( an( antiZIgY( column.(Briefly( a( goat( polyclonal( antiZIgY( antibody( (Gallus( Immunotech( DAIgYZAGAZ5)(was( coupled( to( agarose( beads,( 5ml( of( coupled( beads( was( packed( into( 10mm(diameter( EconoZcolumn( (BioZrad,( 737Z1011)(with( an( appropriate( flow( adaptor((BioZrad,(738Z0015).(The(column(was(run(at(4°C(using(a(AKTA(prime(system(at(a(flow( rate( of( 1ml/min.( Binding( buffer( used( was( PBS( and( elution( buffer( 0.2M(glycine(pH2.5.(The(protein(was(eluted(in(1ml(fractions(into(test(tubes(containing(200µl(1M(Tris(pH(8.6(in(order(to(neutralise(the(eluate.((
2.1.17.3 Platypus#IgE#affinity#purification#For(pFcε2Z4(Dr(Rosy(Calvert(and(Dr(Alex(Taylor(generated(an(antiZplatypus( IgE(column.(Briefly( a( (His)6Ztagged(Platypus( IgEZFc(purified(on(NTA( sepharose(was(sent(to(Eurogentec(to(make(rabbit(antiZplatypus(IgEZFc(antiserum.(Antiserum(was(purified( on( protein( G( sepharose( and( coupled( to( 5ml( HiTrap( CNBrZactivated(Sepharose.(5ml(of(coupled(beads(was(packed(into(10mm(diameter(EconoZcolumn((BioZrad,(737Z1011)(with(an(appropriate( flow(adaptor((BioZrad,(738Z0015).(The(column(was( run( at( 4°C( using( a( AKTA(prime( system( at( a( flow( rate( of( 1ml/min.(Binding(buffer(used(was(PBS(and(elution(buffer(0.2M(glycine(pH2.5.(The(protein(
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was( eluted( in( 1ml( fractions( into( test( tubes( containing( 200µl( 1M(Tris( pH(8.6( in(order(to(neutralise(the(eluate.((
2.1.17.4 Nickel#NTA#affinity#purification#For(hFcµ2Z4His,(hFcµ3Z4His,(cFcυ2Z4His,(and(pFcε2Z4His(purification(was(performed(using(1ml(HiTrap(Nickel(NTA(columns((GE(Healthcare)(and(5ml(HiTrap(desalting(columns( (GE( Healthcare).( The( column( was( run( at( 4°C( using( an( AKTA( prime(system(at(a(flow(rate(of(1ml/min.(The(desalting(column(was(attached(underneath(the(nickel(column.(At(first(the(binding(buffer(used(was(20mM(imidazole,(500mM(sodium( chloride( and( 20mM( sodium( phosphate( pH( 7.4.( The( elution( buffer( used(was( 400mM( imidazole,( 500mM( sodium( chloride( and( 20mM( sodium( phosphate(pH(7.4.(Upon(optimisation( the(binding(buffer(was( changed( to(20mM( imidazole,(500mM( sodium( chloride( and( 20mM( Tris( pH( 7.4( and( the( elution( buffer( was(changed(to(400mM(imidazole,(500mM(sodium(chloride(and(20mM(Tris(pH(7.4.(
 




2.1.20 Dialysis#Protein(was(dialysed(using(dialysis( tubing( (Fisher(Scientific).(Briefly,( the( tubing(was(washed(thoroughly(with(water(and(then(with(the(desired(buffer.(The(dialysis(tubing(was(secured(at(one(end(with(a(dialysis(clip(and(the(protein(was(pipetted(into(the(free(end,(then(the(other(end(was(secured(using(a(dialysis(clip.(The(dialysis(tubing( containing( the( protein(was( placed( into( 1( litre( of( the( desired( buffer( and(kept(at(4°C.(The(buffer(was(changed(regularly((every(4(hours/overnight).((
2.1.21 Size#exclusion#chromatography#Gel(filtration(was(performed(on(a(Gilson(HPLC(system(using(the(Superdex™(200(column( (GE(Healthcare),(which( is( suitable( for( separating( proteins( of(molecular(weights( between( 10( –( 600kDa.( Fractions( were( collected( between( 10( to( 20(minutes,(column(volume(20ml(and(flow(rate(0.75ml/min.(((
2.1.22 DeZglycosylation#Proteins(were(deZglycosylated(using(PNGase(F((glycerol(free)((NEB)(following(the(manufacturer’s( instructions.( For( analysis( with( SDSZPAGE,( 20µg( of( glycoprotein(was(digested(and(for(analysis(with(MS,(100µg(of(glycoprotein(was(digested.((
2.1.23 SDSZPAGE#SDSZPAGE( gels( were( made( at( 12%( acrylamide( (3.43ml( MilliQ( water,( 4ml( 30%(acrylamide/bisacrylamide( ratio( 35:1,( 2.5ml( 1.5M( Tris,( 0.4%( SDS,( pH8.8,( 60µL(10%(APS,(13µL(TEMED)(with(a(5%(stacking(gel( (3ml(MilliQ(water,(700µL(30%(acrylamide/bisacrylamide,(1.25ml(0.5M(Tris,( 0.4%(SDS,(pH(6.8,(25µL(10%(APS,(20µL(TEMED).(The(protein(was(prepared(by(denaturation(at(100°C(for(5(minutes(
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with(either(1x(nonZreducing(Laemmli(sample(buffer((5x(278(mM(TrisZHCl,(pH(6.8,(4.4%( SDS,( 44.4%( (w/v)( glycerol,( 0.02%( bromophenol( blue)( or( 1x( reducing(Laemmli( sample(buffer( (5x(277.8(mM(TrisZHCl,(pH(6.8,(4.4%(SDS,(44.4%((w/v)(glycerol,(0.02%(bromophenol(blue,(11%((v/v)(β(mercaptoethanol).(Gels(were(run(using(the(Atto(gel(system(at(120V(using(1x(running(buffer((10x(running(buffer(30(g(Tris(base,(144(g(Glycine,(100(ml(10%(SDS,(MilliQ(water(up(to(1L).(((
2.1.24 Western#blotting#A(section(of(a(SDS(PAGE(gel(was(transferred(to(a(nitrocellulose membrane(using(a(semiZdry(transfer.(The(blotted(nitrocellulose(was(blocked(using(1%(casein(in(PBS((Life(Technologies)(for(1(hour(at(room(temperature.(The(nitrocellulose(was(then(incubated(with(0.5μg/ml(of(antibody(diluted(into(1%(casein(in(PBS(for(a(further(1(hour.(The(nitrocellulose(was(washed(with(PBS(Tween((0.05%).(The(presence(of(antiZHisZHRP( was( revealed( using( a( HRP( catalysed( chemiluminescence( reaction((Thermo(Scientific).(The(membrane(was(used(to(expose(Fuji(RX(XZray( film((Lot:(C45789)( for(5Z15(seconds.(The( film(was(developed(using(an(XZOMAT(developer((Kodak).(For(IgM(goat(anti(human(IgM(HRP((AbD(Serotec)(was(used.(For(IgY(antiZchicken(IgY(HRP(conjugate((Eurogentec)(was(used.((
 
2.1.25 Mass#Spectrometry#(MS)#
2.1.25.1 Theory#Mass(Spectrometry( (MS)( is( a( technique( that( can(be(used( to(accurately(measure(the( molecular( weight( of( a( protein.( The( sample( is( ionised( using( electrospray(ionisation( (ESI).( This( involves( gently(moving( the( sample( from( liquid( state( into(
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atmospheric(pressure(and(then( into(a(vacuum.(The(dehydrated(charged(protein(molecules( are( accelerated( and( fly( along( a( time( of( flight( tube( (Figure( 2.1).( The(velocity((ν)(the(particles(travel(at,(and(therefore(when(they(reach(the(detector,(is(related(to(the(potential(energy((KE)(they(have.(The(KE(is(!!!!!,(which(is(equal(to(zV(where(z(is(the(charge(of(the(particle(and(V(is(the(potential(difference(between(the(electrodes([Eq.(2].(This(equation(can(be(rearranged(to(make(ν(the(subject([Eq.(3](and( then(combined(with(ν( =(d/t( to(give( rise( to( [Eq.(4].(The(distance( (d)(and(potential( difference( (V)( are( constant( values( and( therefore( the( time( it( takes( the(particle( to( travel( along( the( time( of( flight( tube( is( proportional( to( the(m/z( ratio.(Particles(of(identical(mass(and(charge(have(the(same(kinetic(energy(and(therefore(fly(at(the(same(velocity.(As(mass(and(or(charge(increase(the(velocity(of(the(particle(increases.( The( time( it( takes( for( the( ion( to( reach( the( detector( is( recorded.( In(practice( the( m/z( is( calculated( using( empirically( calculated( values( that( the(instrument(is(calibrated(with,(as(this(is(more(accurate.((
!! = !" = 12!!!( [Eq.#2]#(
! = 2!"! ( [Eq.#3]#(
! = !2! !! ( [Eq.#4]#(





























































































The( resulting( spectrum( has( m/z( on( the( xZaxis( and( intensity( on( the( yZaxis.( A(protein(of( a( particular(molecular(weight(will( have( characteristic( peaks( that( are(further(apart(as(the(charge(state( increases.(The(molecular(weight(of( the(protein(can(be(calculated(from(these(peaks.(((
2.1.25.2 MS#of#proteins#The( proteins( pFcε2Z4His,( hFcµ2Z4His( and( cFcυ2Z4His(were( deZglycosylated( using(PNGase(F((glycerol(free)((NEB)(following(the(manufacturer’s(instructors.(Both(the(glycosylated( and( deZglycosylated( proteins( were( dialysed( into( 10%( acetonitrile(and( 0.1%( formic( acid.( They( were( injected( into( a( Bruker( MaXima( ultrahighZresolution( electrospray( ionisation( quadropole( timeZofZflight(mass( spectrometer(at(40µL/min(at(a( concentration(of(1µg/mL(and( the( spectra(were( recorded.(The(maximum( entropy( calculations( were( performed( using( the( manufacturer’s(algorithm((Bruker(Daltonics).((
2.2 Methods(for(Chapter(4(–(Crystallisation(Trials(




2.2.2.1 Human#IgMZFc#cryoZprotectants#Tris( conditions:( 20%( PEG( 8K,( 0.1M( Tris( pH( 7.5( and( 0.1M( ammonium( sulphate(plus(10,(15(or(20%(sucrose(was(tested.(20%(sucrose(was(used(MES( conditions:( 20%( PEG( 8K,( 0.2M( ammonium( sulphate( and( 0.1M(MES( pH6.5(plus(10,(15(or(20%(sucrose(was(tested.(20%(sucrose(was(used.((
2.2.2.2 Platypus#IgEZFc#cryoprotectants:#Lithium( sulphate( conditions:( 18%( PEG( 8K,( 0.4M( lithium( sulphate,( 0.1M(BisTrisPropane( pH( 6.5( plus( either( 10,( 15,( or( 20%( sucrose( was( tested.( 15%(sucrose(was(used.((Crystals(grown(under(other(crystallisation(conditions(were(tested(without(cryoZprotectant.(
2.2.2.3 Chicken#IgYZFc#cryoZprotectants#Potassium( thiocyanate(conditions:(0.2M(potassium( thiocyanate,(20%(PEG(3350,(0.1M(HEPES(pH7.0(plus(10,(15(or(20%(ethylene(glycol(was(tested.(15%(ethylene(glycol(was(used.(Sodium( formate( conditions:( 1.8M( sodium( formate,( 0.1M( BisTrisMethane( pH6.5(plus(10,(15(or(20%(ethylene(glycol(was(tested.(20%(ethylene(glycol(was(used.((




2.2.4 Preparing#seed#stock#10µl( of( reservoir( solution( were( pipetted( into( the( drop( and( then( transferred,(including(crystals,(into(an(eppendorf(and(vortexed(for(90(seconds.(A(further(50µL(of(reservoir(was(added(to(make(concentrated(seed(stock.((
2.3 Methods(for(Chapters(5(&(7(–(Determination(of(crystal(structures(




































the(position(of(the(spot,(and(therefore(the(unit(cell(dimensions(can(be(calculated.(The(intensity(of(the(spot( is(the(sum(of(all( the(contributing(scatterers(of(the(unit(cell,( for(each(hkl(plane,(which(can(be(described(as( the(structure( factor,(Fhkl.(The(structure(factors(are(complex(quantities(consisting(of(an(amplitude(and(phase.((
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! ! = !!! + !!!!!(!!"!!!) + !!!!!(!.!!"!!!) + !!!! !.!!"!!! +⋯(( [Eq.#7]#
! ! = ! !!!! !!"#!!!!!!! ( [Eq.#8]#
! ! = ! !!!!!"#$!!!! !( [Eq.#9]#(As(the(data(collected(in(a(diffraction(experiment(is(finite(it(is(therefore(known(as(a(Fourier( sum.( For( one( reflection( Fhkl( the( structure( factor( is( written( as( [Eq.( 10],(containing( information( from( all( the( scattering( atoms( in( the( unit( cell.( The(structure(factor(can(also(be(written(as(the(sum(of(all(the(volume(elements((Figure(2.4)(of( the(unit(cell( [Eq.(11].(An( inverse(Fourier(transform(gives(us(the(electron(density,(p(x,y,z)(where(p( is( the(electron(density(expressed( in(electrons(per(unit(volume,(which(has(one(x,y,z(coordinate([Eq.(12].(((
!!!" = !!!!!"(!!!!!"!!!"!)!!!! !*( [Eq.#10]#




! !†( [Eq.#11]#! !,!, ! = !!! !!"#!!!"# !"!!"!!"!"# ‡( [Eq.#12]#(
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Figure#2.4#Volume#element#of#unit#cell#Unit( cell( divided( into( small( volume( elements( from( splitting( the( unit( cell( by( parallel(planes.(Each(volume(element(is(so(small(it(is(said(to(have(one((x,y,z)(coordinate.((Adapted(from(Figure(2.18,(pg.(27,((Rhodes,(2006))((p(x,y,z)(represents( the(scattering(of(all( the(electrons( in( the(unit(cell,(however( it(does(not(account( for( the(thermal(motion(of( the(atoms.(As(can(be(seen( in(Figure(2.5,(as(the(thermal(motion(of(the(atom(increases,(the(scattering(intensity(weakens(the(higher(the(θ(angle.(This(can(be(accounted(for(using(a(BZfactor([Eq.(13],(which(is( the( measure( of( the( rootZmeanZsquare( of( atomic( displacement.( In( reality( the(thermal(motion(is(anisotropic,(however(only(at(very(high(resolutions(can(this(be(resolved.( An( average( of( the( anisotropic( displacement( can( be( added( to( the(structure(factor(to(account(for(this(weakened(density(at(high(θ(angles(and(can(be(seen(in([Eq.(14].(In(a(crystal(the(BZfactors(tend(to(be(higher(than(can(be(accounted(for(by(just(thermal(motion,(because(they(also(take(up(the(effect(upon(the(electron(density( of( having( alternative( conformations,( i.e.( they( include( the( effect( of( static(disorder(within(the(crystal.(








(! ℎ = ! !!!!!"(!!!!!"!!!"!)! !!!!!"#!!/!!§( [Eq.#14]#((
(
Figure#2.5#Scattering#affected#by#thermal#motion#As(the(angle(θ( increases,( the(atomic(scattering(drops(off(due( to(a(Gaussian(smearing(of(the(density(due(to(thermal(motion.(The(magnitude(of(the(drop(off(is(dependent(on(the(BZfactor( and( static( disorder( of( the( crystal.( The( point( atom,( which( cannot( exist,( has( no(thermal(motion(and(shows(no(drop(off(in(atomic(scattering(at(larger(θ(angles.(In(practice(a(real(spherical(atom(with(no(thermal(motion(will(still(show(a(Gaussian(smearing(of(the(density,( and( as( the( thermal(motion( increases( the( atomic( scattering(weakens( further( at(high(θ(angles.((
2.3.2 Molecular#Replacement#As( alluded( to( above,( in( crystallography( the( phase( component( of( the(waveform(cannot( be( experimentally( recorded( and( so( they(must( be( calculated.( The( phase(information(is(the(most(important(component(in(order(to(define(the(structure(as(can( be( seen( from( Figure( 2.6.( There( are( several( ways( to( calculate( the( phase(
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information;( the( easiest( way( is( to( use( the( phases( from( a( homologous( crystal(structure( that( has( already( been( determined.( This( is( known( as( molecular(replacement.( In( order( to( copy( the( phases( the( protein( of( interest( and( the(homologous(model(will(have(to(be(in(the(same(orientation.(In(order(to(search(for(this,(three(translation(parameters(and(three(rotation(parameters((a(rotation(and(a(translation(parameter(in(each(dimension)(will(have(to(be(determined.((
(
Figure#2.6#The#importance#of#phase#information#Top(left(panel(shows(a(duck(and(its(Fourier(transform,(top(right(panel(shows(a(cat(and(its(Fourier(transform.(If(the(amplitudes(of(the(duck(are(combined(with(the(phases(from(the(cat(the(resulting(image(looks(like(the(cat.((Taylor,(2010).((
2.3.2.1 Patterson##Traditionally( a( Patterson( function( was( used( to( calculate( the( rotation( from( the(translation(function.(A(Patterson(function(is(given(by(the(product(of(!!!"#(! + !((where(!(is(defined(!, !,!)(and(is(defined(by([Eq.(15].(The(important(feature(of(a(Patterson(function(is(that(it(can(be(calculated(solely(using(intensities.(A(Patterson(
MATERIALS(AND(METHODS((((Chapter(2(
(( 77(
map( is( essentially( an( interatomic( vector(map( of( the( structure,( and( this( can( be(compared( with( the( Patterson( map( from( the( model( in( order( to( identify( the(rotation(function.(( ! !, !,! = ! !!!" !!!!!"(!!!!"!!")!!" ( [Eq.#15]#(Once(the(rotation(has(been(completed(the(translation(can(be(performed.(Once(the(search(model(and(the(unknown(protein(have(been(orientated(with(each(other(the(phases(can(be(copied(from(the(model(and(used(as(a(starting(point.(The(process(of(refinement(of(the(structure(can(then(be(completed.((
2.3.2.2 Maximum#likelihood#In( PHASER,( maximumZlikelihood( estimation( is( used( to( carry( out( Molecular(Replacement.( This( is( a( statistical( method( that( looks( at( how( well( the( model(‘agrees’( with( the( recorded( data.( So( a( model( will( be( tested( by( looking( at( the(probability(of(the(recorded(data(being(generated(by(the(model.(((Following( the( rotation( functions( the( search( model( is( defined( as( the( ‘correct’(orientation( and( then( the( probability( of( this( orientation( generating( the( data( is(calculated.( The(model( is( then( rotated( slightly( and( the( probability( is( calculated(again.(The(highest(probability(orientation(is(then(taken(and(the(same(process( is(repeated( with( a( translation( function.( ( A( translation( function( ZZscore( is( then(calculated((TFZ)(and(this(is(used(to(assess(whether(the(solution(is(correct.(The(ZZscore( is( calculated( by( comparing( log( likelihood( gain( (LLG)( of( the(
MATERIALS(AND(METHODS((((Chapter(2(
(( 78(
rotation/translation( function(and(a( random(rotation/translation.(The(mean(and(RMS( are( calculated( from( the( random( search.( The(mean( is( subtracted( from( the(search( rotation/translation( and( divided( by( the( RMS( to( give( a( value( that( is( the(number( of( standard(deviations( above( the(mean.(A( correct( solution(will( be(well(above(a(solution(generated(by(random(chance.(A(TFZ(score(of(less(than(5(suggests(that( the(solution( is(not(correct(and(a(TFZ(score(of(more( the(8(suggests( that( the(solution(is(almost(definitely(correct.((
2.3.3 IgMZFc#data#collection#Crystals(were(cryoprotected,(and(flashZcooled(in(liquid(nitrogen(in(crystallisation(loops.(Data(were(collected(at(Diamond(Light(Source.(An(ADSC(Q315r(detector(was(used.( Data( collection( information( for( the( 6( datasets( collected( can( be( found( in(Table(2.1.((
Table#2.1#Data#collection#information#for#IgM1Fc#crystals#
((
2.3.4 Fcε3Z4#data#collection#Crystals(were(cryoprotected,(and(flashZcooled(in(liquid(nitrogen(in(crystallisation(loops.(Crystals(of(Fcɛ3Z4(were(grown(and(data(collected(by(Dr.(Nyssa(Drinkwater(who( kindly( provided( the( data( for( processing.( Data( were( collected( at( Diamond(Light(Source.(For(the(P1(crystals(an(ADSC(Q315r(detector(was(used."250"images"
MATERIALS(AND(METHODS((((Chapter(2(
(( 79(
were$taken$between$167$̊Z417$̊,$at$a$distance$of$290mm,&with&1&̊&oscillations&and&0.7s(exposure(time;(the(wavelength(used(was(0.9795Å.(For(the(P21(crystals(DSDC(Q315r( detector( was( used.( 235( images( were( taken( between( 20°Z184.5°,( at( a(distance(of(290mm,(with(1°(oscillations(and(0.87s(exposure(time;(the(wavelength(used(was(0.9763Å.(((
2.3.5 Image#processing#and#Molecular#Replacement#HKL( 2000( was( used( for( data( processing( (Otwinowski( and( Minor,( 1997).( The(phase( information(was( calculated( using(molecular( replacement(with( an( Fcɛ3Z4(structure.(For(P1(3HA0(was(used(as(a(search(model,(for(P21(3H9Z(was(used(as(a(search(model.((Matthews( probability( analysis( (Matthews,( 1968;( Kantardjieff( and( Rupp,( 2003)(predicts(the(solvent(content(of(the(cell(with(different(numbers(of(molecules(and(compares(this(with(known(solvent(content(of(other(determined(structures(to(give(an( idea( of( the(most( likely( number( of(molecules( in( the( asymmetric( unit.( For( P1(there(were( predicted( to( be( 3( dimers,( i.e.( 3( Fcɛ3Z4(molecules( and( for( P21( there(were(predicted(to(be(2(dimers,(i.e.(2(Fcε3Z4(molecules.((For(the(P1(crystal(form(PHASER((McCoy(et#al.,(2007)(was(used(to(search(for(2,(3(and(4(dimers(as(well(as(5,(6(and(7(monomers(using(chain(A(and(B(of(the(search(model(separately.(Three(solutions(were(determined,(and(preliminary(refinement(carried(out(on(all(three(using(PHENIX((Adams(et#al.,#2010)(The(solution(with(the(best(RZvalues(and(electron(density(was(carried(on(to(further(refinement.(((
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For( the(P21(crystal( form(PHASER((McCoy(et#al.,#2007)(was(used( to(search( for(2(dimers.(As(the(crystal(structure(is( in(the(same(crystal( form(and(the(model(used,(one( solution( was( determined,( and( preliminary( refinement( carried( out( using(PHENIX( (Adams( et#al.,#2010).( The( solution(with( the( best( RZvalues( and( electron(density(was(carried(on(to(further(refinement.(((
2.3.6 Refinement#The( structures( were( rebuilt( using( PHENIX( autobuild( and( refined( using( COOT((Emsley( and( Cowtan,( 2004).( Different( refinement( strategies( were( used.(Refinement( of( individual( atomic( coordinates( is( a( strategy( to( fit( the( atomic(coordinates( to( the( electron( density( with( stereochemical( restraints( (covalent(bonds,( angles,( dihedrals,( planarities,( chiralities,( nonZbonded( interactions).(Rigid(body( refinement( is( a( strategy(whereby( a( section( of( the( protein( is( selected,( for(example(one(chain,(and(this(is(refined(as(a(fixed(group.(BZfactors(can(help(indicate(where(there(are(errors(in(model(building(and(so(refinement(of(individual(atomic(BZfactors( is( common( strategy( to( correctly( build( atoms.# Translation( Libration(Screw( (TLS)( group( refinement( is( a( strategy( whereby( the( protein( is( split( into(groups( that( contain( secondary( or( tertiary( structure( elements( such( as( alpha(helices(or(beta(sheets;(these(are(small(sections(of(the(protein(that(are(thought(to(be(rigid.(These(groups(are(known(as(TLS(groups,(and(can(be(used(in(refinement.(The( structures( were( manually( modeled( in( COOT( to( improve( sideZchain(placement.(((The( refinement(was( repeated( in( iterative( cycles( and( the( structures(were( again(manually(built(with(waters(added(where(appropriate(2FoZFc(density(was(found(at(
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the(3σ(contour(level(and(a(hydrogenZbonding(partner(could(be(found(within(1.8Z(3.0Å.( A( further( refinement( of( individual( atomic( coordinates( and( refinement( of(individual( atomic( BZfactors( was( performed,( but( this( time( the( XZray/stereochemistry( weight( and( XZray/ADP( (atomic( displacement( parameters)(weight(optimization(was(included.(((Carbohydrate(was(modeled(at(the(conserved(Asn(394(site(if(appropriate(2FoZFc(density( was( present.( The( glycosylation( present( in( PDB( 3HA0( was( used( as( the(model,( and( in( order( to( do( this( the( secondary–structureZmatching( (SSM)(superposition( function(was(used( in(COOT((Krissinel(&(Henrick(2004).( In( the(P1(structure( chain( A,( GlcNac2Man3(was( built,(whereas( in( chain(D( no( carbohydrate(was(built,(as(there(was(no(appropriate(electron(density.( In(the(P21(structure(for(all(chains(GlcNac2Man4(was(built.(((Finally(PHENIX(was(used(to(refine(occupancies.(MolProbity(was(used(to(check(the(structure((Chen(et al. 2010).(Refinement(statistics(can(be(found(in(Table(7.1.((
2.3.7 BZfactor#analysis#For( the( BZfactor( analysis( the( BZfactors( were( taken( from( the( PDB( files.( For( the(analysis(comparing(the(Cε3(and(Cε4(domains,(the(BZfactors(were(averaged(from(these( two( chains( together,( and( this( was( used( to( normalise( the( value( for( each(chain.(For(the(analysis(looking(within(the(Cε3(domains,(the(average(BZfactor(was(taken(from(the(Cε3(domain(and(this(was(used(to(normalise( the(value( for( the(NZterminal( and(CZterminal( regions( of( the( Cε3(domains.( The(domain( boundary( for(the( Cε3ZCε4(was( defined( as( residues( 336Z544;( the( Cε3( domain(was( defined( as(
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336Z437(and( the(Cε4(domain(was(defined(as(438Z544;( the(NZterminal( region(of(the( Cε3( domain( was( defined( as( residues( 336Z339,( 359Z372,( 387Z401,( 419Z431(and( the(CZterminal( region(of( the(Cε3(domain(was(defined(as(340Z358,(373Z386,(402Z418,(432Z437.(((
2.3.8 Angle#and#distance#measurements#The( angle( was( measured( using( PyMOL( Molecular( Graphics( System( (Version(1.5.0.4(Schrödinger,(LLC.)(using(the(get_angle(command.(The(angle(was(measured(between(X336ZX497ZY336(or(Y336ZY497ZX336(and(this(was(performed(for(each(chain(where(X(refers(to(the(chain(in(question(and(Y(refers(to(the(paired(chain.((
2.4 Methods(for(Chapter(6(–(Differential(Scanning(Fluorimetry((DSF)((




2.4.2 Protocol#for#method#Method( used( as( described( in( (Niesen( et# al.,( 2007).( For( the( denaturation( steps,(10M( urea( was( used( as( a( stock( solution( and( heated( to( 25°C( before( starting( to(ensure(that(the(urea(had(completely(dissolved.(The(protein(was(in(the(buffer(TBS((25mM( Tris,( 25mM( sodium( chloride,( 0.05%( azide),( the( dye( used( was( SyproZOrange((excitation:(492nm,(emission:(610nm,(Sigma).(The( instrument(used(was(the( mx3005P( (Agilent( Technologies),( with( the( run( protocol:( at( 25°C( for( 10(minutes,(three(measurements(taken(and(the(temperature(increased(by(1°C,(then(a(further(three(measurements(taken,(and(this(was(continued(up(to(95°C.((
2.4.3 Data#analysis#Data( was( analysed( and( graphs( plotted( using( GraphPad( Prism( (Version( 5.0,(GraphPad( Software,( Inc.).( The( first( derivative( plots( were( calculated( using(Graphpad(Prism(and(the(peak(was(taken(as(the(melting(temperature.((
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Chapter(3 PROTEIN(PURIFICATION(3.1 Overview(As(outlined(in(Chapter(1,(in(order(to(study(the(evolution(of(human(IgE,(the(most(important(tools(available(are(evolutionarily(related(proteins(in(different(species.(As(already(discussed,(human(IgM,(chicken( IgY(and(platypus( IgE(represent( three(important( proteins( of( evolutionary( interest( and( can( be( used( to( study( at(which(point(in(evolution(human(IgE(developed(the(unique(receptor(binding(properties(it(possesses( today(and( the( changes( that(occurred( to( facilitate( these(properties.( In(order( to( study( the(proteins(of( interest,( suitable( constructs(need( to(be(designed(and(purification(methods(developed.(((Producing(Fc(fragments(of(antibodies,(for(which(published(purification(protocols(are( not( available,( is( a( significant( challenge.( Human( IgE( antibody( Fc( fragments(have(been(purified(using(a(receptor(fusion(protein((αγ)(column((Shi(et(al.,(1997),(taking( advantage( of( the( high( affinity( between( IgE( and( its( receptor( FcεRI.(Unexpectedly,( platypus( IgE( does( have( some( affinity( for( human( FcεRIα((unpublished(data(in(personal(communication(from(Dr(Rosy(Calvert)(however(the(affinity(is(not(high(enough(for(purification.((In(order(to(prepare(the(antibodies(of( interest,(the(first(step(is(to(design(suitable(constructs.(Several(chicken(IgYZFc,(platypus(IgEZFc(and(human(IgMZFc(constructs(had(already(been(designed(by(Dr(Rosy(Calvert(and(Dr(Alex(Taylor(and(these(were(used(as(a(basis(for(the(new(constructs.(((
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The( first( construct( was( of( human( IgM( containing( the( mouse( kappa( leader(sequence,(Cµ2,(Cµ3(and(Cµ4((hFcµ2Z4).(The(second(construct(was(of(human(IgM(containing(the(mouse(kappa(leader(sequence,(Cµ3(and(Cµ4((hFcµ3Z4).(The(third(construct(was(of(platypus(IgE(containing(the(mouse(kappa(leader(sequence,(Cε2,(Cε3( and(Cε4( (pFcε2Z4).( The( fourth( construct(was( of( chicken( IgY( containing( the(mouse(kappa(leader(sequence,(Cυ2,(Cυ3(and(Cυ4((cFcυ2Z4).(((Two(different(approaches(were( taken( to(clone,(express(and(purify( the(designed(proteins,(and(these(will(be(referred(to(as(purification(Method(1(and(Method(2.(
 
3.1.1.1 Purification#Method#1#The(protein(made(with(this(Method(will(be(expressed(without(a(purification(tag(and(the(protein(will(be(prepared(using(individual(affinity(columns.(The(hFcµ2Z4,(hFcµ3Z4,( pFcε2Z4( and( cFcυ2Z4( constructs( were( inserted( into( the( pCEP4( vector(and(transiently(transfected(into(HEK(293E(cells.(The(cells(were(expanded(and(the(supernatant( harvested.( The( protein( was( purified( on( columns( specific( to( each(protein(and(characterised(by(SDSZPAGE((2.1.17).((







3.3 (Numbering(of(amino(acid(sequences(In(1973((Putnam(et#al.,#1973)(published(the(complete(amino(acid(sequence(of(the(heavy( chain( of( human( IgM( and( defined( a( numbering( system( that( began( at( the(start( of( the(variable( region.( In(1978( (Dorrington(and(Bennich,( 1978)(published(the( amino( acid( sequence( of( the( human( IgE( constant( region( and( defined( a(numbering( system( that,( as( with( Putnam( et# al.,( started( at( the( beginning( of( the(variable( region.( In( 2004( (Suzuki( and( Lee,( 2004)combined( two( published(sequences( of( the( chicken( IgY( heavy( chain( from( (Parvari( et# al.,( 1988)( and((Reynaud( et# al.,( 1987),( containing( the( chicken( IgY( constant( region( with( a(truncated( variable( region( and( the( variable( region( respectively.( They( numbered(the(IgY(sequence(using(Dorrington(and(Bennich’s(numbering(system.(This(system(has(become(convention(and(human(IgM(and(IgE(are(often(referred(to(as(having,(for(example,(a(conserved(glycosylation(site(at(positions(402(and(394(respectively.(This( becomes( problematic( as( it( transpires( that( both( the( human( IgM( sequence(published( by( (Putnam( et# al.,( 1973)( and( the( human( IgE( sequence( published( by((Dorrington( and( Bennich,( 1978)( were( found( to( contain( errors.( The( sequences(have(since(been(corrected(for(both(human(IgM(and(human(IgE(and(can(be(located(at(GenBank:(AAS01770(and(GenBank:(AAB59395(respectively.(For(alignment(of(the( original( and( corrected( sequences( refer( to( Appendix( I.( The( chicken( IgY(sequence( did( not( contain( errors( and( the( sequence( published( by( (Parvari( et#al.,(1988)(is(GenBank:(S00390((variable(region(truncated).(((The(errors(in(the(IgM(and(IgE(amino(acid(sequences(would(change(the(numbering(systems,(however(for(the(sake(of(convention(the(old(numbering(system(has(been(adhered( to.( ( Figure(3.1( shows( the(platypus( IgE(amino(acid( sequence(numbered(
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according( to( Dorrington( and( Bennich.( The( NZlinked( glycosylation( sites( and(disulphide(linkages(are(highlighted.((
(
Figure#3.1#Platypus#IgE#amino#acid#sequence#Sequence(GenBank:(AY055780.(A)(Amino(acid(sequence(containing(the(variable,(CH1,(CH2,(CH3( and( CH4( regions.( NZlinked( glycosylation( sites( highlighted( in( green,( numbered( 315,(325,( 422,( 502( and( 543.( Disulphide( linkages( highlighted( in( yellow.( Domain( boundaries(used( are( exon( boundaries.( B)( Schematic( of( platypus( IgE( constant( region,( internal( and(external((HZ(heavy(chain,(L(–(light(chain)(disulphide(linkages(shown(in(red.(The(possible(NZlinked(glycosylation(sites(are(numbered(and(shown(with(black(lines.((
3.4 Design(of(constructs(An(alignment(of(the(CH1(to(CH4(domains(of(human(IgE,(platypus(IgE,(chicken(IgY(and( human( IgM(was( performed( (Figure( 3.2)( and( revealed( high( conservation( of(cysteine( residues( and( one( NZlinked( glycosylation( site.( In( order( to( design(
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Figure# 3.2# Alignment# of# constant# heavy# chain# regions# of# human# IgE,#
platypus#IgE,#chicken#IgY#and#human#IgM##Human( IgE( sequence( GenBank:( AAB59395.1,( platypus( IgE( sequence( GenBank:(AY055780.1,( chicken( IgY( sequence( (Reynaud( et# al.,( 1987)( (Parvari( et# al.,( 1988)( and(GenBank:( S00390( (truncated)( and( human( IgM( sequence( GenBank:( AAS01770( aligned(using( ClustalW.( The( cysteine( residues( are( highlighted( in( yellow( and( the( asparagine(residues( that( are( predicted( to( have( NZlinked( glycosylation( are( highlighted( in( green.(Asterisks( indicate( residues( that( are( conserved( throughout( all( sequences;( dots( indicate(residues(that(are(conserved(in(two(or(three(sequences.(((
Human IgE Ce1-4 121 --STQSPSVFPLTRCCKNIPSNATSVTLGCLATGYFPEPVMVTCDTGSLNGTTMTLPATT 178 
Platypus Ce1-4  147 –VSSKAPSVFPLVPCCDG--TDSSAVTLGCLVTGYIPEPVTVRWNSGDLVKGVTTFPSVF 203 
Chicken IgY Cu1 142 ASPTSPPRLYPLSACCSD---SAVPPAVGCLLSPSSAGGISWEGSGGTAVAG-------- 190 
Human IgM Cu1-4 143 –GSASAPTLFPLV-SCENSPSDTSSVAVGCLAQDFLPDSITFSWKYKNNSDIS------- 194 
                      ....*...**. .*   .........*** ... .... .    . .. .  . . 
 
Human IgE Ce1-4 179 LTLSGHYATISLLTVS-GAWAKQMFTCRVAHTPSSTDWVDNKTFSVCSRDFTPP---TVK 234 
Platypus Ce1-4  204 DSQSGLYTMSSQVTVSQESWQSQTFTCNVEQMATKTK-INTEVYSDCSKDPIPP---TVK 259 
Chicken IgY Cu1 191 –RVSGTPVKLSFVRLSPGE-KRKSFVCSAAPGGALLK----KEVQVCRVDPVPPVAPEVQ 244 
Human IgM Cu1-4 195 -STRGFPSVLG---------TDEHVVCKVQHPNGNKE----KNVPLPVIAELPP---KVS 237 
                     . .* .  .. ....   .  . ..* .      ..    . ..... ...**   .*. 
 
Human IgE Ce1-4 235 ILQ-SSCDGGGHFPPTIQLLCLVSGYTPGTINITWLEDGQVMDVDLST----ASTTQEGE 289 
Platypus Ce1-4  260 LLH-SSCDPRGDSQASIELLCLITGYSPAGIQVDWLVDGQKAENLFPY---TAPPKREGN 315 
Chicken IgY Cu1 245 VLHASSCTP--SQSESVELLCLVTGFSPASAEVEWLVDG-VGGLLVAS---QSPAVRSGS 299 
Human IgM Cu1-4 238 VFV-PPRDGFFGNPRKSKLICQATGFSPRQIQVSWLREGKQVGSGVTTDQVQAEAKESGP 296 
                    ... ..... .  .  ..*.*...*..*..... **..*.. . .. .   ..... ..  
 
Human IgE Ce1-4 290 –LASTQSELTLSQKHWLSDRTYTCQVTY--QGHTFEDSTKKCADSNPRG--VSAYLSRPS 344 
Platypus Ce1-4  316 RSFSSHSEVNITQDQWLSGKTFTCQVTHLADKKTYQDSARKCADSDPRG--ITVFLTPPS 373 
Chicken IgY Cu1 300 -TYSLSSRVNVSGTDWREGKSYSCRVRHPATNTVVEDHVKGCPDGAQSCSPIQLYAIPPS 358 
Human IgM Cu1-4 297 TTYKVTSTLTIKESDWLSQSMFTCRVDH-RGLTFQQNASSMCGPDQDTA--IRVFAIPPS 353 
                     ...  ....... .*.......*.*.. .  .. ... ..*... ...  . .....** 
 
Human IgE Ce1-4 345 PFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRKEEKQRNGTLTVTSTLP 404 
Platypus Ce1-4  374 PTDLYISKTPKLTCLIIDLVSTEG-MEVTWSRESGTPLSAESFEEQKQFNGTMSFISTVP 432 
Chicken IgY Cu1 359 PGELYISLDAKLRCLVVNL-PSDSSLSVTWTREKSGNLRPDPMVLQEHFNGTYSASSAVP 417 
Human IgM Cu1-4 354 FASIFLTKSTKLTCLVTDLTTYDS-VTISWTRQNGEAVKTHTNISESHPNATFSAVGEAS 412 
                    . ...........**...*  ... . ..*.*... ..   .  .....*.* .. .... 
 
Human IgE Ce1-4 405 VGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRA-APEVYAFA-TPEWPGSRDKRTL 462 
Platypus Ce1-4  433 VNIQDWNEGESYTCRVAHPDLPSPIIKTVTKLPGKRL-APEVYAFPPHQAEVSHGDSLSL 491 
Chicken IgY Cu1 418 VSTQDWLSGERFTCTVQHEELPLPLSKSVYRNTGPTT-PPLIYPFAPHPEELSL-SRVTL 475 
Human IgM Cu1-4 413 ICEDDWNSGERFTCTVTHTDLPSPLKQTISRPKGVALHRPDVYLLPPAREQLNLRESATI 472 
                    . ..**..**...*.*.*..**... .....  *.   .*..*.............. .. 
 
Human IgE Ce1-4 463 ACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTK-------G--SGFFVFSRLEVTR 513 
Platypus Ce1-4  492 TCLIRGFYPENISVRWLLDNKPLPTEHYRTTKPLKDQ-------GPDPAYFLYSRLAVNK 544 
Chicken IgY Cu1 476 SCLVRGFRPRDIEIRWLRDHRAVPATEFVTTAVLPEERTANGAGGDGDTFFVYSKMSVET 535 
Human IgM Cu1-4 473 TCLVTGFSPADVFVQWMQRGQPLSPEKYVTSAPMPEP-------QAPGRYFAHSILTVSE 525 
                    .**...* * .....*. .  ... .  .*......        .    .* .*.. *   
 
Human IgE Ce1-4 514 AEWEQKDEFICRAVHEAASPSQTVQRAVSVNPGK------------------ 547 
Platypus Ce1-4  545 STWEQGNVYTCQVVHEAL-PSRNTERKFQHTSGN------------------ 431 
Chicken IgY Cu1 536 AKWNGGTVFACMAVHEAL-PMRFSQRTLQKQAGK------------------ 568 
Human IgM Cu1-4 526 EEWNTGETYTCVVAHEAL-PNRVTERTVDKSTGKPTLYNVSLVMSDTAGTCY 576 




Figure# 3.3# Alignment# of# CH21CH4# regions# of# hIgE1Fc,# pIgE1Fc,# cIgY1Fc# and#
hIgM1Fc#sequences#to#indicate#design#of#constructs.#StrikeZthrough(regions(were(not(included(in(constructs.(Blue(highlighted(regions(indicate(mutations,( CysteineZAlanine( (CZA)( and( asparagineZglutamine( (NZQ).( Cysteine( and(asparagine( residues( that( remain( in( the( constructs( are( highlighted( yellow( and( green(respectively.( Asterisks( indicate( residues( that( are( conserved( throughout( all( sequences;(dots(indicate(residues(that(are(conserved(in(two(or(three(sequences.(((
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column,(which( contains( a( fusion( of( an( IgG(with( the(αFcεRI( in( place( of( the( Fab(domains((Shi(et#al.,(1997),(for(purification(of(human(IgE.(((
3.5.1 Cell#culture#and#transfection#Identical( methods( of( expression( were( used( for( hFcµ2Z4,( cFcυ2Z4( and( pFcε2Z4.(Any(variations(from(the(general(method(are(described(in(Table(3.1.((The(generic(expression(system(used(has(been(described(previously((Taylor(et#al.,#2009).( The( constructs( pFcε2Z4,( cFcυ2Z4( and( hFcµ2Z4( were( inserted( into( the(pCEP4(vector(and(this(was(used(for(transient(transfections.((Plasmid(DNA(was( transfected( into(HEK(293(using(polyethylenimine( (PEI).(Cells(grown(in(cell(culture(media(fortified(with(geneticin(and(selected(using(0.3mg/ml(hygromycin.( Cultures( were( left( for( three( weeks( to( ensure( all( cells( were(transfected(and(then(transferred(to(media(containing(0.1mg/ml(hygromycin.(((The(cells(were(expanded(into(one(litre,(grown(in(triple(layer(flasks(and(left(until(the( medium( was( depleted( of( nutrients( and( the( cells( were( dead.( ( This( was(indicated( by( yellowing( of( the(medium,( indicating( an( acidic( pH( change,( and( cell(detachment(from(the(surface(of(the(flask(respectively.(Supernatant(was(processed((Chapter(2,(page(60)(and(stored(at(4°C(before(purification.((
3.5.2 Protein#purification#The( supernatant(was( run( overnight( on( a( column( specific( to( the( protein( (Table(3.1).( The( column(was(washed(with( PBS( azide( (0.1%)( for( 100( column( volumes.(
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The(proteins(were(eluted(using(50mM(glycineZHCL(pH(2.5(in(2ml(fractions.(50μl(2M( TrisZHCL( pH( 8( was( added( to( each( fraction( to( change( buffer( to( pH( 7( upon(elution.(((
Table#3.1#Purification#specifics#for#proteins#made#using#method#1#
((An(absorbance(spectrum(of(the(fractions(from(350Z250nm(was(taken(to(indicate(where( protein(was( present( and( these(were( pooled( and( concentrated.( This(was(run(through(a(size(exclusion(column(Superdex(™(200,(using(Tris(buffered(saline((TBS),( to( remove( any( aggregate.( The(Traces( can( be( seen( in( Figure( 3.4A,( Figure(3.5A(and(Figure(3.6A(and(show(protein( is(not(aggregating.(Fractions(containing(eluted( protein( were( pooled,( concentrated( and( buffer( exchanged( into( Protein(Storage(Buffer((PSB)(and(analysed(using(SDSZPAGE.(For(hFcµ2Z4(and(cFcυ2Z4(the(protein(was( analysed( by( nonZreducing( SDSZPAGE( and(western( blotting( (Figure(3.4B&C( and( Figure( 3.5B&C( respectively).( The( predicted( molecular( weight( of(hFcµ2Z4(without(carbohydrate(is(38,567(Da(and(77,134(Da(for(the(monomer(and(





















Figure#3.4#The#hFcµ214#trace,#SDS1PAGE#and#western#A)(SEC(trace(of(hFcµ2Z4,( flow(rate(0.75ml/min.(UV(absorbance(at(280nm.(B)(12%(SDSZPAGE(marker(page(ruler(preZstained(protein(ladder((Fermentas)(Lanes(1Z5(fractions(93Z97( from( A.( Stained( with( instant( blue.( C)( Western( blot( analysis( of( SDSZPAGE( gel(transferred( to( nitrocellulose( and( stained( with( antiZIgM( antibody( (Chapter( 2,( page( 65)(lane(1(nonZreduced(sample(and(lane(2(reduced(sample.(#(
Time%(minutes)%




















Figure#3.5#The#cFcν214#trace,#SDS1PAGE#and#western#A)(SEC( trace(of( cFcυ2Z4,( flow(rate(0.75ml/min.(UV(absorbance(at(280nm.(B)(12%(SDSZPAGE(marker(page(ruler(preZstained(protein(ladder((Fermentas)(Lanes(1Z4(nonZreducing,(lanes(5Z8(reducing.(The(4(samples(are(fractions(13Z16(of(A.(Stained(with(instant(blue.(C)(Western( blot( analysis( of( SDSZPAGE( gel( transferred( to( nitrocellulose( and( stained( with(antiZIgY( antibody( (Chapter(2,( page(65)( lane(1(nonZreduced( sample( and( lane(2( reduced(sample.(#(
Time%(minutes)%


































Figure#3.6#The#pFcε214#trace,#SDS1PAGE#and#western#A)(SEC( trace(of(pFcε2Z4,( flow(rate(0.75ml/min.(UV(absorbance(at(280nm.(B)(12%(SDSZPAGE(marker(page(ruler(preZstained(protein(ladder((Fermentas)(Lanes(1Z8(reducing,(the(8(samples(are(fractions(91Z98(in(peaks(of(trace.(Stained(with(coomasie(blue.(#(3.6 Method(2(Purification(In(order(to(streamline(the(protein(purification(process,(a((His)6Ztag(was(attached(to(the(constructs(hFcµ2Z4((hFcµ2Z4His),(cFcυ2Z4((cFcυ2Z4His)(and(pFcε2Z4((pFcε2Z4His).( A( construct( was( designed,( hFcµ3Z4His,(which( contained( the( mouse( kappa(leader(sequence(and(the(Cµ3(and(Cµ4(domains(with(a((His)6Ztag.(This(meant(that(they(could(all(be(purified(using( the(same(system,( i.e.( a(nickel(NTA(column.(This(had( the( added( benefit( that( any( protein( from( any( species( could( be( successfully(
Time%(minutes)%














purified(without(having(to(create(a(specific(affinity(column.(However,(purification(of( proteins( using( a( (His)6Ztag( from( a( mammalian( cell( culture( is( not( without(problems.(Nickel(NTA(columns(can(undergo(nonZspecific(binding(and(cell(culture(media( usually( contains( foetal( calf( serum( that( has( many( unspecified( proteins(present( that( may( or( may( not( bind( to( the( column( during( purification.( This(purification(process(was(optimised.(((
3.6.1 PIPE#cloning#The(constructs(were(assembled(into(the(pcDNA5(vector.(Polymerase(Incomplete(Primer(Extension((PIPE)(cloning(is(a(technique(used(to(insert(DNA(into(a(vector(without(using( restriction(enzymes.( It( relies(on(a( trait(of(DNA(polymerases,( that(they(are(prone(to(fall(off(the(DNA(template(before(the(sequence(is(complete.(This(leads(to(a(single(stranded(overhang(on(the(ends(of(the(PCR(product.(This(can(be(exploited( if( the(ends(of( the( insert(DNA(and(vector(DNA(are(homologous(to(each(other.(The(single(stranded(ends(of(the(insert(can(anneal(to(the(homologous(single(stranded(ends(of( the(vector.(This(will( form(an(assembled(vector( that(has( ‘nicks’(where( the( single( stranded( ends( do( not( completely( anneal.( This( vector( can( be(transformed(into(E.coli(and(the(E.coli(will(repair(the(‘nicked’(regions(and(replicate(the(plasmid(DNA((Figure(3.7).(PIPE(cloning(was(utilised(in(a(nested(PCR(reaction(to( generate( the( constructs( requires( for(Method( 2( purification.( ( The( vector(was(linearised(and(amplified(using(PCR,(and(this(was(checked(on(a(1%(agarose(gel(to(ensure( that( there( were( no( contamination( products( (Figure( 3.8).( The( insert,(containing(the(gene(of(interest,(was(amplified(using(constructs(made(for(Method(1(as(a(template.(The(first(round(of(PCR(added(the((His)6Ztag(to(the(CZterminal(end(of( the(DNA.(A(1%(agarose(gel(of( the( first(round(PCR(products(was(run(to(check(
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that(there(were(no(contamination(bands((not(shown)(and(a(second(round(of(PCR(was(performed(using(the(cleaned(up(first(round(PCR(products(as(a(template.(This(added(ends(homologous(to(the(vector,(pcDNA5,(so(the(gene(of( interest(could(be(inserted(into(the(vector(using(PIPE(cloning.(The(pcDNA5(vector(already(contained(the(mouse(kappa( leader(sequence.(The( insert(was(checked(on(a(1%(agarose(gel(and(an(example(is(shown(in(Figure(3.8.((
(
Figure# 3.7# Schematic# to# show# Polymerase# Incomplete# Primer# Extention#

























Figure#3.9#Diagram#of#the#Flp#In™#system#Taken(from(life(technologies(Flp(In™(manual.(Diagram(shows(the(process(of( integration(of( expression( construct( into( the( cells.( 1.( The( pFRT/lacZeo(was( stably( transfected( into(HEK(293(cells(and(these(were(maintained(in(culture(with(zeocin.(2.(The(pcDNA5(vector(containing(the(gene(of(interest(was(coZtransfected(with(pOG44(that(contains(the(gene(for(Flp( recombinase.( 3.( The( Flp( recombinase( was( expressed( from( pOG44( and( catalyses( a(recombination(event(between(the(FRT(site( in( the(HEK(293(genome(and(the(FRT(site( in(the(pcDNA5(expression(vector.(4.(This(causes( the(gene(of( interest( to(be( inserted(stably(into(the(HEK(293(genome.(Hygromycin(resistance(is(conferred,(and(zeocin(resistance(is(lost,(allowing(the(transfected(cells(to(be(selected(with(hygromycin.((



































































































































































3.6.4 Optimisation#of#purification#The(1ml(nickel(NTA(columns(selected(for(use(were(HiTrap™((GE(Healthcare).(The(recommended(procedure(for(purification(is(use(of(a(binding(buffer(that(contains(a(small( amount( of( imidazole( to( prevent( nonZspecific( binding,( salt( and( sodium(phosphate.(The(manufacturer’s(recommended(protocol(was(followed(with(100mL(of( filtered( tissue( culture( supernatant( containing( hFcµ2Z4His( (Figure( 3.12).( The(resulting( trace(was(hard( to( interpret(as( imidazole(absorbs(at(280nm(as(well( as(the( protein.( The( first( few( fractions( in( the( elution( series( were( pooled( and(concentrated(for(size(exclusion(chromatography.((
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of(the(HiTrap™(column(in(order(to(separate(the(protein(from(the(imidazole(upon(elution.(This(allowed(a(gradient(of( imidazole(to(be(run(to( identify( the(minimum(concentration(of( imidazole( that( is( required( to( elute( the(protein.(The( result(was(400mM(imidazole( (trace(not(shown).(Once( this(had(been(established,(200mL(of(hFcµ2Z4His( filtered( tissue( culture( supernatant( was( run( over( the( nickel( NTA(column( and( desalting( column( in( sequence,( in( the( binding( buffer.( To( elute( the(protein,(the(elution(buffer((binding(buffer(with(400mM(imidazole)(was(run(over(the( nickel( NTA( column( and( desalting( column( in( sequence( (Figure( 3.13).( The(resulting(trace(showed(a(clear(elution(peak(and(these(fractions(were(successfully(pooled(and(size(exclusion(chromatography(was(used(to(analyse(the(protein(eluted((Figure(3.14).((
(
Figure# 3.13# Nickel# NTA# affinity# chromatography# purification# with# a#



















elution#peak#Fractions( from( elution( peak( from( affinity( chromatography(were( pooled( and( separated(using(SEC(with(Superdex(200.(PBS(was(used(as(elution(buffer.(Flow(rate(0.75ml/minute.(8(fractions(were(collected(from(Figure(3.13,(and(each(line(represents(a(fraction(eluted:(1)(Dark(Green,(2)(Magenta,(3)(Red,(4)(Cyan,(5)(Light(Green,(6)(Orange,(7)(Purple(and(8)(Dark(Blue.((((The( resulting( SEC( trace( showed( that( within( the( affinity( chromatography( peak(there( were( several( different( sized( proteins.( These( were( further( analysed( to(determine( whether( they( were( degradation/aggregation( of( the( hFcµ2Z4His( or(contaminating(proteins.(An(SEC(analytical( run(was(performed(by(reZinjection(of(the( fractions( highlighted( in( Figure( 3.14,( and( this( showed( that( each( peak( was(indeed(a(distinctive(size((Figure(3.15A).(This(indicated(that(it(was(most(likely(that(the(distinct(peaks(were(contaminating(proteins,(although(even(if(the(protein(was(
Time%(minutes)%























Figure#3.15#Analysis#of#peaks#from#SEC#A)(Analytical( SEC( run(of( fractions(4,(7,( 10,(13,(16,(19(and(22( (Figure(3.14)( reZinjected;(these(are(shown(in(dark(blue,(orange,(light(green,(cyan,(red,(purple(and(pink(respectively.(Flow(rate(0.75ml/min.(UV(absorbance(at(280nm.(B)(12%(SDSZPAGE(with(page(ruler(preZstained(protein(ladder((Fermentas)(Lanes(1Z7(fraction(of(first(7(peaks(of(SEC(trace((panel(A).( Stained( with( Instant( Blue( C)( Western( blot( analysis( of( identical( SDSZPAGE( gel(transferred(to(nitrocellulose(and(stained(with(antiZIgM(antibody((Chapter(2,(page(65).(((In( order( to( improve( the( quality( of( protein( once( following( affinity( purification,(three( different( buffers( (including( PBS)(were( screened( to( ascertain(whether( the(protein( was( more( stable( in( another( buffer.( PBS,( TBS( and( HBS( were( screened.(200ml( of( hFcµ2Z4His( supernatant( was( run( over( a( nickel( NTA( column( and( the(fractions( were( pooled.( The( pooled( fractions( were( split( into( 3( aliquots( and(dialysed( into( each( of( the( different( buffers( overnight.( ( After( the( dialysis( the(amount(of(protein(recovered(was(compared(with(the(amount(of(protein(originally(present.( The( phosphate( buffer( showed( the(worst( results(with( only( 48%( of( the(
Time%(minutes)%





























protein(recovered.(The(HBS(buffer(had(60%(recovery(of(protein(and(the(TBS(had(a( 70%( recovery( of( protein.(None( of( these( results( are( optimal,( but( the(TBS(was(significantly(better(than(the(PBS(and(HBS(and(so(the(phosphate(in(the(binding(and(elution(buffer(was(removed(and(replaced(with(50mM(Tris.(100mL(of(hFcµ2Z4His(filtered(tissue(culture(supernatant(was(run(over(a(fresh(column(with(TBS(instead(of( PBS( and( the( resulting( trace( showed( almost( double( the( amount( of( protein(eluted(in(comparison(with(the(runs(performed(with(PBS.(((
(
Figure#3.16#Nickel#NTA#affinity#chromatography#using#TBS#100ml( of( hFcµ2Z4His( filtered( tissue( culture( supernatant( bound( to( nickel( NTA( column(using( recommended( conditions( but( with( TBS( instead( of( phosphate( buffer.( Wash( and(elution(were(performed(in(separate(manual(runs(in(quick(succession.(Fractions(1Z6(were(pooled.( Flow( rate( 1ml/min.( Blue( line( indicates( UV( absorbance( at( 280nm( and( red( line(indicates(conductivity((units(not(shown(on(y(axis).(Conductivity(shows(difference(in(salt(concentration(and(indicates(a(change(in(buffer.((The(fractions(peaks(from(the(affinity(chromatography(run(were(pooled(and(SEC(was( performed( (Figure( 3.17).( This( trace(was( an( improvement( on( the( previous(runs(and(indicated(that(the(protein(was(more(stable(in(the(TrisZbased(buffer(than(the(phosphateZbased(buffer.(SDSZPAGE(was(performed(on(the(fractions(marked(in(Figure(3.17.(This(showed(that(fraction(15(contained(mainly(purified(hFcµ2Z4His(at(the(expected(molecular(weight(of(~100KDa( (78KDa(protein(plus( carbohydrate)(
Wash% Elute%
Time%(minutes)%















with( a( small( amount( of( the( single( chain,( expected( molecular( weight( 40KDa((Figure(3.18).(Fraction(16(of(Figure(3.17(is(run(on(lane(3(of(Figure(3.18,(and(there(is(no(discernable(band(of(hFcµ2Z4His( suggesting( the(elution(peak(contains( some(contamination.(
(
Figure# 3.17# Size# exclusion# chromatography# of# nickel# NTA# column# elution#
peak#Fractions(pooled(from(Figure(3.16(and(separated(using(SEC(with(Superdex(200.(TBS(was(used( as( elution( buffer.( 1XZ6X( denotes( fractions( used( for( SDSZPAGE( analysis( in( Figure(3.18.(Flow(rate(0.75ml/minute(((
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Figure#3.19##Optimised#nickel#NTA#affinity#chromatography#purification#Example( elution( profile( of( affinity( purification( of( pFcε2Z4His( from( tissue( culture(supernatant,(using(nickel(NTA(column(followed(by(a(desalting(column.(Is(comparable(for(all(other(proteins.(The(elution(of(the(protein(was(achieved(with(400mM(imidazole.(Flow(rate(1ml/minute.(UV(absorbance(is(at(280nm.(((
(
Figure#3.20#Optimised#size#exclusion#chromatography#Example(elution(profile(of(SEC(of(pFcε2Z4His(using(SuperdexTM(200.(Is(comparable(for(all(other( proteins.( Flow( rate( 0.75ml/minute.( Proteins( were( eluted( between( 10( and( 25(minutes(according(to(their(respective(sizes.(Blue(line(indicated(absorbance(at(280nm.((
Wash% Elute% Wash%%
Time%(minutes)%





























Figure#3.21#SDS#PAGE#analysis#of#purified#antibodies#12%( SDSZPAGE( showing( in( first( lane( of( all( panels( the( marker( page( ruler( preZstained(protein(ladder((Fermentas).(Stained(with(Instant(Blue.(The(expected(band(for(hFcµ2Z4His(is(77KDa(without(glycosylation((dimer(38KDa(without(glycosylation).(The(expected(band(for( cFcυ2Z4His( is( 77KDa( without( glycosylation;( the( three( bands( may( indicate( three(distinct( glycosylation( states.( The( expected( band( for( pFcε2Z4His( is( 77KDa( without(glycosylation.(The(expected(band( for(hFcµ3Z4His( is(51KDa(without(glycosylation( (dimer(25KDa(without(glycosylation).((((




























de1glycosylation#12%( SDSZPAGE( showing( in( first( lane( of( all( panels( the( marker( page( ruler( preZstained(protein(ladder((Fermentas).(Stained(with(Instant(Blue.(DeZglycosylation(performed(using(PNGaseF(enzyme,(this(enzyme(is(36KDa(and(red(arrows(indicate(its(position(on(gel.(For(each( protein( left( panel( shows( glycosylated( reduced( protein( band( (orange( arrows)( and(right(panel(shows(deZglycosylated(band((green(arrows).(In(all(cases(the(deZglycosylated(band( is( smaller( than( the( glycosylated( band.( The( sizes( of( the(molecular(weight(marker(appear( to( be( slightly( incorrect( as( PNGaseF( is( 36KDa( and( the( deZglycosylated( proteins(should( run( at( 38KDa,( however( the( correct(pattern( is( present( showing( that( the(protein(has(been(successfully(deZglycosylated(and(that(it(is(~4KDa(smaller(than(the(glycosylated(protein.((

















al.,(2007)(compared(crystal(structures(with(and(without((His)6Ztags(and(showed(that( purification( tags( do( not( generally( have( a( significant( effect( on( protein(structure((Previous( structural( studies( of( human( and( mouse( IgM( have( focused( on( both(commercially( bought( whole( human( IgM( (Czajkowsky( and( Shao,( 2009),( human(and(mouse(IgM(purified(from(human/mouse(serum(and(digested((Perkins(et#al.,#1991)(or(mouse(IgM(purified( from(E.coli( (Müller(et#al.,(2013).(Other(methods(of(whole( monoclonal( IgM( purification( include( purification( using( hybridoma( cell(lines((Apiratmateekul(et#al.,(2009)(and(purification(using(Sepharose(coated(with(2Zmercaptopyridine.(There(no(published(methods(for(purification(of(human(IgM(recombinantly( or( mouse( IgM( in( mammalian( tissue( culture.( Proteins( made(recombinantly( in( E.coli( can( encounter( problems( with( protein( folding.( Proteins(with(many(cysteine(residues(can(misZfold(and(be(hard(to(refold(correctly.(It(is(of(course(possible(to(successfully(reZfold(antibody(domains(made(in(E.coli(however(the(more(artificial(the(process(the(more(room(there(is(for(error.(Producing(IgM(in(mammalian( cell( culture( allows( for( native( glycosylation( and( correct( protein(folding(without(any(other(artificial(reZfolding(steps.(The(conserved(glycosylation(site( may( be( important( functionally( as( it( is( conserved( in( all( of( the( antibodies,(whereas(the(other(glycosylation(sites(are(not.(((
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The( crystal( structure( of( chicken( IgY( domains( Cυ3( and( Cυ4( in( the( cFcυ3Z4(fragment( has( been( determined( and( this,( along( with( cFcυ2Z4( was( made(recombinantly( in( NS0( mouse( myeloma( cells( (Taylor( et# al.,( 2008,( 2009).( This(construct( contains( a( C340S( and( the( glycosylation( site( mutation( N307Q.( This(construct( was( used( as( a( basis( for( the( cFcυ2Z4( construct( used( in( this( thesis,(however(NS0(mouse(myeloma(cells(were(not(used.(The(protein(yields( from( the(NS0(cell(line(were(low(and(so(Method(1(was(initially(used(and(then(Method(2(to(make(cFcυ2Z4(and(cFcυ2Z4His(respectively.(These(methods(led(to(an(improvement(in( the( protein( yield( from( around( 1mg/litre( to( an( average( of( 5.3mg/litre.( The(protein(produced(using(the(method(in((Taylor(et#al.,(2008),(Method(1(and(Method(2( all( show( a( pattern( of( three( bands( ranging( from( 70KDa( to( 100KDa.( The(theoretical( molecular( weight( with( the( (His)6Ztag( attached( without( the(glycosylation( is( 77,042( Da.( In( the(MS( analysis( individual( glycoforms( cannot( be(resolved.( Chicken( IgY( contains( both( high( mannose( and( complex( type(glycosylation.( The( mutated( Asn308( site( has( complex( glycosylation,( the(glycosylation( site( Asn407( is( highZmannose( (Suzuki( and( Lee,( 2004).( The( study(performed( by( Suzuki( and( Lee( used( IgY( from( chicken( serum,( however( this(glycosylation( pattern( is( also( seen( in( IgY(made( recombinantly( in( HEK( 293( cells((Kondo(et#al.(2012).(There(is(no(published(experimental(analysis(of(platypus(IgE(glycosylation( and( so( the( assumption( has( been( made( that( is( also( has( a( high(mannose(glycosylation,(as(the(conserved(site(in(both(human(IgE(and(chicken(IgY(contain(high(mannose.(((To(further(the(carbohydrate(analysis(of(these(proteins(the(methods(described(in((Suzuki(and(Lee,(2004;(Arnold(et#al.,#2006;(Kondo(et#al.,(2012)(could(be(used(to(
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unambiguously( determine( the( carbohydrate( present( on( the( conserved(glycosylation(site.((In(conclusion,(constructs(were(designed(of(pFcε2Z4/(pFcε2Z4His,(cFcυ2Z4/(cFcυ2Z4His,( hFcµ2Z4/( hFcµ2Z4His( and( hFcµ3Z4His.( These( constructs( had( mutations(introduced( from( NZQ( in( all( but( the( conserved( glycosylation( site( to( reduce(heterogeneity(of(the(proteins(produced.(The(NZterminal(cysteine,(which(natively(binds( to( the( light( chains,( was( removed( to( prevent( nonZnative( disulphide( bond(formation.( Two(methods( of( producing( the( recombinant( antibody( Fc( fragments(have( been( successfully( developed.( Both( of( these(methods( have(merit,( however(the( second( method( was( on( balance( selected( as( the( superior( method( of(purification.( Protein(purified(during( the( second(method(was( analysed(by(MS( in(order( to( identify( the( accurate( molecular( weight( of( the( proteins,( thereby(identifying( the( dominant( glycoforms( present.( Although( individual( glycoforms(could( not( be( identified,( the( dominant( glycoform( identified( for( cFcν2Z3His( was(GlcNAc2Fuc1MAN3(and( for(pFcε2Z4His(was(GlcNAc2Fuc1Man6.(There(as(been(some(work(published(on(the(glycosylation(of(chicken(IgY((Suzuki(and(Lee,(2004;(Kondo(
et# al.,( 2012)( however( currently( this( is( the( first( analysis( of( platypus( IgE(carbohydrate(that(has(been(performed.(
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Chapter(4 CRYSTALLISATION(TRIALS(4.1 Overview(The( ability( to( determine( the( threeZdimensional( structures( of( proteins( and(DNA(has( dramatically( influenced( understanding( of( how( healthy( organisms( function,(what( happens( when( this( goes( wrong( in( disease( and( how( this( can( be(prevented/treated.( One( of( the( most( important( ways( to( determine( these(structures(is(using(XZray(diffraction.(The(structure(of(DNA(was(determined(using(XZray( fibre( diffraction,( and( one( of( the(most( successful(methods( of( determining(highZresolution( protein( structures( is( XZray( crystallography.( However,( the(main(bottleneck(for(XZray(crystallography(is(the(availability(of(wellZordered(crystals.(((In(order(to(examine(closely(the(structure/function(relationships(of(proteins(that(are( evolutionarily( related( to( human( IgE,( crystal( structures( would( be( very(instructive.( Structural( studies( of( immunoglobulin( M( (IgM)( have( not( led( to( a(crystal(structure(of(the(Fc(region((which(comprises(the(murine(Cµ2,(Cµ3(and(Cµ4(domains)( and( neither( has( there( been( a( crystal( structure( of( Fcµ3Z4( (which(comprises(the(Cµ3(and(Cµ4(domains).(The(crystal(structures(of(the(Cµ2(and(the(Cµ4(domains( individually(have(been(determined((Müller(et#al.,(2013),(but( these(do( not( tell( us( any( information( about( the( arrangement( of( the( domains.( As(described(in(Chapter(1,(the(mouse(Cµ4(domain(was(found(to(have(a(novel(mode(of(association.(A(crystal(structure(of(IgY(Fcυ3Z4((which(comprises(the(Cυ3(and(Cυ4(domains)( has( been( determined( (Taylor( et# al.,( 2007).( This( shows( that( IgY( has(features( of( both( human( IgE( and( IgG( as( discussed( in( Chapter( 1.( The( crystal(structure( of( IgYZFc( (which( comprises( the( Cυ2,( Cυ3( and( Cυ4( domains)( would(
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4.3.1 XZray#crystallography#In(order(for(our(eyes(to(perceive(an(object,(our(brain(interprets(visible(light(rays(scattered(by(an(object,(after(focusing(by(the(lens(in(our(eyes.(The(object(must(be(roughly( no( smaller( than( the( wavelength( of( the( light( in( order( for( the( object( to(scatter( the( light.( Scattering( from( a( single( protein(molecule( can( in( principle( be(achieved(using(XZrays,(although(it(is(not(currently(possible(to(produce(a(focused(image( of( a( single( molecule( for( two( reasons.( The( first( reason( is( that( a( single(molecule(scatters(XZrays(too(weakly,(and(the(second(is(that(no(lens(exists(to(focus(XZrays.(We(can(overcome(both(these(problems(by(using(XZray(crystallography,(a(technique( whereby( diffraction( is( obtained( from( a( crystalline( protein.( The( first(problem(is(overcome(by(using(a(crystal,(as(the(ordered(protein(molecules(diffract(and( amplify( the( signal,( thus( explaining( the( need( for(wellZordered( crystals.( The(second( problem( is( overcome( by( measuring( the( intensities( of( the( spots( in( the(diffraction( pattern( and( mathematically( calculating( the( electron( density( image.(This(requires(also(solving(the(phase(problem,(which( in(this( thesis(was(achieved(by(a(technique(known(as(molecular(replacement,(as(described(in(Chapter(2((page(75).((
4.3.2 Growing#protein#crystals#Protein(crystals(form(when(protein(molecules(dissolved(in(solution(precipitate(in(an(ordered(arrangement.(Such(crystals(are(grown(by(slow(precipitation(of(protein(out(of(solution,(and(the(conditions(that(enable(this(are(different(for(every(protein.(In(order( to(grow( large(single(crystals( for(diffraction(studies(conditions(must(be(optimised( (Figure(4.1).( If( either( the(protein( or( precipitation( concentrations( are(
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too( high( the( protein( will( precipitate( out( of( solution( too( quickly,( leaving( an(amorphous((disordered)(precipitate;(if(they(are(too(low(the(protein(will(remain(in(solution.(In(order(to(form(a(crystal(the(first(few(protein(molecules(must(arrange(themselves( in( an(ordered(way( forming(a(nucleation( site.(Once(a(nucleation( site(has( formed,( lower( concentrations( of( protein( and/or( precipitate( can( support(crystal(growth.(The(aim(is(to(create(a(situation(where(a(few(nucleation(sites(form(and(the(rest(of( the(protein(molecules(are( then(available( to(build(up(the(crystals((Figure(4.1).(
(










where( there( is( a( reservoir( containing( a( precipitant( in( solution( and( a( drop( of(protein( mixed( with( reservoir( on( a( raised( platform.( The( drop( will( slowly(equilibrate( to( the( surrounding( conditions( causing( slow( changes( in( protein( and(precipitation(concentrations,(encouraging(crystal(formation((Figure(4.2).((
(
Figure#4.2#Sitting#drop#vapour#diffusion#schematic#The(reservoir(contains(precipitant(solution(and(each(drop(is(made(up(of(a(different(ratio(of( protein/reservoir.( The( drop( and( reservoir( are( then( sealed;( this( allows( for( diffusion(through( the( vapour( phase( between( the( reservoir( and( the( drop,( which( allows( the(precipitant(and(protein(concentration(to(slowly(change,(leading(to(crystal(growth.((
4.3.3 Judging#crystal#quality#The(ultimate(way(to(judge(crystal(quality(is(to(perform(a(diffraction(experiment,(but(there(are(a(few(hallmarks(of(wellZdiffracting(crystals,(such(as(sharp(edges,(and(smooth( faces,( and( they( will( often( appear( brighter( or( change( colour( under(polarised(light((birefringence).(((






very( obvious(where( the( protein( backbone( and( sideZchains( should( be(modelled,(however(the(lower(the(resolution(of(the(diffraction(pattern,(the(lower(the(quality(of( the( resulting( electron( density(map( (Figure( 4.3).( Lower( resolution( diffraction(can( also( make( solving( the( phase( problem( difficult,( and( without( this( electron(density(cannot(be(calculated.((
(
Figure#4.3#The#importance#of#high1resolution#diffraction#Each(panel(shows(the(electron(density(calculated(from(diffraction(data(at(the(resolution(in(Å(specified(in(the(top(left(hand(corner(of(the(panel.(The(electron(density(is(the(white(mesh(and(the(yellow(backbone(is(the(protein(modelled(into(that(electron(density.(All(the(electron(density(is(shown(at(the(1σ(level.((
4.3.5 Radiation#damage#During(the(diffraction(experiment(the(protein(crystal(is(exposed(to(radiation,(and(this(begins( to(disrupt( the(molecules(and(disorder( the(crystal.(Primary(radiation(
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damage( is( dose( dependent( and( causes( photoelectrons( to( be( created( that( can(disrupt( the( protein( molecules( and( water( in( the( crystal;( this( is( an( unavoidable(consequence(of(XZray(crystallography.(Secondary(radiation(damage(is(caused(by(the( creation( of( free( radicals( principally( OHZ,( and( this( is( especially( damaging( in(high(solvent( crystals(as( radiolysis(of(water( can( lead( to(hydrated(electrons.(This(damage(can(be(significantly(reduced(if(the(crystal(is(cryoZcooled,(or(by(reduction(of( the( time( that( the( crystal( spends( in( the( XZray( beam.( Radiation( damage( can(prevent(a(complete(data(set(from(being(collected(from(a(crystal,(because(although(the( crystal(may(have( shown(highZresolution(diffraction( to(begin(with,( radiation(damage(can(quickly(destroy(the(crystal.((
4.4 Crystallisation(of(Human(IgMZFc(





























1/σ(I)# 15.4(2.4)(Brackets(indicated(highest(resolution(shells(Rmerge:(! = ! !!!",!! !!!"!!!" !!!",!!!!" ((
4.4.2 Post#crystallisation#treatments#of#hFcµ2Z4#The(diffraction(of(crystals(grown(in(the(ammonium(sulphate(24Zcondition(screen(were( not( of( high( enough( resolution( to( determine( the( crystal( structure.( As( the(crystals(were(so(promising,(several(postZcrystallisation(techniques(were(used(to(try(and(improve(the(diffraction(resolution.(




4.4.2.2 CrossZlinking#If(a(crystal( is(chemically(crossZlinked(before(cryoZprotection,( it(can(help( to(hold(the(crystal(in(an(ordered(state(and(increases(its(mechanical(strength,(protecting(it(from(any(lattice(disorder(created(from(the(cryoZprotection.(The(hFcµ2Z4(crystals(were(crossZlinked(using( the(method(described(by(Heras(&(Martin(2005.(Briefly,(crystals(were(transferred(from(the(crystallisation(drop(to(a(coverslip(containing(2µl(of(stabilising(solution((the(condition(for(which(the(crystal(was(grown(in).(This(coverslip( was( suspended( over( a( 400μl( reservoir( of( stabilising( solution,( with( a(microbridge(containing(2μl(of(25%(glutaraldehyde.(This(was(left(to(equilibrate(for(30( minutes,( 90( minutes,( 3( hours( and( 5( hours.( Crystals( that( were( crossZlinked(showed( minor( improvement( in( diffraction( compared( with( the( other( crystals(tested,(with(the(majority(of(the(crystals(diffracting(between(8(and(10Å(resolution,(and( the( crossZlinked( crystals( diffracting( between( 7( and( 8Å( resolution.( The(crystals( that( had( undergone( equilibration( for( 30Z90(minutes( showed( improved(diffraction.( The( crystals( that( had( been( left( to( equilibrate( for( 3( hours( or( more,(showed(poorer(diffraction.((




4.4.2.4 Macroseeding#To(increase(the(size(of(some(of( the(smaller(hFcµ2Z4(crystals,(macroseeding(was(performed.(This(technique(involved(transferring(previously(grown(small(hFcµ2Z4(crystals(through(a(series(of(wash(steps,(into(a(condition(of(lower(superZsaturation(to( encourage( further( crystal( growth,( rather( than( promoting( new( crystal(formation.(The(crystals(were(sealed(up(in(the(final(condition(but(this(consistently(led(to(dissolution(of(the(crystals(after(an(over(night(soak.((
4.4.2.5 “Silver#Bullet”#screening#A(“Silver(Bullet”(screen(is(a(commercial(screen((Hampton(Research)(that(contains(a(selection(of(small(molecules(that(have(been(shown(to(stabilise(crystal(formation(by( promoting( hydrogen( bonding( and( electrostatic( interactions.( A( 96( well(crystallisation(plate(was(set(up(with(12%(PEG(8K,(0.1M(ammonium(sulphate(and(0.1M(Tris(pH(9.0(in(all(of(the(reservoirs.(The(drops(contained(1000nL(protein(at(3mg/ml,( 250nL( of( “Silver( Bullet”( condition( and( 250nL( of( reservoir.( The( drops(remained(clear(and(no(crystals(grew.((
4.4.2.6 Soaking#Soaking( crystals( in( solutions( with( a( higher( ionic( strength( has( been( shown( to(improve( crystal( quality.( Unlike( dehydration,( this( method( does( not( attempt( to(
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shrink( the( crystal( lattice( (Heras( &( Martin( 2005).( The( hFcµ2Z4( crystals( were(transferred( from( the( crystallisation( drop( to( 2µl( of( stabilising( solution( and(suspended(over(a(400μl( reservoir(of( the( same(solution,(but( supplemented(with(either( 10( or( 20%( ethylene( glycol,( 20( or( 30%( sucrose,( 0.2M( or( 0.4M( lithium(sulphate.(This(was(left(to(equilibrate(for(30(minutes.(The(majority(of(the(crystals(showed(little(or(no(diffraction(and(crystal(quality(was(worse(than(control(crystals(that(had(not(been(treated.(The(only(exception(was(with(20%(sucrose,(where(the(crystal(quality(remained(similar(to(control(crystals.(
 
4.4.2.7 Streak#seeding#Streak(seeding(can( improve(crystal(quality(by(allowing( fewer,( larger( crystals( to(grow.( A( cat’s( whisker( is( used( to( touch( an( already( formed( crystal,( removing( a(microscopic( nucleation( site.( The( cat’s( whisker( can( then( be( dipped( into( new(conditions( allowing( the(nucleation( sites( to( be(deposited.( This( technique( can(be(used( to( allow( larger( crystals( to( grow( by( providing( the( nucleation( sites( and(conditions( that( only( support( growth( (Figure( 4.1).( The( hFcµ2Z4( crystals( were(touched(with(a(cat’s(whisker(and(this(was(dipped(into(a(preZequilibrated(screen.(The(drops(remained(clear(and(no(crystals(grew.((
4.4.2.8 Temperature#screening#Altering( the( temperature( at( which( the( protein( crystals( are( grown( can( cause(crystallisation(to(occur(faster(or(slower(depending(on(what(is(required.(Growing(crystals(more( slowly(may( improve( their( degree( of( order.( The( hFcµ2Z4( crystals(were(grown(at(18°C.(To(investigate(the(effect(of(temperature,(the(conditions(14%(
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PEG( 8K,( 0.1M( Tris( pH7.5( and( 0.2M( ammonium( sulphate( were( set( up( at( five(different( temperatures,( using( the( TG40( device( as( described( in( Chapter( 2( (page(69).(The(temperatures(screened(were(22°C,(18°C,(14°C,(10°C(and(6°C.(Drops(were(set(up(with(2µl(of(protein,(1µl(of( reservoir(and( they(were(streak(seeded(with(a(cat’s(whisker.(The(crystals(failed(to(grow(at(any(of(the(temperatures(screened.((




Figure#4.5#hFcµ214#crystal#diffraction#Top(left(hand(panel(shows(crystals(grown(in(14%(PEG(8K,(0.1M(ammonium(sulphate(and(0.1M(Tris(pH(7.5.(Arrow(indicates(crystal(tested(at(Diamond(Light(Source.(Top(right(panel(shows(cryoZcooled(crystal( in(nylon( loop.(Diffraction( images( from(left( to(right(show(test(images(at(0°,(60°(and(90°,(see(Chapter(2((page(130)(for(more(details.((Images:(Dr(Nyssa(Drinkwater)((











Figure#4.7#The#hFcµ214His#crystals#grown#from#new#conditions#A)(Crystals(grown( in(20%(PEG(8K,(0.2M(ammonium(sulphate(and(0.1M(MES(pH(6.5.(B)(Example( of( crystal( cryoZprotected( in( a( nylon( loop( at( Diamond( Light( Source( C)( Best(diffraction(obtained(from(these(crystals;(arrow(indicates(diffracts(to(9Å(resolution.(This(has(been(attributed(to(serendipitous(dehydration(of(the(crystal(before(cryoZcooling.((
4.5 Crystallisation(of(platypus(IgE(






Figure#4.8#pFcε214#crystals#in#lithium#sulphate#241condition#screen#A)(Hit(conditions(17%(PEG(8K,(0.1M(BisTrisPropane(pH(6.5(and(0.2M(lithium(sulphate.(Drop:( 2000nL( protein( added( to( 1000nL( reservoir.( Protein( concentration( 1.6mg/ml.( B)(Hit(condition(18%(PEG(8K,(0.1M(BisTrisPropane(pH(6.5(and(0.2M(lithium(sulphate.(Drop:(2000nL( protein( added( to( 1000nL( reservoir.( Protein( concentration( 1.6mg/ml.( C)( Hit(conditions(14%(PEG(8K,(0.1M(BisTrisPropane(pH(6.5(and(0.2M( lithium(sulphate.(Drop:(2000nL(protein(added(to(1000nL(reservoir.(Protein(concentration(1.6mg/ml.((The(24Zcondition( lithium(sulphate(screen(gave(rise( to(many( fine(needles.(These(needles(were(fragile(and(extremely(hard(to(handle(and(cryoZcool(without(causing(damage(to(the(crystals.(The(best(diffraction(seen(from(these(crystals(was(to(12Å(resolution((Figure(4.9).((
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4.5.2 Post#crystallisation#treatments#of#pFcε2Z4#In( order( to( try( to( strengthen( and( enlarge( the( crystals,( a( number( of( postZcrystallisation(treatments(were(attempted.((
4.5.2.1 Additive#screening#As( explained( previously( with( hFcµ2Z4,( additive( screening( can( stabilise( and(enhance( crystallisation.( An( additive( screen( (Hampton( additives( screen)( was(performed( on( pFcε2Z4.( A( 96( well( plate( was( set( up( using( the( conditions( 0.1M(sodium(citrate(pH(5.5.(The(drop(setup(was(1000nL(of(protein,(250nL(of(additive(screen(and(250nL(of(reservoir.(No(crystals(grew.((
4.5.2.2 Macroseeding#As( explained( previously( with( hFcµ2Z4,( macroseeding( can( be( used( to( try( to(increase( crystal( size.( The( pFcε2Z4( crystals( grown( were( all( fine( single( needles,(which(are(hard( to(handle.(Crystals(were( too( fragile( to(move(and(so( the(drop( in(which( they( were( grown( was( gently( diluted( in( four( steps( to( reduce( the( superZsaturation(of( the(drop.( (Most(of( the(crystals(dissolved,(however(a( few(remained(and(these(were(successfully(cryoZcooled,(and(one(showed(clear(diffraction(to(10Å(resolution.(Only(one(image(was(obtained(and(the(crystal(quickly(deteriorated(due(to(radiation(damage.((
4.5.2.3 Temperature#screening#As(explained(previously(with(hFcµ2Z4,( altering( the( temperature( can( change( the(rate(at(which(crystals(grow.(Two(pFcε2Z4(conditions(were(tested,(14%/16%(PEG(
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8K,( 0.4M( lithium( sulphate,( 0.1M( BisTrisMethane( pH( 6.5( at( five( different(temperatures(using(the(TG40(device((see(Chapter(2,(page(69).(The(temperatures(screened(were(25°C,(21°C,(17°C,(13°C(and(9°C.((The(drops(were(streak(seeded.(At(25°C( no( crystals( grew( and( at( the( lower( temperatures,( more( precipitation(occurred.((
4.5.3 Capillary#diffusion#Instead(of(using(the(vapour(diffusion(method(of(crystallisation,(liquid(or(capillary(diffusion(can(be(used.(This(involves(putting(the(precipitant(solution(on(one(side(of(the( capillary( and( the( protein( solution( on( the( other( side( and( allowing( the( two(solutions(to(mix(slowly(by(diffusion,(permitting(crystal(formation(in(the(capillary.((The(CrystalHarp™(system((Molecular(Dimentions)(was(used( to( try( to(crystallise(pFcε2Z4.(This(system(has(two(advantages(compared(with(vapour(diffusion.(Firstly(the( capillaries( can( be( cryoZprotected( and( directly(mounted( onto( the( beamZline,(ensuring( the( crystals( are( not(mechanically( damaged.( Secondly( a(much( broader(range(of(protein/precipitant(concentrations(can(be(tested(within(one(capillary,(as(the(protein/precipitant(concentration(will(vary(along(the(capillary,(whereas(in(a(drop(the(protein/precipitant(concentration(will(be(evenly(distributed(throughout(the(drop.(A(CrystalHarp™(plate(was(set(up(using(the(manufacturer’s(instructions.(The(precipitation(conditions(were(14(and(16%(PEG(4K,(0.2M(lithium(sulphate(and(0.1M( Tris( pH( 7.0( and( 7.5( and( the( protein( concentration( was( at( 1.5mg/ml.( No(crystals( grew( and( so( CrystalHarp™( plates( were( set( up( with( the( ProComplex((Qiagen)(commercial(screen.(Crystals(failed(to(grow(in(any(of(the(96(conditions.(((
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Figure#4.10#Protein/seed#concentration#optimisation#screen#Schematic( of( a( MRC( Wilden( crystallisation( plate( (Hampton( Research).( There( are( 96(reservoirs,(labelled(A1,(A2(etc(to(H12.(Protein(and(seed(concentration(were(optimised.(1,(2,( 3( and( 4( refer( to( four( crystallisation( conditions( used.( Each( condition( was( tested( in(duplicate,(with( four( different( protein( concentrations,( 0.45mg/ml,( 0.9mg/ml,( 1.4mg/ml(and(1.8mg/ml(and(three(different(seed(concentrations:stock,(1:10(and(1:20(dilutions.(For(example( A1( contains( 18%( PEK( 8K,( 0.1M(Mes( pH( 5.5,( 0.2M( ammonium( sulphate,( 0.45(mg/ml(of(protein(and(seed(stock.(Upper(drops(contained(500nL(protein,(400nL(reservoir(and(100nL(seed,(lower(drops(contain(500nL(protein,(150nL(reservoir(and(100nL(seed.((

























identical(conditions(to(the(previous(hit.(The(hit(from(E6(ProComplex(was(selected(to( be( the(next(most( promising( as( the(drop( contained(many( fine( single( needles.(The( hit( conditions( were( 12%( PEG( 8K,( 0.1M( calcium( acetate( and( 0.1M( sodium(cacodylate(pH(6.5.(This(was(expanded(to(a(24Zcondition(screen:(8Z18%(PEG(8K(in(1%(increments(giving(rise(to(six(PEG(concentrations(and(0.1M(sodium(cacodylate(pH(5.0Z6.5(in(0.5(pH(unit(increments,(giving(rise(to(four(different(pH(conditions.(This(will(be(referred(to(as(the(24Zcondition(sodium(cacodylate(screen.(((
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Figure(4.12(shows(the(results(of( the( first(round(optimisation(screens( for(pFcε2Z4His.(Panels( A,( B,( C( and( D( show( selected( results( from( the( 24Zcondition( sodium(citrate( screen( and( panels( E( and( F( show( selected( results( from( the( 24Zcondition(sodium(cacodylate(screen.(For(both(screens(the(crystals(are(larger(than(the(initial(hits,(although(none(of(the(crystals(are(ideally(suited(for(a(diffraction(experiment.(((





















Figure# 4.14# Results# from# first# protein# concentration/seed# optimisation# of#















Figure# 4.15# Results# from# first# protein# concentration/seed# optimisation# of#








Figure# 4.16# Results# from# first# protein# concentration/seed# optimisation# of#
















Figure# 4.18# Sodium# citrate# results# for# second# protein/seed# concentration#








Figure# 4.19# Sodium# cacodylate# results# for# second# protein/seed#






















Figure# 4.21# Results# of# third# protein# concentration/seed# optimisation# of#





















Figure#4.23#Results#of#protein#buffer#screen#for#pFcε214His#A)(Conditions(are(18%(PEG(6K(and(0.1M(sodium(citrate(pH(5.5.(The(drop(was(set(up(with(500nL(protein(and(500nL(reservoir,(the(protein(concentration(was(0.89(mg/ml(and(the(protein(was(in(the(buffer(0.1M(sodium(phosphate(pH(7.0.(B)(Conditions(are(18%(PEG(6K(and( 0.1M( sodium( citrate( pH( 5.5.( The( drop(was( set( up(with( 500nL( protein( and( 250nL(reservoir,( the( protein( concentration(was( 1.0(mg/ml( and( the( protein(was( in( the( buffer(0.1M(MES(pH(6.2.(C)(Conditions(are(18%(PEG(6K(and(0.1M(sodium(citrate(pH(5.5.(The(drop(was(set(up(with(500nL(protein(and(500nL(reservoir,(the(protein(concentration(was(0.95(mg/ml(and(the(protein(was(in(the(buffer(0.1M(HEPES(pH(7.5.(D)(Conditions(are(16%(PEG(6K(and(0.1M(sodium(citrate(pH(5.5.(The(drop(was( set(up(with(500nL(protein( and(250nL(reservoir,( the(protein(concentration(was(0.77(mg/ml(and(the(protein(was( in(the(buffer(TBS.(E)(Conditions(are(16%(PEG(6K(and(0.1M(sodium(citrate(pH(5.5.(The(drop(was(set( up( with( 500nL( protein( and( 500nL( reservoir,( the( protein( concentration( was( 1.05(mg/ml(and(the(protein(was( in(the(buffer(0.1M(sodium(citrate(pH(5.5.(E)(Conditions(are(16%(PEG(6K(and(0.1M(sodium(citrate(pH(5.0.(The(drop(was(set(up(with(500nL(protein(and(250nL(reservoir,(the(protein(concentration(was(0.60(mg/ml(and(the(protein(was(in(the(buffer(0.1M(BisTrisPropane(pH(6.5.((









4.5.8 MicroZseed#matrix#screening#MicroZseeding(is(a(method(whereby(crystals(are(grown(in(a(different(condition(to(the(one(in(which(the(seed(has(been(grown((Ireton(and(Stoddard,(2004).(Crystals(grown(in(the(24Zcondition(sodium(citrate(screen(were(made(into(seed(stock(and(this(was(used(with(the(four(commercial(screens(used(above.(The(result(shows(the(expected( crystals( in( the( conditions( where( there( is( sodium( citrate( present,( but(there(were(no(other(promising(hits(in(other(conditions.((
4.6 Crystallisation(of(chicken(IgY(
4.6.1 Initial#Hits#cFcυ2Z4#Dr.( Nyssa( Drinkwater( found( two( hit( conditions,( 20%( PEG3350( and( 0.2M( triZsodium( citrate( and( 20%( PEG( 3350( and( 0.2M( potassium( thiocyanate.( These(conditions(were( developed( into( 24Zcondition( screens;( 18Z24%( PEG( 3350,( with(2%(increments,(giving(rise(to(six(PEG(concentrations(and(0.2M(triZsodium(citrate(pH( 4.5Z6.0( in( 0.5( pH( unit( increments( giving( rise( to( four( pH( conditions.( This( is(referred(to(as(the(triZsodium(citrate(24Zcondition(screen.(Also(18Z24%(PEG(3350,(with(2%( increments,( giving( rise( to( six(PEG( concentrations( and(0.2M(potassium(thiocyanate( in( each( condition( and( 0.1M( HEPES( pH( 6.5Z8.0( in( 0.5( pH( unit(increments(giving(rise(to(four(pH(conditions.(This(is(referred(to(as(the(potassium(thiocyanate( 24Zcondition( screen.( The( SaltRX( (Hampton( Research)( commercial(screen(was(also(used,(and(condition(28(led(to(a(promising(hit:(2M(sodium(formate(and(0.1M(BisTrisPropane(pH(7.0.(This(was(developed(into(a(16Zcondition(screen:(1.6Z1.9M( sodium( formate( in( 0.1M( increments( leading( to( four( sodium( formate(conditions( and( 0.1M( BisTrisPropane( pH( 5.5Z7.0( with( 0.5( pH( unit( increment(
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leading( to( four( pH( conditions.( This( is( referred( to( as( the( 16Zcondition( sodium(formate(screen.((The(crystals(from(each(of(the(initial(hits(were(reproduced(and(the(conditions(that(produced( the(best(crystals(were(2M(sodium(formate,(0.1M(BisZTrisZPropane(pH(7.0((Figure(4.24).(To(increase(the(size(of(the(crystals,(seed(stock(was(added(to(the(16Zcondition(sodium(formate(screen(to(encourage(bigger(crystals(to(grow.(These(were(tested((Figure(4.25)(and(showed(only(very(lowZresolution(diffraction.(((
(







4.6.1 IgYZFc#diffraction#details#The(potassium( thiocyanate(24Zcondition( screen(was( set(up(and(produced( small(brickZlike( crystals,( which( although( quite( small,( had( sharper( edges( than( those(grown( under( the( previous( conditions.( These( crystals( were( tested( and( showed(diffraction( to( about( 7Å( resolution,( which( was( the( best( diffraction( seen( so( far((Figure(4.26).((
(
Figure# 4.26# The# cFcυ214# crystals# grown# in# potassium# thiocyanate#


























Figure# 4.27# Crystals# grown# with# cFcυ214# in# potassium# thiocyanate#
conditions#A)(Conditions(are(20%(PEG(3350,(0.2M(potassium(thiocyanate(and(0.1M(HEPES(pH(7.0.(The( drop( ratio( was( 500nL( protein,( 400nL( reservoir( and( 100nL( seed.( The( protein(concentration( was( 1.8mg/ml.( B)( Conditions( are( 22%( PEG( 3350,( 0.2M( potassium(thiocyanate( and( 0.1M( HEPES( pH( 6.5.( The( drop( ratio( was( 500nL( protein( and( 500nL(reservoir.( The(protein( concentration(was( 1.8mg/ml.( C)( Conditions( are( 20%(PEG(3350,(0.2M(potassium(thiocyanate(and(0.1M(HEPES(pH(7.0.(The(drop(ratio(was(500nL(protein,(400nL( reservoir( and( 100nL( seed,( which( was( added( after( the( drop,( has( been( left( to(equilibrate( for( 3½( hours.( The( protein( concentration(was( 1.8mg/ml.( D)( Conditions( are(22%(PEG(3350,(0.2M(potassium(thiocyanate(and(0.1M(HEPES(pH(6.5.(The(drop(ratio(was(500nL( protein,( 400nL( reservoir( and( 100nL( seed.( The( protein( concentration( was(1.8mg/ml.((







These( initial( hits( were( optimised( using( a( combination( of( altering( the( crystal(growth( conditions( and( postZcrystallisation( treatments.( None( of( these( attempts(led( to( crystals( that( diffracted( to( sufficiently( high( resolution.( The( protein(preparation( method( was( altered( in( order( to( attempt( to( improve( the( protein(purity( and( heterogeneity,( although( this( was( unsuccessful( and( did( not( improve(crystal(quality.(((The( initial( IgMZFc( crystals( had( good(morphology( and(were( easily( reproducible,(typically(diffracting(to(a(resolution(of(between(12Z9Å.(This(was(a(promising(start,(and(so(steps(were(taken(to(try(and(increase(the(order(of(these(crystals.(Annealing,(crossZlinking,(dehydration,(soaking(and(macroseeding(are( five(methods(that(can(be(used(to(improve(crystals(that(have(already(been(grown.(The(first(four(work(on(the(principle( that( the(order(of( the( crystalline( lattice(of( the( crystals,(which(have(already(been(grown,(can(be(improved,(and(the(fifth(method(aims(to(increase(the(size(of(the(crystal.(Annealing(presumes(that(lattice(disorder(has(been(introduced(into(the(crystals(during(cryoZcooling,(and(that(allowing(the(crystal( lattice( to( ‘reZadjust’(will( improve( the(order.(This(was(not( the(case( for( the( IgMZFc(crystals,(as(any(attempt(at(annealing(decreased(the(order(of( the(crystals.(This(suggests( that(the( reason( the( crystals( diffracted( only( to( low( resolution( was( due( to( intrinsic(disorder,( not( the( cryoZcooling.( With( crossZlinking,( the( IgMZFc( crystals( showed(minor(improvement(if(left(to(equilibrate(for(30(or(90(minutes,(but(deteriorated(if(left(longer.(This(suggests(that(the(IgMZFc(crystals(can(be(protected(against(some(minor( mechanical( stress( during( cryoZprotection( and( crystal( handling.( The(crystals( that(were(dehydrated(did(not( show(any( improvement(or(deterioration,(which( suggests( that( the( solvent( content( is( not( causing( any( problems( with( the(
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order(of(the(crystal(lattice.(Soaking,(in(order(to(increase(the(ionic(strength(in(the(mother(liquor(has(been(shown(in(some(cases(to(improve(crystal(quality.(The(IgMZFc( crystals(were(not( improved,( and( in(most( cases( the( crystals(deteriorated,( the(only(exception(being(20%(sucrose;(although(it(did(not(improve(the(crystal(quality,(this(was( a( good( solution( for( cryoZprotection.( The( ionic( strength( of( the( crystals(thus(appears(to(be(optimal.(Macroseeding(caused(the(crystals(to(dissolve(and(so(was(not(pursued(further.(((The(next( options( to( improve( the( IgMZFc( crystals(were( “Silver(bullet”( screening,(streak( seeding( and( temperature( screening.( “Silver( Bullet”( screening( failed( to(produce(crystals(at(all.(Streak(seeding(encourages(fewer,( larger(crystals(to(grow(by( providing( nucleation( sites,( and( reducing( the( reservoir( conditions( to( only(support(crystal(growth(and(not(allow(new(nucleation(sites( to( form.(However(as(with(“Silver(Bullet”(screening,(the(crystallisation(conditions(are(being(altered(and(there( is(always( the(possibility( that(no(crystals(will(grow(unfortunately( this(was(the( case( with( IgMZFc.( Crystals( also( failed( to( grow( at( any( of( the( five( different(temperatures( screened(using( the(TG40(device( or(when( attempts(were(made( to(grow(the(crystals(at(4°C(in(the(standard(crystallisation(plates(in(the(cold(room.((The( crystallisation( conditions( were( slightly( altered,( reducing( the( PEG( 8K(concentration( and( increasing( the( pH,( and( this( led( to( crystals( of( the( best(morphology(grown(to(date.(These(crystals(showed(diffraction(to(4.5Å(resolution.(The( space( group( was( determined( to( be( P21212.( The( cell( dimensions( were( a:(255.18,(b:348.99(and(c:(52.61.(However,(these(crystals(and(their(diffraction(were(anisotropic,( and( so( the( data( was( not( good( enough( to( determine( the( crystal(
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structure.( After( several( unsuccessful( attempts( at( reZproducing( these( crystals( it(was(decided(that(the(best(course(of(action(would(be(to(improve(the(quality(of(the(protein( preparation.( Once( the( new( protein( production( method( had( been(developed,( crystallisation( trials( of( this( new( IgMZFc( protein( were( set( up( in( the(same( conditions( as(before.( Crystals( grew( readily,( however( they(were(of( poorer(quality(than(had(been(seen(with(the(previous(protein(preparation.(It(was(thought(that(the(different(protein(preparation(was(changing(the(crystallisation(conditions(and(so(new(initial(screens(were(set(up.(These(screens( led(to(new(crystallisation(conditions(being(determined.(Although( these(were( very( similar( to( the(previous(conditions,(the(slightly(altered(conditions(led(to(very(small(crystals(with(a(better(morphology.(However,(these(crystals(showed(very(poor(diffraction,(which(at(very(best(was(to(9Å(resolution.(((Although(a(crystal(structure(has(not(yet(been(determined,(to(current(knowledge(this(is(the(furthest(advance(yet.(Future(attempts(to(crystallise(IgMZFc(should(focus(on(increasing(the(size(of(the(crystals(grown(in(the(current(conditions,(and(protein(concentration(and(seed(optimisation(might(be(used(to(achieve(this.((Initial( crystallisation(screens(of(platypus( IgEZFc(gave(rise( to( fine(needles.(These(crystals(were(very(fragile(and(hard(to(handle(without(causing(mechanical(stress.(The(best(diffraction(seen(for(these(crystals(was(around(10Å(resolution,(which(is(not( of( high( enough( resolution( to( determine( the( crystal( structure.( Post(crystallisation(methods(were(attempted(to(try(to(stabilise(the(crystals,(with(little(success.( Macroseeding( was( attempted( to( improve( the( size( of( the( crystals,( and(those( that( survived( were( successfully( cryoZprotected.( These( also( showed(
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diffraction( to(around(10Å(resolution(only.( It( is(essential( to(either( improve( their(size(and/or(mechanical(strength(or(to(grow(the(crystals(in(a(way(that(meant(they(did(not(need(to(be(handled.((For(these(reasons(capillary(diffusion(was(attempted,(but( this( was( unsuccessful,( probably( because( the( crystal( growth( method( is( so(different(that(new(conditions(would(need(to(be(screened.(To(improve(the(size(of(the( crystals,( several( rounds( of( protein/seed( concentration( optimisation( were(undertaken,( but( this( did( not( lead( to( any( major( improvements( in( the( crystals.(However,( it( did( highlight( that( the( protein( could( crystallise( in( very( low( protein(concentrations,( and( that( for( these( particular( crystallisation( conditions,( growth(conditions( and( nucleation( formation( are( able( to( occur( at( almost( identical(conditions.(If(the(protein(concentrations(are(dropped(low(enough(not(to(support(nucleation,( there( is( very( little( protein( left( in( the( solution( to( form( large( crystals(suitable( for( a( diffraction( experiment.( Ethylene( glycol( was( used( to( slow( down(crystal( growth,( but( this( was( unsuccessful,( probably( because( adding( ethylene(glycol(altered(the(crystallisation(conditions(too(much.((Future(attempts(to(crystallise(platypus(IgE(should(focus(on(increasing(the(size(of(the( crystals( grown( in( current( conditions( and( attempting( to( find( a( new( crystal(form(that(may(behave(differently.((Initial(crystallisation(screens(of(IgYZFc(gave(rise(to(small(brickZlike(crystals.(These(crystals(appear(to(have(good(morphology(and(although(not(much(crystallisation(optimisation(has(yet(been(performed,(they(are(already(showing(diffraction(to(7Å(resolution.(In(order(to(improve(these(crystals,(the(first(step(would(be(to(perform(more(protein/seed(optimisation(to(attempt(to(grow(bigger(crystals.(This(could(be(
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5.3 Integration(of(datasets:(round(1(There( were( five( datasets( collected,( and( these( were( processed( using( Mosflm((Powell( et# al.,( 2013).( The( default( autoZindexing( settings( were( used,( selecting(images( at( 1( and( 180( degrees.( The( unit( cell( was( determined( to( be( primitive(orthorhombic( (oP)( in( four( of( the( five( datasets.( This( means( that( a≠b≠c( and(
































3# 0.680( 0.173( 99.90( 14.70( 4.88(
2# 0.655( 0.239( 99.50( 7.30( 4.43(
1# 0.346( 0.119( 93.30( 8.00( 4.88(
Rmeas(:((! = ! !!!! !!!!!!!" !!!"!!!",!!!!" (
Rp.i.m(:(! = ! !!!! !!!!!!!" !!!"!!!",!!!!" (





























4# 0.314( 0.066( 99.50( 22.20( 7.16(
2# 0.100( 0.031( 99.40( 10.20( 7.16(
3# 0.155( 0.042( 99.00( 13.20( 7.15(
1# 0.208( 0.074( 96.70( 7.10( 7.16(
Rmeas(:((! = ! !!!! !!!!!!!" !!!"!!!",!!!!" (
Rp.i.m(:(! = ! !!!! !!!!!!!" !!!"!!!",!!!!" ((





Figure#5.4#Self1rotation#function#for#cluster#4#The(xZaxis(is(equivalent(to(a,(the(yZaxis(is(equivalent(to(b(and(the(zZaxis(is(equivalent(to(c.(The( Chi( 180( section( has( peaks( along( x,( y( and( z,( therefore( a( twoZfold( axis( is( predicted(along(a,(b(and(c.(The(Chi(60(section(shows(a(clear(sixZfold(axis(along(x,(therefore(a(6Zfold(axis(is(predicted(along(a.(The(Chi(120(section(agrees(with(this,(showing(a(weak(threeZfold(along(x.(The(peaks(on(the(Chi(90(section(look(as(though(they(could(be(explained(by(noise.((The( size( of( the( IgMZFc( hexamer( was( estimated( from( previous( models( of( IgM,((Figure(5.5,(Müller(et#al.,(2013).(The(murine(IgMZFc(hexameric(model(was(chosen(to(estimate(dimensions(from,(as(all(the(human(IgMZFc(models(are(pentameric.((
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Figure#5.8#Density#and#backbone#after#PHASER#solution#1#Pink(and(yellow(lines(indicate(chains(of(the(Cγ3((indicated(Cµ4),(shown(as(backbone(only.(The(blue(mesh(is(the(2FoZFc(electron(density(at(1σ( level.(The(backbone(roughly(follows(the(electron(density.(Green(mesh(shows(positive(difference(density(and(red(mesh(shown(negative(difference(density,(both(shown(at(2σ(level.(Positive(difference(density(indicates(where( domains( should( be( placed.( There( is( clear( positive( density( present( on( the( right(hand(side(of(the(picture(indicating(where(the(next(domain(could(be(placed.((






















1# 0.120( 0.039( 99.50( 9.60( 5.63(
2# 0.173( 0.050( 99.40( 11.30( 5.63(
Rmeas(:((! = ! !!!! !!!!!!!" !!!"!!!",!!!!" (
Rp.i.m(:(! = ! !!!! !!!!!!!" !!!"!!!",!!!!" ((




Figure#5.10#Density#and#backbone#after#PHASER#solution#2#Pink(and(yellow(lines(indicate(chains(of(the(Cγ3((indicated(Cµ4),(shown(as(backbone(only.(The(blue(mesh(is(the(2FoZFc(electron(density(at(1σ( level.(The(backbone(roughly(follows(the(electron(density.(Green(mesh(shows(positive(difference(density(and(red(mesh(shown(negative(difference(density,(both(shown(at(2σ(level.(Positive(difference(density(indicates(where( domains( should( be( placed.( There( is( clear( positive( density( present( on( the( right(hand(side(of(the(picture(indicating(where(the(next(domain(could(be(placed.((5.13 (Discussion(A( single( dataset( at( the( resolution( collected(was( not( sufficient( to( determine( the(crystal(structure.(Six(of(the(best(datasets(were(analysed(and(combined(in(various(ways.( In( the( first( round( the( integration( aimed( to( provide( the( best( possible(resolution( of( 4.43Å,( however( the( statistics( suffered.( Multiple( searches( of( the(single(Cµ4(and(Cµ3(domain(pairs(as(well(as(the(Cε4,(Cε3(and(Cε2(domain(pairs(did(not(lead(to(a(successful(solution.(The(data(were(reZintegrated(to(7.16Å(resolution(in(order(to(improve(the(statistics,(at(the(expense(of(the(resolution.(A(selfZrotation(function( was( performed( and( revealed( 6Zfold( NCS( indicating( the( structure( is(hexameric.( This,( along( with( the( unit( cell( dimensions( was( used( to( predict( the(contents(of(the(unit(cell.(This(revealed(that(the(most(likely(packing(in(the(unit(cell(was(4(hexamers(of(IgMZFc(and(the(most(likely(symmetry(arrangement(was(a(P2(
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Chapter(6 THERMAL(STABILITY((6.1 Overview(Dorrington(and(Bennich(in(1973(discovered(that(the(melting(temperature(of(IgE(is(56°C.(Immunoglobulin(G(has(a(melting(temperature(of(~73°C((Liu(et#al.,(2009),(and( thus( IgE( is( substantially(more( thermally( labile.( As( discussed( in( Chapter( 1,(Dorrington(and(Bennich,(1973,(predicted(that(the(thermal(sensitivity(of(IgE(lies(in(the(Cε3Z4(region(of(the(protein,(as(in(their(experiments(the(fragment(containing(Cε3(was(the(first(fragment(to(become(irreversibly(denatured.(They(also(correctly(predicted(that(this(same(domain(is(responsible(for(receptor(binding.((Exploring(the(thermal(stability(of(human(antibodies(such(as(human(IgE(and(IgM,(as( well( as( antibodies( from( other( species( such( as( chicken( IgY,( bovine( IgG( and(platypus( IgE,( will( reveal( the( differences( in( the( thermal( stability( of( the( CH3(domains.(These(proteins(will(be(invaluble(in(revealing(the(evolution(of(the(unique(properties( of( human( IgE( by( helping( to( understand( where( this( thermal( lability(originated(and(how(this(relates(to(function(and(receptor(binding.(For(example(it(is(unknown(whether(the(CH2(domains(in(human(IgM,(platypus(IgE(and(chicken(IgY(play( a( similar( structural( role( to( the( human( Cε2( domains( in( stabilising( the( Cε3(domains.(In(human(IgE(this(stabilisation(of(the(Cε3(by(the(Cε2(domains(leads(to(a(much( slower(dissociation( rate( of( the( Fcε2Z4/FcεRI( complex( compared(with( the(Fcε3Z4/FcεRI( complex.( However( receptor( binding( in( the( evolutionarily( related(proteins(has(not(been(studied(as(extensively.(Receptor(binding(to(platypus(IgE(is(unknown.(Human(IgM(binds(to(FcµR((Kubagawa(et#al.,(2009)(and(FcαµR,(which(it(
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shares(with(IgA((Shibuya(et#al.,(2000)((Ghumra(et(al.,(2009).(Chicken(IgY(binds(to(CHIR(at(a(site(more(similar(to(the(human(FcαRI(IgA(binding(sites(than(FcεRI(and(FcγRIII(binding(sites(in(human(IgE(and(IgG((Taylor(et#al.,(2008).(Although(this(is(perhaps(unsurprising,(as(IgA(is(thought(to(have(evolved(from(IgY(and(IgM(before(the(gene(duplication(which(led(to(the(evolution(of(IgE(and(IgG(from(IgY((Gambón(Deza(et#al.,#2007;(GambónZDeza(et#al.,( 2009),( it( raises( questions( about( how( the(receptor(binding(of(FcεRI/IgE(originated.(Comparison(of(the(thermal(stability(of(the(CH2(domains(of(these(proteins(is(an(important(step(in(this(process.((
6.2 Aims(of(Chapter(To(investigate(the(thermal(stability(and(unfolding(of(the(following(fragments:(
• Two( Fc( fragments( of( human( IgE( one( containing( the( Cε2,( Cε3( and(Cε4( domains( (hFcε2Z4)( and( one( containing( the( Cε3( and( Cε4(domains((hFcε3Z4)((
• One( Fc( fragment( of( platypus( IgE( containing( the( Cε2,( Cε3( and(Cε4(domains((pFcε2Z4)(
• Two(Fc( fragments(of(human(IgM(one(containing(the(Cµ2,(Cµ3(and(Cµ4( domains( (hFcµ2Z4)( and( one( containing( the( Cµ3( and( Cµ4(domains((hFcµ3Z4)(
• Two(fragments(of(chicken(IgY(one(containing(the(Cυ2,(Cυ3(and(Cυ4(domains( (cFcυ2Z4)( and( one( containing( the( Cυ3( and(Cυ4(domains((cFcυ3Z4).(6.3 Thermal(unfolding(
6.3.1 Differential#Scanning#Fluorimetry#(DSF)#To(investigate(the(thermal(unfolding(of(the(Fc(regions(of(human(IgE,(human(IgM,(chicken(IgY(and(platypus(IgE,(Differential(Scanning(Fluorimetry((DSF)(was(used.(This(technique(involves(adding(a(fluorescent(dye((SyproZOrange),(which(binds(to(hydrophobic(patches,(to(the(protein(of( interest.(When(the(protein(is( fully(folded(there(are(essentially(no(hydrophobic(patches(exposed(and(so( the(SyproZOrange(
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Figure#6.1#Differential#Scanning#Fluorimetry#(DSF)#schematic#Grey( lines( indicate(polypeptide(chain,(orange(balls( indicate(molecules(of(SyproZOrange,(green( zigzag( arrows( indicate( excitation( at( 492nm,( and( orange( zigzag( lines( indicate(fluorescence(emission(at(610nm.(A)(The(protein(is(tightly(folded(and(so(no(hydrophobic(patches(are(exposed,( there( is(nowhere( for( the(SyproZOrange( to(bind(and(so( it(does(not(fluoresce.( B)( The( protein( has( been( heated( to( a( temperature( that( causes( it( to( start( to(unfold,( hydrophobic( patches( are( exposed( and( SyproZOrange( binds( to( these( and(fluoresces.( C)( The( protein( begins( to( aggregate( reducing( the( hydrophobic( patches(available(for(the(SyproZOrange(to(bind,(therefore(decreasing(the(fluorescence.(((
6.3.2 Thermal#stability#of#bFcγ2Z3#Thermal(unfolding(of(bFcγ2Z3((see(2.4.1( for(purification(details)( in(the(presence(of( increasing(concentrations(of(urea(was(measured(by(DSF((Figure(6.2A).(A first 
derivative plot (Figure(6.2B) was calculated for these data and the peak indicated the 
melting temperatures of the protein. bFcγ2-3 showed one-state unfolding, in the 










temperature decreased until in the presence of 6M urea the melting temperature had 
dropped to 56°C (Figure( 6.2,Table( 6.1). This is consistent with melting of whole 
human IgG at 73.6±0.4° (Liu et al., 2009) and IgG1-Fc at Tm1 65°C and Tm2 82°C 
(Wozniak-Knopp et al., 2012). 
#
(
Figure#6.2#DSF#profiles#of#bFcγ213#Blue(line(indicates(no(urea(present,(orange(1M(urea,(green(2M(urea,(purple(3M(urea,(red(4M( urea,( brown( 5M( urea,( pink( 6M( urea( and( black( 7M( urea.( The( dye( used( is( SyproZOrange,(excitation(at(492nm,(emission(610nm.(Measurements(were(taken(on(Stratagene(MX3005p( instrument.( Protein( concentration(was( 5µM.( A)( Fluorescence( profiles;( curve(mean(of(3(repeats((error(in(Appendix(iii)(B)(Smoothed(first(derivative(curves(calculated(using(Graph(Pad(Prism,(and(the(peaks(indicate(melting(temperature.((((
Table#6.1#Melting#temperatures#bFcγ213#
Urea#concentration#(M)# Tm(bFcγ213)#(°C)#0( 72(1( 68(2( 66(3( 64(4( 63(5( 60(6( 56((
6.3.3 Thermal#stability#of#pFcε2Z4,#hFcε2Z4#and#hFcε3Z4#As(with(bFcγ2Z3,(the(thermallyZinduced(unfolding(of(pFcε2Z4,(hFcε3Z4(and(hFcε2Z4(was(measured(in(the(presence(of(increasing(concentrations(of(urea(by(DSF,(and(











































first( derivative( plots( were( calculated( to( indicate( melting( temperatures( (Figure(6.3B,D&F).( The( hFcε3Z4( data( shows( a( single( unfolding( event( at( all( urea(concentrations,( which( occurs( at( 55°C( in( the( absence( of( urea( and( at( lower(temperatures( as( the( urea( concentration( increases( (Figure( 6.3,( Table( 6.2).( ( This(implies( that( the( Cε3( and( Cε4( domains( unfold( cooperatively.( ( The( hFcε2Z4( data(shows(a(twoZstate(unfolding,(the(first(event,(in(the(absence(of(urea,(at(55°C,(and(the(second(at(64°C((Figure(6.3C&D).(The(latter(is(taken(to(be(the(unfolding(of(the(Cε2( domains,( occurring( after( that( of( Cε3( and( Cε4.( ( Both( Tm1(hFcε2Z4)( and(Tm2(hFcε2Z4)(decrease(with(increasing(urea(concentration((Figure(6.3C&D,(Table(6.2).((For(hFcε3Z4,(3M(urea(causes(complete(unfolding(in(the(absence(of(heating,(whereas(6Z7M(urea(is(required(to(achieve(this(for(the(Cε2(domains.(((The(intensity(of(the(signals(from(hFcε3Z4(are(consistently(smaller(than(those(from(hFcε2Z4,(which(may(be(due(to(differences(in(the(aggregation(properties(of(the(two(proteins( as( denaturation( occurs.( ( Aggregation( reduces( the( hydrophobic( surface(area( to(which( SyproZOrange(molecules( can(bind,( thus( reducing( the( signal.( ( The(Cε3(domains,(and(in(particular(their(NZterminal(regions((see(Chapter(7),(are(more(flexible( and( perhaps( inherently(more( prone( to( unfolding( in( hFcε3Z4( compared(with(hFcε2Z4,(thus(promoting(aggregation(of(the(former.((However,(the(stabilising(effect( of( the( (Cε2)2( domain( pair( upon( the( hFcε3Z4( region( is( relatively( modest,(since( the( Tm( and( Tm1( values( for( hFcε3Z4( and( hFcε2Z4( respectively( are( similar(under(all(urea(conditions( (Table(6.2).(pFcε2Z4(also(shows(a( twoZstate(unfolding(pattern( with( the( first( event( in( the( absence( of( urea( occurring( at( 58°C,( and( the(second( event( occurring( at( 67°C( (Figure( 6.3E&F,( Table( 6.3).( These( are( higher(
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Figure#6.3#DSF#profiles#of#hFcε214,#hFcε314#and#pFcε214#Blue(line(indicates(no(urea(present,(orange(1M(urea,(green(2M(urea,(purple(3M(urea,(red(4M(urea,(brown(5M(urea,(pink(6M(urea(and(black(7M(urea.(A)(Trace( for(hFcε3Z4;(each(curve(is(mean(of(three(repeats((error(in(Appendix(iii)(B)(First(derivative(plot(for(the(data(in(A;( calculated(using( three( repeats.( C)(Trace( for(hFcε2Z4;( each( curve( is(mean(of( three(repeats((error(in(Appendix(iii).(D)(First(derivative(plot(for(the(data(in(C;(calculated(using(three( repeats.( E)( Trace( for( pFcε2Z4;( each( curve( is( mean( of( three( repeats( (error( in(Appendix(iii).(F)(First(derivative(plot(for(the(data(in(E;(calculated(using(three(repeats.(The(dye( used( is( SyproZOrange,( excitation( at( 492nm,( emission( 610nm.(Measurements(were(taken( on( Stratagene( MX3005p( instrument.( Smoothed( first( derivative( curves( were(calculated(using(Graph(Pad(Prism,(and(the(peaks( indicate(melting( temperature.(Protein(concentration(was(5µM.((
Table#6.2#Melting#temperatures#for#hFcε314#and#hFcε214##
Urea#Concentration#(M)# Tm(hFcε314)#(°C)# Tm1(hFcε214)#(°C)# Tm2(hFcε214)#(°C)#
0# 52( 55( 64(
1# 47( 50( 63(
2# 39( 45( 57(
3# Z( 39( 53(
4# Z( Z( 49(
5# Z( Z( 46(
6# Z( Z( 42(
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First derivative of pFcε2-4





















First derivative of hFcε2-4





















First derivative of hFcε3-4






































6.3.4 Thermal#stability#of#hFcµ2Z4#and#hFcµ3Z4#As(with(hFcε2Z4,(hFcε3Z4(and(pFcε2Z4(the(thermallyZinduced(unfolding(of(hFcµ2Z4(and(hFcµ3Z4(was(measured(in(the(presence(of(increasing(concentrations(of(urea(by( DSF,( and( first( derivative( plots( were( calculated( to( indicate( melting(temperatures((Figure(6.4).(The(hFcµ2Z4(did(not(show(twoZstate(unfolding(as(seen(for(human(and(platypus( IgE,(but( it(was(also(not( completely(oneZstate(unfolding(compared( to( bFcγ2Z3( and( hFcε3Z4( (Figure( 6.4C).( hFcµ3Z4( clearly( showed( oneZstate(unfolding(at(58°C,((Figure(6.4A,(Table(6.4)(in(the(absence(of(urea,(and(this,(as(for(hFcε3Z4,(shows(that(the(Cµ3(and(Cµ4(domains(unfold(cooperatively(in(this(subZfragment.(The(first(derivative(plot(for(hFcµ2Z4,(in(the(absence(of(urea,(shows(a(second(peak,(suggesting(a(twoZstate(unfolding(event((Figure(6.4B),(with(the(first(unfolding( event( at( 54°C,( and( the( second( at( 72°C,( (Table( 6.4).( In( urea( this(disappears,(suggesting(that(the(Cµ2(domains(have(either(completely(unfolded,(or(are( now( unfolding( cooperatively( with( Cµ3( and( Cµ4.( The( Cµ2( domains( may(unexpectedly( promote( the( Cµ3( and( Cµ4( domains( to( unfold( at( a( lower(temperature,(as(in(the(absence(of(urea(hFcµ3Z4(unfolds(at(58°C,(4°C(higher(than(hFcµ2Z4.(This(is(the(opposite(of(what(occurs(with(the(hFcε2Z4(and(hFcε3Z4(where(the(former(is(more(stable(than(the(latter.(In(the(presence(of(3M(urea(the(Fcµ3Z4(
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still(shows(a(substantial(unfolding(peak(at(44°C((Figure(6.4A,(Table(6.4),(whereas(the(hFcµ2Z4(unfolding(peak(in(the(presence(of(3M(urea(shows(a(much(lower(peak(at( 37°C( (Figure( 6.4C,( Table( 6.4).( Increasing( concentrations( of( urea( reduce( the(Tm(Fcµ3Z4),( Tm1(Fcµ2Z4)( and( Tm2(Fcµ2Z4).( 6M( urea( is( required( to( cause(complete(unfolding(of(hFcµ2Z4(whereas(5M(urea(is(required(to(completely(unfold(hFcµ3Z4( at( all( temperatures( showing( that( the( human( Cε2( domains( are( more(stable(than(platypus(Cε2(and(human(Cµ2(domains.((
(
Figure#6.4#DSF#profiles#unfolding#of#hFcµ214#and#Fcµ314#Blue(line(indicates(0M(urea(present,(orange(1M(urea,(green(2M(urea,(purple(3M(urea,(red(4M( urea,( brown( 5M( urea,( pink( 6M( urea( and( black( 7M( urea.( The( dye( used( is( SyproZOrange,(excitation(at(492nm,(emission(610nm.(Measurements(were(taken(on(Stratagene(MX3005p( instrument.( Protein( concentration(was( 5µM.( A)( Thermal( profile( of( hFcµ2Z4;(calculated(using(three(repeats(B)(First(derivative(plot(for(the(data(in(A;(calculated(using(three( repeats.( C)( Thermal( profile( of( hFcµ3Z4;( calculated( using( three( repeats.( D)( First(derivative(plot( for( the(data( in(C;(calculated(using(three(repeats.(Smooth( first(derivative(curves( calculated( using( Graph( Pad( Prism.(Melting( temperature( is( the( peak( of( the( first(derivative(curve.(((
hIgM%Fcµ3)4





























First derivative of hIgM Fcµ2-4





















First derivative of hIgM Fcµ3-4































0# 58( 54( 72(
1# 49( 49( Z(
2# 48( 47( Z(
3# 44( 37( Z(
4# 39( 35( Z(
5# 36( Z( Z(
6# Z( Z( Z((
6.3.5 Thermal#stability#of#chicken#IgY#Fcυ2Z4#and#Fcυ3Z4#The( thermalZinduced( unfolding( of( cFcυ2Z4( and( cFcυ3Z4( was( measured( with(increasing(concentrations(of(urea(by(DSF.(The(thermal(profiles(of(both(the(cFcυ2Z4(and(cFcυ3Z4(show(oneZstate(unfolding( in( the(absence(of(urea,( suggesting( that(the(Cυ2,(Cυ3(and(Cυ4(domains(all(unfold(cooperatively((Figure(6.5A&C).(The(first(derivative(plot(for(cFcυ3Z4(and(cFcυ2Z4(in(the(absence(of(urea(confirms(oneZstate(unfolding,(with(melting(temperatures(of(cFcυ3Z4(and(cFcυ2Z4(of(73°C,(and(71°C,((respectively( (Figure( 6.5B&D,( Table( 6.5).( This( suggested( that( despite( having( an(extra(domain,(IgY(is(behaving(in(a(similar(manner(to(IgG;(this(may(be(related(to(the(fact(that(IgY(has(an(IgGZlike(function(in(chickens((Warr(et#al.,#1995),(however(it( is(an( informative(comparison(that(may(shed( light(on(what(the(differences(are(between(the(CH2(domains(in(IgY,(IgM(and(IgE.((In( the(presence(of(urea( the(cFcυ2Z4(appears( to(show(oneZstate(unfolding( in( the(thermal( profile( (Figure( 6.5C)( however( when( the( first( derivative( plots( are(calculated(the(melting(temperatures(are(somewhat(ambiguous((Figure(6.5B).(The(first( derivative( curve( in( the( presence( 1M( urea( is( straightforward( and( shows( a(melting( temperature( of( 68°C,( Tm1(Fcυ2Z4).( In( the( presence( of( 2M( urea( the(
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melting( temperature( is( 65°C,( Tm1(cFcυ2Z4),( however,( the( first( derivative( curve(shows(a(broadening(suggesting(that(a(second(unfolding(event(is(occurring,(but(it(is( too( ambiguous( to( assign( a( temperature.( In( the( presence( of( 3M(urea( the( first(derivative( curve( has( two( clear( peaks,( suggesting(melting( temperatures( of( 61°C(and(68°C.(The(melting(temperature(of(61°C(follows(the(trend(from(the(previous(melting( temperature( of( 65°C,( and( so( is( assigned( to( Tm1(cFcυ2Z4),(whereas( the(dominant(peak(on(the(first(derivative(curve(at(68°C(appears(to(be(due(to(a(second(unfolding(event,(Tm2(cFcυ2Z4),(which(may(follow(on(from(the(broadening(of(the(previous( first( derivative( curve.( In( the( presence( of( 4M( urea( the( melting(temperature( is(66°C(which( follows(on( from(the(previous(Tm2(cFcυ2Z4)(of(68°C,(although( the( left( side( of( the( peak( shows( broadening( suggesting( that( the( first(unfolding(event(may(not(have(finished(but(is(less(dominant.(In(the(presence(of(5M(urea( the(melting( temperature( is(65°C,(Tm2(cFcυ2Z4)(and( in( the(presence(of(6M(urea( the(melting( temperature( is(61°C(Tm2(cFcυ2Z4)(but( the(peaks(both( show(a(left( side( broadening( suggesting( that( the( first( unfolding( event( is( still( occurring((Figure(6.5D).(In(the(presence(of(urea(the(cFcυ3Z4(still(shows(oneZstate(unfolding((Figure( 6.5A)( and( the( first( derivative( plots( provide( unambiguous( melting(temperatures( ranging( from( 71°C( in( the( presence( of( 1M( urea( to( 60°C( in( the(presence( of( 6M( urea( (Figure( 6.5B).( With( hFcε2Z4( and( hFcε3Z4( it( was( easy( to(assign( the( peak( associated( with( Cε2( and( the( Cε3Z4( unfolding( events( as( the(difference( in( melting( temperatures( was( ~10°C.(With( cFcυ2Z4( and( cFcυ3Z4( the(melting( temperatures( are(within( less( than( 5°C( of( each( other( and( so( it( is(more(difficult.(Despite(this,(the(Tm2(cFcυ2Z4)(values(appear(to(match(more(closely(with(the(cFcυ3Z4(than(the(Tm1(cFcυ2Z4)(values,(especially(as(the(urea(concentrations(
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increase,(although(some(of(the(Tm1(cFcυ2Z4)(values(in(low(concentrations(of(urea(do( correspond( with( cFcυ3Z4,( suggesting( that,( as( with( IgM,( urea( is( causing( the(domains(to(behave(in(a(different(manner(than(with(thermal(denaturation(alone.(The( cFcυ2Z4( and( cFcυ3Z4( are(much(more( stable( than( the( IgE(or( IgM(molecules(tested.(The(melting(temperatures(are(more(comparable(with(bFcγ2Z3,(which(may(correlate(with(the(fact(that(the(function(of(IgY(is(closer(to(the(function(of(IgG(than(IgE(or(IgM.((
(
Figure#6.5#Thermal#unfolding#of#cFcυ214#and#cFcυ314#Blue(line(indicates(0M(urea(present,(orange(1M(urea,(green(2M(urea,(purple(3M(urea,(red(4M( urea,( brown( 5M( urea,( pink( 6M( urea( and( black( 7M( urea.( Dye( used( sypro( orange,(excitation( at( 492nm,( emission( 610nm.( Measurements( were( taken( on( Stratagene(MX3005p( instrument.( Smooth(of( first( derivative( calculated(using( graph(pad(prism,( the(peaks( of( the( first( derivative( indicate( melting( temperature.( Protein( concentration( was(5µM.(A)(Thermal(profile(of(cFcυ3Z4;(calculated(using(three(repeats((error(in(Appendix(iii)(B)( First( derivative( plot( for( the( data( in( A;( calculated( using( three( repeats( (error( in(Appendix( iii).( C)( Thermal( profile( of( cFcυ2Z4;( calculated( using( three( repeats( D)( First(derivative(plot(for(the(data(in(C;(calculated(using(three(repeats.(((
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First derivative of cFcυ3-4





















































First derivative of cFcυ2-4





























0# 73( 71( Z(
1# 71( 68( Z(
2# 69( 65( Z(
3# 67( 61( 68(
4# 64( Z( 66(
5# 62( Z( 65(
6# 60( Z( 61((
6.4 Discussion(Thermal( unfolding( provides( insights( into( the( stability( of( the( protein( being(studied.( It(has( long(been(known(that(human(IgE(has(a( low(melting(temperature(compared(with(other(antibodies.(The(Cε3(domain(is(the(least(thermodynamically(stable(part(of(the(molecule,(despite(being(the(interaction(site(for(the(strongest(of(all( known( receptorZantibody( interactions.( Looking( at( the( thermal( stability( of(evolutionarily( related(molecules( such( as( platypus( IgE,( human( IgM( and( chicken(IgY(provides(a(method(of(probing(the(evolution(of(human(IgE.((The( results( for( the( proteins( that( were( examined,( in( the( absence( of( urea,( are(summarised( in( Table( 6.6.( The( thermal( unfolding( of( bFcγ2Z3( occurs( in( a( single(unfolding( event( at( 72°C.( The( thermal( unfolding( of( hFcε3Z4( occurs( in( a( single(unfolding( event( at( 52°C,( indicating( that( Cε3( and( Cε4( unfold( cooperatively.( The(unfolding(of(hFcε2Z4(occurs(as(a(twoZstate(process,(with(the(first(event(attributed(to(the(Cε3(and(Cε4(domains(cooperatively(unfolding(at(54°C(and(the(second(event(attributed(to(the(Cε2(domains(unfolding(at(64°C.(IgY(is(thought(to(be(a(precursor(of(IgG(and(IgE(and(has(been(described(as(having(the(domain(structure(of(IgE(and(the( function(of( IgG.( In( the(absence(of(urea( the(melting(of( the(cFcυ3Z4(shows(as(
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(When(the(first(derivative(is(plotted(for(cFcυ2Z4(in(2Z4M(urea(then(there(is(a(slight(indication(of(a(twoZstep(unfolding(process(occurring.(This(suggests(that(although(the( Cυ2,( Cυ3( and( Cυ4( domains( generally( unfold( cooperatively,( the( urea( is(encouraging(the(Cυ2(domains(to(behave(slightly(differently.((In(the(absence(of(urea(the(Cµ2(domains(appear(to(begin(unfolding(at(around(the(same(temperature(as(IgYZFc,(however(in(the(presence(of(1M(urea(or(more(the(Cµ2(domains( seems( to( unfold( cooperatively( with( the( Cµ3( and( Cµ4( domains( at( the(lower(temperatures.(The(Cµ2(domain(appears(to(be(particularly(sensitive(to(urea,(as(in(low(concentrations(of(urea(this(twoZstate(unfolding(is(lost.((So(far(these(results(can(be(used(to(make(speculations(about(the(common(ancestor(of( all(modern(antibodies( and(how( this(has( evolved.(The( common(ancestor(may(have(had(a(similarly(stable(CH2,(CH3(and(CH4(domains.(IgM(is(the(most(primitive(of(the( antibodies( studied( and( although( in( the( absence( of( urea( the( hFcµ2Z4( shows(weak( twoZstate( unfolding,( in( the( presence( of( urea( the( domains( unfold(cooperatively.( Throughout( evolution( reptiles( and( birds( developed( IgY( that(retained( the( stability( of( the(CH2(domains( and( improved( the( stability( of( the(CH3(and(CH4(domains,(as(can(be(seen(with(cFcυ2Z4(and(cFcυ3Z4,(which(show(melting(temperatures( of( 71°C( and( 73°C( respectively.( Mammals( however( evolved( IgG,(which(has(very(stable(CH3(and(CH4(domains(and(no(CH2(domain(as(can(be(seen(with(bFcγ2Z3,(with(a(melting(temperature(of(72°C,(and(IgE,(which(show(decreased(stability(in(the(CH2(and(CH3/4(domains.(The(platypus(Cε2(domains,(which(have(a(
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melting(temperature(of(58°C,(are(more(stable(than(the(human(Cε2(domains,(with(a(melting(temperature(of(54°C,(in(support(of(this(hypothesis.((In( order( to( test( this( hypothesis( further,( thermalZunfolding( data( from( the( IgE(molecules( of( a( marsupial( and( other( mammals( such( as( the( mouse( would( be(instructive,(as(well(as(looking(at(more(primitive(IgY(molecules(such(as(crocodilian(IgY
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Chapter(7 HIGHZRESOLUTION( CRYSTAL( STRUCTURES( of(hFcε3Z4(7.1 Overview(As( discussed( in( Chapter( 1,( the( uniquely( slow(offZrate( of( human( IgE( from(FcεRI((koff##=(1.9(x(10Z4(sZ1),( in(the(absence(of(allergen,(causes(longZterm(sensitisation(of(mast(cells.(This(slow(offZrate( is(reproduced(with(the(IgEZFc(fragment(containing(the(dimer(of(Cε2Z4(domains.(The(Fcε3Z4(fragment,(lacking(the(Cε2(domains,(has(a(faster(offZrate( (koff((=(3.2(x(10Z3sZ1)( (McDonnell(et#al.,#2001).(The(binding( site( for(FcεRI(on(the(IgE(contains(two(subZsites,(one(on(each(of(the(Cε3(domains((Garman(
et#al.,#2000;(Holdom(et#al.,#2011).(The(Cε2(domains( are(not(directly( involved( in(receptor( binding,( however( they( noticeably( contribute( to( the( slow( offZrate(observed.( Despite( this( difference( in( offZrate( the( overall( affinities( of( IgEZFc( and(Fcε3Z4(for(FcεRI(are(similar,(and(both(are(high,((Ka(≈(1010(MZ1).((The(CD23(binding(site( is(between(the(Cε3(and(Cε4(domains;( the(affinity(of(both( IgEZFc(and(Fcε3Z4(for(CD23( is( lower( (Ka(≈(107(MZ1),(with(one(binding( site( in( each( chain.( ( The(Cε3(domain(is(therefore(the(critical(domain(for(receptor(binding.(((When( expressed( alone,( the( Cε3( domain( shows( no( recognisable( secondary(structure( or( hydrophobic( core( formation,( in( contrast( to( Cε2( and( Cε4( that( form(folded(domains,(but(in(isolation(Cε3(can(bind(FcεRI,(albeit(with(very(much(lower(affinity((Henry(et#al.,(2000).(The(“molten(globule”(nature(of(this(domain(has(been(further(characterised(by(NMR((Borthakur(et#al.,#2011).( ( It( is(also( the(domain( to(which( NZlinked( carbohydrate( is( attached,( at( a( site( (Asn394)( that( is( conserved(
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across( other( immunoglobulin( classes;( in( IgE( the( glycosylation( is( of( the( highZmannose(type((Arnold(et#al.,(2004;(Plomp(et#al.,(2014).((As(described(in(Chapter(1,(there(are(now(several(crystal(structures(of(both(IgEZFc(and(Fcε3Z4(alone(and(in(complex(with(soluble(IgEZbinding(extracellular(domains(of(FcεRI((sFcεRIα)(and(CD23((sCD23).( (The( first(crystal(structure(was(of(Fcε3Z4(bound(to(sFcεRIα((1F6A)((Garman(et#al.,(2000),(this(was(followed(by(apo(Fcε3Z4((1FP5)((Wurzburg(et#al.,(2000).(The(first(structure(of(IgEZFc((1O0V)(caused(much(surprise( when( it( revealed( an( asymmetrically( bent( conformation( (Wan( et# al.,(2002).( Three( new( crystal( forms( of( Fcε3Z4(were( then( determined( (3H9Y,( 3H9Z,(3HA0)( revealing( conformational( flexibility( in( these( structures( (Wurzburg( and(Jardetzky,(2009).( IgEZFc(bound(to(sFcεRIα( (2Y7Q)(was(determined(along(with(a(higher( resolution( structure( of( free( IgEZFc( (2WQR)( (Holdom( et# al.,( 2011).( The(structure( of( Fcε3Z4( bound( to( calciumZfree( sCD23(was( then( determined( (4EZM)((Dhaliwal( et#al.,( 2012)( and( subsequently( the( calciumZbound( structure(was( also(determined( (4GKO)( (Yuan(et#al.,( 2013).( ( The(most( recent( structures( are( that( of(Fcε3Z4(bound(by(a(DARPin((Kim(et#al.,#2012)(and( IgEZFc(bound(by( two(antiZIgE(antibody(Fab(fragments((Drinkwater(et#al.,(2014).((In( these( structures,( the( Cε3( domains( are( found( to( move( apart( into( an( “open”(conformation(to(accommodate(FcεRI(binding(between(them,(compared(with(the(uncomplexed( fragments.( However,( binding( to( CD23( between( the( Cε3( and( Cε4(domains(causes(the(Cε3(domains(to(adopt(a(more(“closed”(conformation,(and(in(this( way( the( binding( to( the( two( receptors,( while( occurring( at( distant( sites( at(
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either( end( of( the( Cε3( domains,( is( mutually( exclusive( (Dhaliwal( et# al.,( 2012);(Borthakur( et# al.,( 2012).( The( two( receptor( binding( sites( are( thus( allosterically(linked.((
7.2 Aims(of(Chapter(To(solve(and(refine(two(new(crystal(structures(of(human(IgE(Fcε3Z4(and(perform(analysis(of(their(quaternary(structural(dynamics(and(intrinsic(domain(flexibility.(A( new( method( was( developed( to( define( the( ‘open’/’closed’( and( ‘swing’(measurements( of( the( crystal( structures.( The( intrinsic( flexibility( of( the( Cε3(domains( was( analysed( by( performing( a( BZfactor( analysis( on( the( new( crystal(structures,( and( they( were( compared( with( all( other( Fcε3Z4( and( Fcε2Z4( crystal(structures.((
7.3 The(new(hFcε3Z4(crystal(structures(The( two( crystal( structures( of( Fcε3Z4( that( have( been( determined( are( shown( in(Figure(7.1.(The(first(structure( is(at(2.2Å(resolution(and(is( in(a(new(crystal( form,(space( group(P1,(which( contains( three(molecules( (six( chains)( in( the( asymmetric(unit( and( provides( six( more( unique( views( of( the( Fcε3Z4( chains.( The( second(structure( is( at( 1.92Å( resolution,( space( group( P21,( and( is( the( highest( resolution(Fcε3Z4( structure( to( date,( revealing( unprecedented( detail( regarding( the(carbohydrate( structure.( This( crystal( form( has( been( reported( previously( by(Wurzburg(and(Jardetzky(at(2.45Å(resolution((3H9Z).(((
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7.3.1 Structure#solution#The( structures( were( determined( using( molecular( replacement;( for( details( see(Chapter(2((page(79).(3HA0(was(used(as(a(search(model(for(the(P1(structure(and(3H9Z(was(used(as(a(search(model(for(the(P21(structure.((
7.3.2 Refinement#The( structures( were( rebuilt( using( PHENIX( autobuild( and( refined( using( COOT((Emsley( and( Cowtan,( 2004).( This( included( refinement( of( individual( atomic( BZfactors,( xyz( coordinates,( TLS( parameters( and( rigid( body( refinement.( The(structures( were( manually( modeled( in( COOT( to( improve( sideZchain( placement((see(Chapter(2,(page(80).((The( refinement(was( repeated( in( iterative( cycles( and( the( structures(were( again(manually(built(with(waters(added(where(appropriate(FoZFc(density(was(found(at(the(3σ(contour(level(and(a(hydrogenZbonding(partner(could(be(found(within(1.8Z(3.0Å.( A( further( refinement( of( individual( atomic( coordinates( and( refinement( of(individual( atomic( BZfactors( was( performed,( but( this( time( the( XZray/stereochemistry(weight( and(XZ( ray/ADP( (atomic( displacement( parameters)(weight(optimization(was(included((see(Chapter(2,(page(80).(((Carbohydrate(was(modeled(at(the(conserved(Asn(394(site(if(appropriate(2FoZFc(density( was( present( at( the( 3σ( contour( level.( The( glycosylation( present( in( the(3HA0(search(model(was(used(as( the( starting(point,( and( in(order( to(do( this,( the(SSM(superposition(function(was(used( in(COOT((Krissinel(and(Henrick,(2004).( In(the(P1(structure((GlcNAc)2(Man)3(was(built(onto(chains(A,(B,(C,(E(and(F,(whereas(
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in(chain(D(no(carbohydrate(was(built,(as(there(was(no(appropriate(2FoZFc(density.(In( the( P21( structure( (GlcNAc)2(Man)4( was( built( onto( chains( A( and( C( and((GlcNAc)2(Man)3(was(built(onto(chains(B(and(D.((Finally(PHENIX(was(used( to( refine(atomic(occupancies.(MolProbity(was(used( to(check( the( structure( (Chen( et# al.,# 2010).( Refinement( statistics( can( be( found( in(Table(7.1.((
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Wilson#B## 42.89( 33.74(Brackets(indicate(highest(resolution(shells(Rsym:((! = ! !!!",!! !!!"!!!" !!!",!!!!" (Rcryst(or(Rfree((! = ! !!"# ! !!"#!!!"# (
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(7.4 Conformation(of(the(NZlinked(carbohydrate(A(branched,(triZ(or(tetraZantennary,(highZmannose(type(carbohydrate(chain(is(NZlinked( to(Asn394( (Arnold(et#al.,( 2004)( in( each(Cε3(domain,( as( seen( in(previous(crystal( structures( of( IgEZFc( and( Fcε3Z4( at( different( resolutions( and( exhibiting(varying( degrees( of( disorder.( A( schematic( of( the( carbohydrate( composition( and(connectivity(of(the(P1(and(P21(structures(is(shown(in((Figure(7.2,(although(there(is(heterogeneity( in( the(overall(mannose(content(and( in( the( length(of( the(branches((Arnold(et#al.,(2004;(Plomp(et#al.,(2014)(in(any(population(of(Fcε3Z4(molecules.(In(the( six( chains( of( the( P1( form,( the( number( of( carbohydrate( units( visible( ranges(from(nothing(to((GlcNAc)2(Man)3,(and(in(the(P21(form,( from((GlcNAc)2(Man)2(to((GlcNAc)2(Man)4.(((
(
#Figure#7.2#Schematic#of#carbohydrate#connectivity Blue(hexagons( represent(GlcNAc,( red(hexagons( represent(Man.(Top(of( each(hexagon( is(atom(1,(numbering(clockwise.(For(example(the(connectivity(between(the(GlcNAc(and(Man(is(a(1Z4(linkage.((




A(remarkable( feature(of(one(of( the(carbohydrate(chains( in( the(P21(crystal( form,(chain( B,( is( that( while( the( terminal( units( are( well( defined,( there( is( almost( no(electron(density(for(the(covalent(connection(of(the(first(GlcNAc(unit(to(Asn394,(or(for(the(immediately(adjacent(aminoZacid(residues(of(the( loop((Figure(7.3A).(The(covalent(connection(between(the(Asn394(and(the(first(GlcNAc(is(well(defined(in(chains(A,(C(and(D((Figure(7.3B).((
(
Figure#7.3#Electron#density#for#carbohydrate#at#Asn394#in#chain#B#and#D#of#




























7.5 Quaternary(structural(comparisons(In(their(earlier(analysis(of(the(quaternary(structural(variation(in(IgEZFc(and(Fcε3Z4,(Wurzburg(and( Jardetzky(defined( two(motions(of( the(Cε3(domains( relative( to(each(other,(an(“opening/closing”(and(a(“swing”((Wurzburg(and(Jardetzky,(2009).(The( Cε4( domain( pair( is( virtually( identical( in( all( structures( and( provides( a(reference(point(for(comparing(the(disposition(of(the(Cε3(domains.((These(authors(defined(two(distance(measurements:(Cα(of(residue(394(of(one(chain((X)(to(Cα497(of(the(other(chain((Y),(and(Cα336(X)(to(Cα336(Y).(These(were(displayed(as(a(2d(plot( (Figure( 1.8).( Here( an( alternative( system( is( described.( ( These( two(measurements(have(been(combined(with(one(measurement(of(the(angle(defined(by(Cα336(X)ZCα497(X)ZCα336(Y)(or(Cα336(Y)ZCα497(Y)ZCα366(X);(each(dimer(will(therefore(have(two(measurements(for(this(angle.(The(rational(for(using(only(one(angle(measurement( is( that( the(actual(movement(of( the(Cε3(domains( is(one(concerted( movement,( encompassing( both( ‘swing’( and( ‘open’( and( ‘closed’(movements(as(defined(by((Wurzburg(and(Jardetzky,(2009).((((This( angle( has( been(measured( for( the( two( structures( presented( here,( the( four(published( Fcε3Z4( structures,( the( apo( Fcε2Z4( structure,( the( Fcε2Z4/sFcεRI(complex,( the( Fcε3Z4/sFcεRI( complex,( the( Fcε3Z4/sCD23( complex,( the( extended(Fcε2Z4/Fab( complex( and( the( DARPin( E2_79/Fcε3Z4( complex( (Figure( 7.5).( This(very( clearly( shows( that( the( FcεRIZbound( structures( are( by( far( the(most( ‘open’(structures.( The( CD23Zbound( structures( are( the( most( ‘closed’( although( there( is(overlap(with(the(uncomplexed(Fcε3Z4(structures.(The(Fcε3Z4(structures,(including(that(with(DARPin(bound,(range(from(‘closed’(to(more(‘open’(but(none(are(as(open(
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7.6 Flexibility(of(the(Cε3(domains(The(new(P1(and(highZresolution(P21(structures(both(showed(disorder(in(the(loops(and(adjoining(βZstrands(of(the(region(of(Cε3(most(distant(from(the(Cε4(domains.(The(two(halves(of(the(Cε3(domain(will(here(be(referred(to(as(the(“NZterminal”(and(“CZterminal”(regions,(as(indicated(in(Figure(7.6.(While(this(has(been(seen(in(other(Fcε3Z4((and(also(some(IgGZFc)(structures,(it(is(particularly(marked(in(the(new(P1(form,(Figure(7.6A.( (This(prompted(an(analysis(of(the(relative(BZfactors(across(all(of(the(Fcε3Z4(and(IgEZFc(structures,(comparing(Cε3(with(Cε4,(and(also(the(NZ(and(CZterminal(regions(of(Cε3.(((In( order( to( compare( BZfactors( from( structures( refined(with( different( protocols(and(at(different(resolutions,(the(values(for(each(chain(or(domain(were(normalised(by(dividing(by(the(average(BZfactor(of(the(structure(in(question((Chapter(2,(page(81).( (This(analysis(revealed((Figure(7.6B)( that( in( the( free(Fcε3Z4(structures,( the(Cε3( domains( consistently( showed( greater( intrinsic( flexibility( than( the( Cε4(domains,( despite( the( range( of( different( crystal( packing( environments.( This(pattern( is( also( seen( in( the( E2_79( DARPinZbound( Fcε3Z4( in( which( the( DARPin(molecules( are(bound( to( the(Cε3(domains.( ( In( the( free( IgEZFc( structure,( and( the(FabZbound( extended( IgE( Fcε2Z4( structure,( the( opposite( effect( is( seen.( In( the(former( case( it( appears( to( be( in( part( due( to( the( stabilising( effect( on( one( Cε3(domain(by( the( (Cε2)2(domain(pair,(which( folds(back(against(one(Cε3(domain( in(the(acutely(bent(structure((Wan(et#al.,(2002);( in( the( latter(case( it( is(presumably(due( to( Fab( stabilisation( (Drinkwater(et#al.,#2014).( The( binding( of( FcεRI( (across(the(NZterminal(regions(of(the(two(Cε3(domains)(and(CD23((between(the(Cε3(and(
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Figure# 7.6# B1factor# analysis# of# Fcε314# shows# differential# flexibility# in# N1

































































































































Fcε3Z4(structure.(The(first(structure(is(in(a(new(crystal(form,(space(group(P1,(and(gives( a( further( six( unique( views( of( an( hFcε3Z4( chain.( The( second( is( the( same(crystal( form( as( previously( published( by( Wurzburg( and( Jardetzky( to( 2.45Å( in(space(group(P21((3H9Z).(((In( the(majority( of( the( carbohydrate( chains( that( have( been(modelled( for( Fcε3Z4(and(Fcε2Z4(there(is(good(protein(backbone(density(for(Asn394(and(surrounding(residues.( For( these( residues( there( is( mostly( good( side( chain( density,( however(density( is( commonly( missing( for( Arg393( and( Lys391.( There( is( clear( density(present( for( the( covalent( connection( and( the( first( and( second( GlcNAc( and( the(density(fades(away(towards(the(end.(The(carbohydrate(built(in(chain(A(of(the(P21(form( is( the( most( extensive( seen( in( hFcε3Z4( or( Fcε2Z4( structures.( The( most(remarkable(observation(is(that(in(chain(B(of(the(P21(structure(the(density(for(the(covalent( connection( to( the( carbohydrate( is( very( poor,( to( the( extent( that( when(building(in(the(carbohydrate,(the(loop(containing(the(Asn394(had(to(be(built(after(the( carbohydrate,( whereas( the( density( for( the( terminal( mannose( units( is( well(defined.(A(similar(observation(but(to(a(lesser(extent(can(be(made(with(chains(A,(C(and(D(of(the(P1(structure(and(chain(F(of(3HA0.(The(reason(for(this(appears(to(be(that(the(carbohydrate(is(‘anchored’(by(its(contacts(with(the(Cε4(domain.(This(can(be( visualised( in( chain( A( of( the( P21( form,(as( the( terminal( mannose( units( make(several( contacts(with( Cε3( and(Cε4( (Figure( 7.4).(Many( of( these( contacts( involve(ordered( water( molecules,( some( of( which( are( involved( in( more( than( one(interaction,(and(all(which(have(well(defined(electron(density.(The(overall(effect(of(this(is(to(produce(a(stable(pocket(in(which(the(carbohydrate(can(be(held.((
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(The(BZfactor(analysis(confirms(that(in(the(Fcε3Z4(apo(structures(the(Cε3(domain(is(more(disordered(than(the(Cε4(domain,(and(within(the(Cε3(domain(the(NZterminal(region( is( more( disordered( than( the( CZterminal( region.( The( same( pattern( is(observed(in(the(E2_79(DARPin/Fcε3Z4(complex.(The(presence(of(the(Cε2(domains(reduces(the(disorder(in(the(Cε3(domains(with(both(the(bent(and(extended(Fcε2Z4(structures,( although( in( the( apo( Fcε2Z4( structure( the(NZterminal( end( of( the( Cε3(domain( still( shows(more( disorder( than( the( CZterminal( end.( The( extended,( FabZbound( Fcε2Z4( structure( shows( the( opposite( effect,( with( the( NZterminal( end(stabilised( by( the( bound( Fab( domains.( As( expected,( the( FcεRIZbound( structure(shows(the(Cε3(to(be(more(ordered(than(the(Cε4,(because(the(binding(site(for(the(FcεRI(is(located(within(the(NZterminal(region(of(the(Cε3(domain.(The(CD23Zbound(structures(show(that(the(Cε3(and(Cε4(domains(are(both(as(ordered(as(each(other,(with(the(NZterminal(end(of(the(Cε3(domain(showing(slightly(more(disorder(than(the(CZterminal(end.(((This( overall( picture( suggests( that( the( Cε2( domains( help( to( stabilise( the( Cε3(domains,( which(may( thus( stabilise( the( Fcε2Z4/FcεRI( interaction.( This( evidence(helps( to(explain( the( finding( that( the(offZrate( for( the(dissociation(of(Fcε3Z4( from(FcεRI( is( an( order( of( magnitude( faster( than( the( offZrate( for( the( dissociation( of(Fcε2Z4( from( FcεRI,( as( the( Cε2( domains( are( acting( to( stabilise( the( Cε3( and(therefore( the( FcεRI( binding( site.( The( stabilisation( of( the( Cε3( domains( prior( to(FcεRI( binding( will( also( reduce( the( entropic( penalty( of( the( formation( of( the(complex.( The( CD23( binding( site( is( located( at( the( CZterminal( end( of( the( Cε3(
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domain(at(the(junction(with(Cε4,(and(so(it(is(therefore(unsurprising(that,(despite(the(absence(of(the(Cε2(domains(in(the(crystal(structure,(the(Cε3(and(Cε4(domains(are(similarly(ordered.( It( is(also(unsurprising( that( the(NZterminal(end(of( the(Cε3(domain(shows(more(disorder(than(the(CZterminal(end( in(view(of( the( location(of(the(CD23(binding(site.((The(movements(of( the(Cε3(domains( in(relation(to(the(Cε4(domains(have(always(been(hard( to(define,(as( it( is(not(as(simple(as(an( ‘open’(or( ‘closed’(conformation,(because( as( the( domains( ‘close’( they( also( ‘swing’( past( each( other.( As( described(above,(Wurzburg(and(Jardetzky(used(two(separate(measurements(combined(into(a( 2d( plot( to( illustrate( both( the( ‘open’( and( ‘closed( changes( and( the( ‘swing’(movement.(They(propose(that(the(X336ZY336(distance(is(a(good(measurement(of(the(‘swing’(motion(of(the(domains,(as(these(are(the(NZterminal(residues(in(the(Cε3(domain(and(that(the(X336ZX497(distance(is(a(good(measurement(of(how(‘open’(or(‘closed’(the(domain(is,(as(residue(497(is(located(on(the(Cε4(domain(in(the(region(that( interfaces( with( the( other( Cε4( domain.( Since( the( movement( of( the( Cε3(domains( is( a( single,( concerted( conformational( change,( it( was( decided( to(encompass(both(aspects(in(a(single(measurement.(Instead(of(these(two(distances(it(is(proposed(that(one(angle,(measured(between(the(X336ZX497ZY336(takes(into(account(the(‘open’(and(‘closed’(motion,(as(well(as(the(‘swing’.(((When( this(angle( is(measured( in(all(of( the( IgE( fragments(a(much(clearer(pattern(emerges.(The(FcεRI(bound(structures(are( the(most( ‘open’(and(with( the(greatest(‘swing’(whereas(the(CD23Zbound,(DARPinZbound,(FabZbound(and(apo(structures(
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are(all(more( ‘closed’(and( ‘swing’( the( least.(There( is(not(much(variation(between(the(four(chains(analysed(for(the(FcεRIZbound(and(the(six(chains(analysed(for(the(CD23Zbound(structures.(The(hFcε2Z4(structure(and(the(FabZbound(structure(lie(in(the(middle(of(the(range(and,(as(with(the(FcεRIZbound(and(CD23Zbound(structures,(there( is( not( much( variation( within( the( chains.( The( apo( hFcε3Z4( structures,(however,( show( great( variation,( some( within( the( same( structure.( Some( of( the(chains(are(even(more( ‘closed’(than(the(CD23Zbound(structure,(but(none(of(them(even(come(close(to(being(as(‘open’(as(the(FcεRIZbound(structures.(The(bend(in(the(Cε2(domain( appears( to(make(no(difference( to( the( ‘opening’( and( ‘closing’( of( the(Cε3(domains,(which(is(perhaps(somewhat(surprising(as(the(Cε2(domains(stabilise(the(Fcε2Z4/sFcεRI(complex.(It(is(clear(that(they(do(not(do(this(by(‘opening’(up(the(Cε3(domains,(and(it(is(more(likely(to(be(due(to(stabilising(the(Cε3(domains.((The( two( crystal( structures( determined( add( important( information( to( our(knowledge(of( the(Fcε3Z4(region(of( IgE.(The(P21(structure(shows(unprecedented(detail(for(the(carbohydrate,(revealing(that(is(able(to(make(contacts(with(both(the(Cε3( and( Cε4( domains,( an( aspect( that( has( never( been( seen( before( in( an( IgE(structure.( The( P1( structure( is( a( new( crystal( form( that( gives( us( a( further( six(independent( views( of( the( Fcε3Z4( chains,( in( new( crystal( packing( environments.(The( BZfactor( analysis( reveals( the( relative( flexibility( of( the( Cε3( domains( and(supports(the(idea(that(the(Cε2(domains(slow(the(dissociation(rate(of(FcεRI(from(Fcε2Z4( because( they( enhance( the( overall( stabilisation( of( the( Cε3( domains.(
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Chapter(8 FINAL(DISCUSSION((The(aim(of( this( thesis( is( to(explore( the(evolution(of( the( structure(of(human( IgE(and(its(unique(receptor(binding(properties.(This(was(attempted(from(two(angles.(Firstly,( the( structures( of( evolutionarily( related( proteins( of( interest( i.e.( platypus(IgE,( chicken( IgY( and( human( IgM( were( studied.( Purification( protocols( were(developed(and(the(proteins(were(successfully(crystallised.(Their(thermal(stability(was( analysed( using( DSF( for( comparison( with( human( IgE.( Secondly( two( new(crystal(structures(of(human(Fcε3Z4(were(determined,(one(of(which(was(at(1.92Å(resolution,( the(highest(yet( seen( for(an(Fcε3Z4( structure.(The(overall(quaternary(structure( and( intrinsic( flexibility( of( the( Cε3( domains( of( these( structures,( along(with( all( other( IgE( structures( published,( were( examined.( A( new( method( for(analysing( the( quaternary( structures( was( developed( revealing( insights( into(receptor(binding.((Various(constructs(of(the(evolutionarily(related(proteins(platypus(IgE,(human(IgM(and(chicken(IgY(were(designed(for(purification.(The(constructs(consisted(of(the(Fc(domain(of(the(protein,(either(the(CH2ZCH4(domains(or(the(CH3ZCH4(domains.(The(constructs( retained( the( conserved( glycosylation( site( but( all( other( glycosylation(sites(were(removed(in(order(to(produce(more(homogenous(protein(preparations.(Purification,(both(with(and(without(a((His)6Ztag,(were(successfully(developed(and(optimised.(The(proteins(were(shown(to(be(pure(by(SDSZPAGE(analysis.(Proteins(produced(from(method(2((cFcυ2Z4His,(hFcµ2Z4His,(hFcµ3Z4His(and(pFcε2Z4His)(were(analysed( by(MS( and( although( individual( glycoforms( could( not( be( resolved,( for(
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each( protein( the( molecular( weights( calculated( were( consistent( with( a(glycosylated(protein(of(the(molecular(weight(expected.((To(produce(crystals(of(Fc(fragments(of(human(IgM,(platypus(IgE(and(chicken(IgY,(commercial( screens( were( set( up( and( initial( conditions( discovered.( For( each( of(these(proteins,(crystals(were(successfully(produced,(however(the(crystals(did(not(diffract( to(high(enough(resolution( for(structural(determination.(These(hits(were(extensively( optimised( using( a( combination( of( altering( the( crystal( growth(conditions( and( a(wide( range( of( postZcrystallisation( treatments.( Very( significant(steps(have(been(taken(with(the(crystallisation(of(all(three(proteins.(For(platypus(IgEZFc( the( best( crystals( diffracted( to( 12Å,( for( human( IgMZFc( the( best( crystals(diffracted( to( 4.5Å( and( for( chicken( IgYZFc( the( best( crystals( diffracted( to( 7Å(resolution.((The(resolution( for( the( IgMZFc(data( is(on( the(borderline( for(a(structure(solution.(Six( datasets,(which( had( data( that( extended( to( between( 4.5Z6Å( resolution,(were(combined.( Extensive( attempts( were( made( to( determine( the( crystal( structure(using( molecular( replacement.( The( IgMZFc( was( discovered( to( be( hexameric,(suggesting( that( hexamer( formation( occurs( in( the( absence( of( the( tailpiece( in(human( IgMZFc.( The( packing( of( the( unit( cell( was( successfully( predicted( and(allowed( a( partial( solution( to( be( found,( with( the( location( of( the( Cµ4( domains.(There( is(space(within(the(unit(cell( for(the(Cµ3(and(Cµ2(domains,(and(promising(electron(density(for(at(least(the(Cµ3(domains.(Work(is(onZgoing(to(determine(the(crystal(structure(using(these(datasets.((
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The(thermal(unfolding(of(the(proteins(of(interest(was(explored(as(this(provides(an(insight(into(the(stability(of(the(protein(being(studied.(Human(IgE(has(a(uniquely(low(melting(temperature(compared(with(other(antibodies.(Despite(being(the(site(for(both(FcεRI(and(CD23(binding,(the(Cε3(domain(is(the(least(thermodynamically(stable(part(of(the(molecule.((It(has(been(shown(here( that( the( thermal(unfolding(of(human(IgEZFc(occurs(as(a(twoZstep(process(with(the(Fcε3Z4(domains(unfolding(cooperatively(at(52°C,(Tm1,(and( the( Cε2( domains( unfolding( at( 64°C,( Tm2.( In( the( presence( of( urea( a( similar(pattern( is( seen.(The( thermal(unfolding(of( platypus( IgEZFc( also(occurs( as( a( twoZstep(process( although( the(melting( temperatures( are(higher,(with(Tm1(58°C(and(Tm2( 67°C.( This( shows( that( all( the( domains( of( platypus( IgEZFc( are( more(thermodynamically(stable(than(those(of(human(IgEZFc,(supporting(the(theory(that(human( IgEZFc,( and( the( Cε3( domain( in( particular,( has( become( more( thermally(labile(through(evolution.(((In(the(absence(of(urea,(chicken(IgYZFc(shows(a(oneZstep(unfolding(with(a(Tm1(of(71°C,( and( cFcυ3Z4( also( shows( a( oneZstep( unfolding( with( a( Tm1( of( 73°C.( This(suggests(that(the(Cυ2ZCυ4(domains(are(unfolding(cooperatively,(similar(to(what(is(observed( here( with( bovine( IgGZFc( and( as( reported( by( other( for( hIgGZFc((Demarest( et# al.,# 2006).( The( IgYZFc( is( much( more( thermally( stable( than( both(platypus( and( human( IgEZFc.( However,( in( the( presence( of( increasing(concentrations(of(urea,(there(is(some(evidence(for(twoZstep(unfolding,(suggesting(that( the( urea( is( discouraging( cooperative( unfolding( of( the( Cυ2ZCυ4( domains.(
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Nevertheless,(the(substantially(greater(thermostability(of(the(cIgYZFc(is(consistent(with(the(idea(that(hIgE(has(become(more(thermally(labile(during(evolution.((Looking(now(at(IgMZFc,(the(most(primitive(of(all(the(antibodies,(it(is(shown(here(that( in( the( absence( of( urea,( IgMZFc( undergoes(weak( twoZstep( unfolding(with( a(Tm1(of(54°C(and(a(Tm2(of(72°C.(The( former(value( is( similar( to( the(unfolding(of(hFcε3Z4(and( the( latter( is( similar( to( cFcυ2Z4(and(bFcγ2Z3.( In( contrast( to(what( is(seen( with( the( chicken( IgYZFc,( in( the( presence( of( urea( the( twoZstep( unfolding(behaviour( disappears,( suggesting( that( the( urea( is( encouraging( the( Cµ2ZCµ4(domains(to(unfold(more(cooperatively.((From(an(evolutionarily(perspective( these( results( suggest( that(when(an( IgMZlike(molecule( emerged( as( the( first( antibody,( the( CH3ZCH4( domains( may( have( been(primarily(stabilised(by(forming(pentamers/hexamers.(The(analysis(of(the(thermal(stability( of( human( IgMZFc( and(hFcµ3Z4(was(performed(using( fragments( lacking(both(the( tailpiece(and(only(containing(a(pair(of(Fc(chains.( In( its(native(state( the(Cµ4(domains(are(connected(by(disulphide(bridges( in( the( tailpiece,(and(between(the(Cµ3(domains,(allowing(stabilisation(of(the(Fcµ3Z4(domains.(This(could(be(an(explanation(as(to(why,(with(these(connections(removed,(the(Fcµ3Z4(shows(a(very(low(melting( temperature,( whereas( with( the( Cµ2( domains( present,( the( melting(temperature(is(more(comparable(to(IgG.(An(IgYZlike(molecule(is(thought(to(have(evolved(next( from( IgM,( and( this( is( reflected( in( the(high( thermal( stability( of( the(chicken(IgY(fragments(studied(here.(The(subsequent(divergence(of(IgY(leading(to(IgG( and( IgE,( by( gene( duplication( of( IgY,( saw( IgG( retaining( the( high( thermal(
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stability(of(IgY,(but(IgE(losing(it.(Platypus(IgE,(as(an(example(of(an(evolutionarily(primitive( IgE( molecule,( shows( higher( thermal( stability( than( the( human( IgE,(consistent(with(the(idea(that(the(IgE(molecule(has(become(more(thermally(labile(through(evolution.((The( analysis( of( the( intrinsic( flexibility( and( quaternary( structures( of( the( human(Cε3( domains( in( the( newly( determined( and( earlier( IgEZFc( and( Fcε3Z4( crystal(structures(confirms(that(they(are(very(flexible(and(that(they(are(stabilised(by(the(Cε2(domains,(although(it(is(not(necessarily(the(bent(structure(that(is(causing(this(stabilisation.(The(Cε2(domain(stabilisation(of(the(Cε3(domains(is(what(causes(the(uniquely(slow(dissociation(rate(of(IgE(from(FcεRI.((The(BZfactor( analysis( showed( that( in( the( apo(Fcε3Z4(and( in( the(DARPin/Fcε3Z4(complex( crystal( structures( the( Cε3( domains( are(more( disordered( than( the( Cε4(domains.( In( particular( the( NZterminal( region( of( the( Cε3( domains( are( more(disordered(than(the(CZterminal(region.(The(presence(of(the(Cε2(domains,(as(with(both( the( bent( and( extended( Fcε2Z4( structures,( reduces( the( disorder( of( the( Cε3(domains.( Within( the( Cε3( domains( the( Fcε2Z4( apo( structure( follows( the( same(pattern(as(the(apo(Fcε3Z4(structures(with(the(NZterminal(region(displaying(more(disorder( than( the( CZterminal( end.( Conversely,( the( extended( FabZbound( Fcε2Z4(structure(displays(higher(disorder( in( the(CZterminal(regions(of( the(Cε3(domains(than(the(NZterminal(regions,(although(this(can(be(explained(by(the(presence(of(the(Fab( domains.(Upon( FcεRI( binding,( the( Cε3(domains( are( stabilised(with( the( Cε4(domains(showing(relatively(more(disorder.(Upon(CD23(binding(both(the(Cε3(and(
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Cε4(domains(are(stabilised(equally.(Thus(the(Cε3(domain(appears(to(be(primarily(stabilised(only(by(receptor(binding,(since(in(the(apo(Fcε2Z4(even(the(presence(of(the(Cε2(domains,(despite(an(overall(stabilising(effect(on(Cε3,(does(not(stabilise(the(NZterminal( region( of( the( domain.( FcεRI( binding( opens( up( the( IgE( molecule,(whereas(CD23(binding(closes(it.(The(apo(structures(can(be(as(closed(as(the(CD23(bound(structure,(but(are(never(as(open(as(the(FcεRI(structure.(This(suggests(that(the(FcεRI(has(to(bind(in(order(for(IgE(to(form(the(‘open’(conformation.((The( two( new( crystal( structures( of( human( Fcε3Z4( provide( 6( new( and( unique(chains( for( analysis( in( the( P1( structure,( and( unprecedented( detail( for(carbohydrate(in(any(IgE(structure(in(the(P21(crystal(form.(((In(chain(A(of(the(P21(structure,(several(contacts(can(been(seen(between(the(highZmannose(type(carbohydrate(and(the(Cε4(domain(of( the(protein,(despite( the( fact(that( the( covalent( linkage( occurs( within( the( Cε3( domain.( The( carbohydrate(appears(to(be(stabilised(in(a(pocket(in(the(Cε4(domain,(with(few(contacts(with(the(protein(around(the(covalent(linkage.(In(fact,(in(chain(B(of(the(P21(structure(there(is( extremely( poor( electron( density( for( the( covalent( connection( between( the(protein( at( Asn394( with( the( carbohydrate,( despite( excellent( density( for( the(carbohydrate( itself.( This( further( supports( the( idea(of( the( carbohydrate( is( being(stabilised(by(its(contact(with(the(Cε4(domains(rather(than(the(Cε3(domains.(In(IgG(the(carbohydrate(is(of(the(complex(type(and(it(lies(across(a(hydrophobic(patch(on(the(Cγ2((homologous(to(Cε3)(domains.(When(this(carbohydrate(is(removed(from(IgG,(binding(activity(to(FcγR(is(lost.(In(IgE(removal(of(this(carbohydrate(has(little(
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or(no(effect(on(FcεRI(binding.(It(may(be(suggested(that(the(lack(of(carbohydrate(contact( with( the( human( IgE( polypeptide( in( Cε3( may( contribute( to( its( high(thermodynamic(instability.(This(carbohydrate(is(present(in(human(IgM,(platypus(IgE( and( chicken( IgY.( In( chicken( IgY( and( human( IgM( it( is( known( that( the(carbohydrate( is( of( the( highZmannose( type( (Arnold( et# al.,# 2005;( Kondo( et# al.,#2012).(If(this(hypothesis(is(correct,(the(carbohydrate(in(chicken(IgY(should(make(contact(with(the(Cυ3(domains,(similar(to(the(situation(with(IgG,(as(indeed(it(does(in( the(Fcυ3Z4(crystal(structure((Taylor(et#al.,(2009).( It( is(hard(to(predict(exactly(what( would( happen( with( the( carbohydrate( in( the( platypus( IgE,( but( it( might(perhaps(be(an(intermediate(between(chicken(IgY(and(human(IgE.((In( conclusion,( evidence( is( presented( here( that( demonstrates( that( human( IgE( is(less(thermally(stable(than(the(oldest(extant(IgE,(i.e.(platypus(IgE,(and(before(that(IgY;(this(suggest(that(human(IgE,(in(particular(the(Cε3(domains,(is(becoming(more(‘unstable’(during(evolution.(Examination(of( the( intrinsic( flexibility(of( the(human(Cε3(domains( shows( that( evolution(has( supported( the( intrinsic( instability(of( the(Cε3( domains,( and( allowed( the( protein( to( be( stabilised( by( the( Cε2( domains.( In(constrast( in( IgG( the( equivalent( of( the( ‘Cε2’( domains( are( absent,( replaced( by( a(flexible( hinge( region,( and( the( domain( homologous( to( the( Cε3( domains,( Cγ2,( is(intrinsically(stable.(The(conserved(carbohydrate,(despite(being(covalently(linked(to(the(Cε3(domains,(appears(to(be(stabilised(by(contact(with(Cε4(rather(than(Cε3.(The( bent( structure( is( thought( to( be( important( for( stabilising( the( Cε3( domains,(however,( from( analysis( of( the( bent( and( extended( structures( of( IgE,( the( Cε3(domains(are(not(significantly(different( from(each(other,(suggesting(that( it( is( the(
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presence( of( the( Cε2( domains,( rather( than( the( bend( itself,( which( is( acting( to(stabilise(the(Cε3(domains.(Therefore(human(IgE(has(inherent(instability(in(its(Cε3(domains,( which( has( valuable( functional( properties,( namely,( coping( with( two(receptorZbinding( activities( at( different( sites( in( Cε3,( with( allosteric( interaction(between( the( two( sites,( and(different(quaternary( structural( arrangements(of( the(Cε3( domains( in( the( two( receptor( complexes.( Structures( for( IgMZFc,( IgYZFc( and(platypus( IgEZFc( will( in( due( course( further( test( this( hypothesis( and( enable( the(evolution(of(the(structure(and(function(of(the(antibody(molecule(to(be(traced.((
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correct IgM V-4   1 MSVSFLIFLPVLGLPWGVLSQVQLQQSGPGLVKPAQTLSLTCAISGDSVSSNSATWNWIR  60 
old {incorrect}   1 --------------------EVTLTESGPALVKPKQPLTLTCTFSGFSLSTSRMRVSWIR  40 
                                        .* * .*** **** * *.***. ** *.*.      *** 
 
correct IgM V-4  61 QSPLRGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCA 120 
old {incorrect}  41 RPPGKALEWLARINNNDKFY--WSTSLRTRLSISKNDSKNQVVLIMLNVNPVDTATYYCA  98 
                    . * . **** *     * *   . *...*..*    ****  * .  *.* *** **** 
 
correct IgM V-4 121 REN--YYGSGRYNWFDPWGQGTLVTVSSGSASAPTLFPLVSCENSPSDTSSVAVGCLAQD 178 
old {incorrect}  99 RVVNSVMAGYYYYYMDVWGLGTTVTVSSGSASAPTLFPLVSCENS-DPSSTVAVGCLAQD 157 
                    *          *   * ** ** **********************   .*.********* 
 
correct IgM V-4 179 FLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYAATSQVLLPSKDVMQGTDEHVVCKVQH 238 
old {incorrect} 158 FLPDSITFSWKYKNNSDISSTRGFPSVLRGGKYAATSQVLLPSKDVMQGTDEHVCKWVQH 217 
                    ******************************************************   *** 
 
correct IgM V-4 239 PNGNKEKNVPLPVIAELPPKVSVFVPPRDGFFGNPRKSKLICQATGFSPRQIQVSWLREG 298 
old {incorrect} 218 PNGDKEKDVPLPVIAELPPKVSVFVPPRDGFFGDPRKSKLICQATGFSPR--QVWSLREG 275 
                    *** *** ************************* ****************  **  **** 
 
correct IgM V-4 299 KQVGSGVTTDQVQAEAKESGPTTYKVTSTLTIKESDWLSQSMFTCRVDHRGLTFQQNASS 358 
old {incorrect} 276 KQVGSGVTTDQVQAEAKESGPTTYKVTSTLTIKESDWLSQSMFTCRVDHRGLTFQQNASS 335 
                    ************************************************************ 
 
correct IgM V-4 359 MCVPDQDTAIRVFAIPPSFASIFLTKSTKLTCLVTDLTTYDSVTISWTRQNGEAVKTHTN 418 
old {incorrect} 336 MCGPDQDTAIRVFAIPPSFASIFLTKSTKLTCLVTDLTTYDSVTISWTRQNGEAVKTHTN 395 
                    ** ********************************************************* 
 
correct IgM V-4 419 ISESHPNATFSAVGEASICEDDWNSGERFTCTVTHTDLPSPLKQTISRPKGVALHRPDVY 478 
old {incorrect} 396 ISESHPNATFSAVGEASICEDDWNSGERFTCTVTHTDLPSPLKQTISRPKGVALHRPDVY 455 
                    ************************************************************ 
 
correct IgM V-4 479 LLPPAREQLNLRESATITCLVTGFSPADVFVQWMQRGQPLSPEKYVTSAPMPEPQAPGRY 538 
old {incorrect} 456 LLPPAREQLNLRESATITCLVTGFSPADVFVQWMQRGQPLSPEKYVTSAPMPEPQAPGRY 515 
                    ************************************************************ 
 
correct IgM V-4 539 FAHSILTVSEEEWNTGETYTCVVAHEALPNRVTERTVDKSTGKPTLYNVSLVMSDTAGTC 598 
old {incorrect} 516 FAHSILTVSEEEWNTGETYTCVVAHEALPNRVTERTVDKSTGKPTLYNVSLVMSDTAGTC 575 
                    ************************************************************ 
 
correct IgM V-4 599 Y 599 





OLD {Incorrect}   1 -----------------SQVQLVQSGAEVRKPGASVRVSCKASGYTFIDSYVGWIRQAPG  43 
human IgE V-Ce4   1 MDWTWILFLVAAATRVHSQTQLVQSGAEVRKPGASVRVSCKASGYTFIDSYIHWIRQAPG  60 
                                     ** *******************************. ******* 
 
OLD {Incorrect}  44 HGLEWIHWINPNSGGTNYAPRFQGRVTMTRDASFSTAYMDLRSLRSDDSAVFYCAKSNPF 103 
human IgE V-Ce4  61 HGLEWVGWINPNSGGTNYAPRFQGRVTMTRDASFSTAYMDLRSLRSDDSAVFYCAKSDPF 120 
                    *****. ************************************************** ** 
 
OLD {Incorrect} 104 YSN-YNFNYSSSQ----QGTEVTYTVSGAYTLPVFPLTRCCKNIPSNATSVTLGCLATGY 158 
human IgE V-Ce4 121 WSDYYNFDYSYTLDVWGQGTTVTVSSASTQSPSVFPLTRCCKNIPSNATSVTLGCLATGY 180 
                     *  *** ** .     *** ** . . . .  *************************** 
 
OLD {Incorrect} 159 FPEPVMVTWNTGSLNGT--TLPATTLTLSGHYATISLLTVSGAWAKQMFTCRVAHTPSST 216 
human IgE V-Ce4 181 FPEPVMVTWDTGSLNGTTMTLPATTLTLSGHYATISLLTVSGAWAKQMFTCRVAHTPSST 240 
                    ********* *******  ***************************************** 
 
OLD {Incorrect} 217 --VNNKTFSVCSRDFTPPTVKILQSSCNGLGHFPPTIEL-CLVSGYTPGTINITWLQNGQ 273 
human IgE V-Ce4 241 DWVDNKTFSVCSRDFTPPTVKILQSSCDGGGHFPPTIQLLCLVSGYTPGTINITWLEDGQ 300 
                      * *********************** * *******.* ****************. ** 
 
OLD {Incorrect} 274 VMDVDLSTASTESQGELASTESQLTLSQKHWLSDRTYTCQVTYQGHTFQDSTKKCADSNP 333 
human IgE V-Ce4 301 VMDVDLSTASTTQEGELASTQSELTLSQKHWLSDRTYTCQVTYQGHTFEDSTKKCADSNP 360 
                    ***********  .******.*.*************************.*********** 
 
OLD {Incorrect} 334 RGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRKEEKQR 393 
human IgE V-Ce4 361 RGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRKEEKQR 420 
                    ************************************************************ 
 
OLD {Incorrect} 394 NGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAFATPEW 453 
human IgE V-Ce4 421 NGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAFATPEW 480 
                    ************************************************************ 
 
OLD {Incorrect} 454 PGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSRLEVTR 513 
human IgE V-Ce4 481 PGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSRLEVTR 540 
                    ************************************************************ 
 
OLD {Incorrect} 514 AEWQEKDEFICRAVHEAASPSQTVQRAVSVNPGK 547 
human IgE V-Ce4 541 AEWEQKDEFICRAVHEAASPSQTVQRAVSVNPGK 574 
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